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ABSTRACT 
 
Fluorescent-Detected Retrotranslocation of an Endoplasmic Reticulum-Associated 
Degradation (ERAD) Substrate in a Mammalian In Vitro System. (December 2007) 
Judit Wahlman, B.S., University of Western Ontario 
Chair of Advisory Committee: Dr. Arthur E. Johnson 
 
Secretory proteins that are unable to assemble into native proteins in the endoplasmic 
reticulum (ER) are transported back into the cytosol for degradation. Many cytosolic and 
ER resident proteins have been identified so far as being involved in this 
retrotranslocation process, but it is difficult to determine whether these proteins have a 
direct or indirect effect. Interpretations are further complicated if the loss of a specific 
protein is obscured by the presence of another protein that is partially or wholly 
redundant. To overcome these limitations, a mammalian in vitro system was developed 
that allowed to monitor retrotranslocation synchronously and in real time in the absence 
of concurrent translocation.  
To examine the roles of different components in ER-associated degradation (ERAD), 
well-defined and homogeneous mammalian ER microsomes were prepared 
biochemically by encapsulating a fluorescent-labeled ERAD substrate with specific 
lumenal components. After mixing ATP, specific cytosolic proteins, and specific 
fluorescence quenching agents with microsomes, substrate retrotranslocation was 
initiated. The rate of substrate efflux from microsomes was monitored spectroscopically 
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and continuously in real time by the reduction in fluorescence intensity as the fluorescent 
substrates passed through the ER membrane and were exposed to the quenching agents. 
Retrotranslocation kinetics were not significantly altered by replacing all lumenal 
proteins with only protein disulfide isomerase, or all cytosolic proteins with only the 19S 
proteasome cap. Retrotranslocation was blocked by affinity-purified antibodies against 
Derlin1, but not by affinity-purified antibodies against Sec61α or by membrane-bound 
ribosomes. Since the substrate also photocrosslinked Derlin1, but not Sec61α or TRAM, 
retrotranslocation of this ERAD substrate apparently involves Derlin1, but not the 
translocon. By labeling either the C- or N-terminus, it was revealed that the N-terminus 
of one ERAD substrate leaves the ER lumen first. This finding suggests that the protein 
is retrotranslocated as a linear polymer in a preferred direction. 
When RRMs were reconstituted with a fluorescent-labeled ERAD substrate and 
various ions. Ca2+ ions in the ER lumen increased the rate and extent of 
retrotranslocation, while Ca2+ ions in the cytosol decreased retrotranslocation. This 
approach therefore provides the first direct evidence of the involvement and importance 
of specific ionic requirements for ERAD. 
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CHAPTER I 
INTRODUCTION 
Protein sorting at the endoplasmic reticulum membrane 
In eukaryotic cell, genes located on a double-stranded DNA in the nucleus encode 
the vast majority of cellular proteins. According to Crick’s central dogma, RNA is made 
from the DNA template by transcription and protein from the messenger RNA by 
translation. Proteins are composed of amino acids and each of them is encoded by three 
base pairs. There are twenty amino acids and sixty-four possible code words, out of 
which three are stop codons (Palade, 1975). Proteins are synthesized by ribosomes, 
which are two-thirds RNA and one-third protein.  There is a small and a large subunit in 
each ribosome, where the small subunit binds the mRNA and the large subunit contains 
two binding sites for tRNA. The transfer tRNA carries the appropriate amino acid that 
will be attached to the growing polypeptide when the anticodon of the tRNA recognizes 
the codon on the mRNA (Moore and Steitz, 2003). 
Most protein synthesis occurs in the cytosol of the cell and the synthesized protein 
either remains cytosolic or directed to a specific compartment. For example, both 
secretory and membrane proteins are targeted to the endoplasmic reticulum (ER) 
(Berridge, 2002). These proteins are transported across or integrated into the ER 
membrane at sites called translocons. 
 
____________ 
This dissertation follows the style of Cell. 
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Figure 1. Schematic representation of a eukaryotic cell. Living organisms are composed of cells, which 
typically range from 5-30 µm in animals and 10-100 µm in plants. The eukaryotic cell encloses several 
organelles with distinct functions that are separated from one another by a tightly sealed lipid bilayer. 
These compartments include the cytosol, smooth and rough endoplasmic reticulum (ER), Golgi complex, 
nucleus, mitochondrion, free ribosomes, peroxisome, and lysosome. The figure was downloaded from 
http://nobelprize.org/nobel_prizes/medicine/laureates/1999/illpres/index.html. 
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The endoplasmic reticulum 
The ER is an important eukaryotic cell compartment with specialized folding 
apparatus (Fig. 1). While mitochondria and chloroplasts may have evolved by 
endosymbiosis, the periplasm of gram-negative bacteria is perhaps the precursor of the 
ER. The periplasm of the gram-negative bacteria performs the folding and processing of 
the outer membrane proteins. Hence, it contributes to the maintenance of the outer 
membrane that separates the bacteria from its surroundings (Keenan et al., 2001). The 
ER similarly can be termed as a protein folding and processing factory of those proteins 
that reside in the plasma membrane, or in membranous organellar compartments, or are 
secreted into the extracellular medium.  
In yeast, the ER processes almost one-third of the total proteins synthesized 
(Ghaemmaghami et al., 2003). These proteins eventually leave the ER (unless they are 
resident ER proteins) through the secretory pathway (ER-Golgi-plasma membrane) 
(Figs. 1 and 11) (Helenius et al., 1992). The ER is also the organelle where most of the 
membrane lipids are made for the cell (de Kroon et al., 2003). These newly-synthesized 
lipids and properly-folded proteins normally depart from the ER by vesicular transport 
through the Golgi to their final destination (Watson and Stephens, 2005). Mitochondria 
may receive its membrane lipids through direct contact sites with the ER (Schneiter, 
2007). Other organelles, such as peroxisomes, might obtain some of their membrane 
proteins through the ER  (Fig. 1) (Geuze et al., 2003). 
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Targeting to the ER membrane 
Proteins have to traverse lipid bilayers to travel from one cellular compartment to 
another. This process is usually accomplished via a membrane protein complex, the 
translocation or translocon pore, which is an aqueous channel (Johnson and van Waes, 
1999). Newly-synthesized mammalian proteins enter the ER lumen or integrate into the 
ER membrane via the translocon co-translationally, at the same time that the protein is 
being synthesized by a membrane-bound ribosome. However, yeast imports the majority 
of its proteins post-translationally into the ER. 
Proteins are directed to the translocon by a 17-35-residue signal sequence at the N-
terminus. The largely hydrophobic signal sequence in a ribosome-nascent chain complex 
(RNC) binds to the signal recognition particle (SRP) (Flanagan et al., 2003), which in 
turn binds to the SRP receptor in the ER membrane. The SRP-SRP receptor interactions 
therefore target the signal sequence-containing RNC to a translocon in the ER 
membrane. Both the SRP and the SRP receptor are GTPases, and upon GTP hydrolysis 
the SRP releases the signal-sequence. Following nascent chain transferal to the 
translocon, the nascent protein translocates into the ER lumen or integrates into the 
membrane while it is still being synthesized by a ribosome (Fig. 2) (Egea et al., 2005; 
Keenan et al., 2001; Walter et al., 2000).   
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Figure 2. Current view of co-translational protein synthesis at the ER membrane. When the signal 
sequence emerges from the ribosome, it binds to the signal recognition particle (SRP). The SRP-ribosome 
complex is then targeted to the SRP receptor and the ribosome docks on the translocon. The nascent 
polypeptide is transferred to the translocon and translocated into the ER lumen and the SRP dissociates 
from its receptor following GTP hydrolysis. The signal peptide is cleaved off the growing nascent chain in 
the ER lumen by the signal peptidase (SP). The figure was downloaded from 
http://nobelprize.org/nobel_prizes/medicine/laureates/1999/illpres/index.html. 
  
The translocon 
Many scientific studies have examined the molecular mechanism of translocation 
through the ER membrane. These studies have established that the translocation process 
involves a core heterotrimeric membrane protein complex that is well conserved from 
bacteria to human (Johnson and van Waes, 1999). The translocon forms an aqueous 
channel that allows the newly synthesized protein to pass through the ER membrane 
(Crowley et al., 1994).  
 
 
 6
The largest component of the heterotrimeric Sec61/SecY translocon is the α-subunit, 
named Sec61α in higher eukaryotes, Sec61p in yeast, and SecY in bacteria. This protein 
has ten transmembrane segments, and both of its termini are in the cytosol. The β-
subunit with one transmembrane segment is called Sec61β in mammals, and Sbh1p in 
yeast, Secβ in archaea, while SecG in eubacteria with two transmembrane segments. The 
γ-subunit spans the membrane once and is called Sec61γ in mammals, Sss1p in yeast, 
and SecE in eubacteria and archaea (Osborne et al., 2005). 
Calcium homeostasis in the ER 
A dynamic Ca2+ storage and cell signaling are amongst the many roles of the ER 
(Berridge, 2002). The ER can receive and release multiple signals, including 
intracellular messengers such as Ca2+, inositol 1,4,5- triphosphate, reactive oxygen 
species, sphingosine-1-phosphate, and sterols (Gorlach et al., 2006). For example, the 
ER participates in removing excess Ca2+ ions from the cytoplasm after cellular activation 
(Verkhratsky and Petersen, 2002). The concentration of Ca2+ in the ER lumen is a 
thousand times greater then in the cytoplasm (Ca2+ ER : 100-800 µM, Ca2+ Cytosol : 0.1-1 
µM) (Fig. 3) (Demaurex and Frieden, 2003; Mogami et al., 1999) (Fig. 3). 
The major functions of the ER influence each other, since an increase in the amount 
of misfolded proteins within the ER can change Ca2+ homeostasis, while variations in the 
lumenal Ca2+ content can disturb proper protein synthesis (Burdakov et al., 2005). The 
role of Ca2+- binding proteins in the ER is important, since some of them (calreticulin, 
calnexin, BiP etc.) require Ca2+ for their activity (Llewelyn Roderick et al., 1998). If the 
[Ca2+] falls below ~50 µM in the ER lumen, the chaperone activity of these proteins may 
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be completely inhibited (Corbett and Michalak, 2000). Disturbance in Ca2+ homeostasis 
can trigger ER stress that ultimately can result in cell death (Groenendyk and Michalak, 
2005). Additionally, the majority of ER chaperones and folding enzymes have a low 
affinity and high capacity for Ca2+ ions thereby serving as a passive storage (Brostrom 
and Brostrom, 2003). When Ca2+ ions were depleted from the ER, glycoprotein 
processing was inhibited. These glycoproteins remained in the high mannose 
configuration (Cooper et al., 1997). The unprocessed glycoproteins are then recognized 
by the ER quality control apparatus and retained within the ER. If the proper Ca2+ 
content is restored in these cells, these retained proteins can traffic towards the Golgi 
(Helenius and Aebi, 2004; Parodi, 2000). Relatively little is known about the 
requirements for Ca2+ ions in the folding of nonglycosylated proteins. 
There are multiple ways that Ca2+ can exit and enter the ER. Ca2+ is released via 
either inositol 1,4,5-triphosphate receptors (InsP3Rs) or ryanodine receptors (RYRs) 
(Varadi and Rutter, 2004) (Fig. 3). The translocon itself may participate in passive Ca2+ 
release from the lumen over time (Flourakis et al., 2006; Van Coppenolle et al., 2004), 
although in vitro fluorescence quenching experiments proved that it is not the case 
(Hamman et al., 1998). The translocon should be able to move chemically and sterically 
different proteins across the ER membrane while preserving the permeability barrier 
contrary to ion-channels that allow specific ions transport (Crowley et al., 1994).  
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Figure 3. Various mechanisms of Ca2+ ion regulation inside and outside of the ER. 
 
Ribosomes have to form an ion tight seal with the translocon on the cytosolic side to 
prevent small ions entering in and out of the ER during co-translational translocation 
(Johnson, 2003). 
One of the most important regulators of the ER-located Ca2+ release channels is Ca2+ 
itself (Kang and Park, 2005). When the Ca2+ concentration increases in the ER lumen 
over the buffering capacity of the ER, these channels (RyRs and InsP3Rs) become more 
likely to be open (Xu et al., 2000). The Ca2+ from the ER lumen can also be depleted by 
 
 
 9
chelating agent, response to hormones, or various SERCA pump inhibitors (Ferzandi and 
MacGregor, 1997).   
Ca2+ ions enter the ER via Sarco (Endo) plasmic Reticulum Ca2+ ATPases (SERCA) 
pump (Vangheluwe et al., 2005) (Fig. 3). When the Ca2+ level in the ER declines, it can 
be replenished through SERCA2b; hence a constant Ca2+ level is maintained in the ER 
(Berridge et al., 2003). Decrease in [Ca2+]ER can increase the velocity of Ca2+ uptake by 
SERCA pumps (Yano et al., 2004). ER chaperones, calnexin, calreticulin and Erp57, 
have been shown to interact physically with SERCA 2b in a Ca2+ dependent manner 
(John et al., 1998; Li and Camacho, 2004). Erp57 causes disulfide bond formation in the 
L4 region of the SERCA 2b pump that slows its Ca2+ pumping (Li and Camacho, 2004).  
TRAM2, TRAM homologue with an unclear function that is associated with the ER 
translocon directly interacts with SERCA 2b by its C-terminus (Stefanovic et al., 2004). 
It was suggested that this contact has an important regulatory role in maintaining a high 
Ca2+ concentration in the ER during protein synthesis. This interaction also links the 
translocon to the Ca2+ concentration in the ER (Stefanovic et al., 2004). 
General overview of protein folding 
Proteins must fold properly into their three-dimensional structure in order to fulfill 
their biological functions. For short proteins, the protein primary sequence and its 
environment determine its final structure and folding pathway, for longer proteins, 
individual domains may fold independently before assembling into the final structure. 
Proteins often have different conformational states that result in different functional 
states. When a protein reaches a stable conformational state via different folding 
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intermediates, this state is typically presumed to have the lowest potential energy, and is 
called the native structure (Bryngelson et al., 1995). This lowest potential energy model 
implies that protein folding may reach the final conformation without external energy 
input or additional factors, but this pathway may only apply to small proteins (Anfinsen 
and Scheraga, 1975; Jaenicke, 1991a; Jaenicke, 1991b). Protein folding is sometimes 
slow and inefficient, because partially-folded off pathway intermediates can also fold 
into a low energy states that may have long lifetimes (Daggett and Fersht, 2003a; 
Daggett and Fersht, 2003b). The possibility of such states increases as the length of the 
proteins increases, thus proteins can fold in vitro without help, but the in vivo folding of 
proteins, especially long proteins may require chaperones to reduce incorrect folding or 
irreversible aggregation (Gething and Sambrook, 1992). 
Because of the deleterious effects of protein misfolding in the cell, chaperones and 
folding factors are amongst the most abundant proteins in the cell, and they frequently 
conserved from bacteria to eukaryotes (Ellenberg et al., 1997). In contrast to 
prokaryotes, eukaryotic cells contain several organelles surrounded by lipid bilayers 
(Fig. 1). To enter such an organelle, proteins usually cross the lipid membrane in an 
unfolded linear state (Johnson and van Waes, 1999). These proteins then fold inside the 
organelle assisted by the folding machinery specific for the compartment (mitochondria, 
ER, or chloroplast in plants).   
Protein folding in the ER 
The ER is a compartment that has been evolved to facilitate complex protein folding, 
modification and oligomerization. The ER lumen contains soluble proteins at 
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concentrations higher than 100 mg/ml concentration of proteins. This crowded and dense 
proteinaceous environment must have a well-organized and methodical system in order 
to carry out accurate protein folding and avoid protein aggregation (Marquardt et al., 
1993).  This is important, since hydrophobic elements of newly-synthesized proteins are 
exposed (Stevens and Argon, 1999; Tu and Weissman, 2004). As a result, the ER lumen 
contains many proteins that function as molecular chaperones to promote folding and 
prevent aggregation (Fig 4) (van Anken and Braakman, 2005). 
The ER also differs from other organelles by an oxidizing environment and a unique 
glycosylation machinery (Kowarik et al., 2002; Molinari and Helenius, 2000). Many 
posttranslational modifications, occur in the ER lumen, such as glycosylation, disulfide 
bond formation, proline isomerization, and GPI anchor addition (Kleizen and Braakman, 
2004).  
ER resident enzymes and chaperones that assist the folding include BiP, an Hsp70 
chaperone (Kar2p in yeast) with its co-chaperones (Hsp40), PDI and PDI-related 
proteins that belong to the protein disulfide isomerase family, and members of peptidyl-
prolyl isomerase family (Fig. 4). Many chaperones that play a role in N-glycosylation 
have been identified up to this date. These include calnexin (Cne1p in yeast), 
calreticulin, EDEM (Htm1p in yeast), and OS-9 (Yos9p in yeast). Several enzymes are 
involved in removing/adding glucose and mannose residues back to the carbohydrate 
moiety (Ruddock and Molinari, 2006) (Fig. 4). 
 
 
 
  
 
Figure 4. ER resident chaperones and folding enzymes. Proteins in the ER are sorted according to their protein families.  The homologues between 
yeast and mammalian proteins are shown in the same row, and other common names are listed there as well. This table was adapted from (van Anken 
and Braakman, 2005).
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Protein disulfide isomerase (PDI) 
PDI was first identified in 1963 by Anfinsen’s group as a protein that catalyzes 
oxidative folding in vivo. PDI has two important functions in the ER (Goldberger et al., 
1963). The first is to catalyze the formation or reshuffling of disulfide bonds, and the 
other is to bind unfolded proteins to help folding, and thereby act as a molecular 
chaperone (Bardwell et al., 1991). PDI is of one the most abundant proteins in the cell, 
comprising almost 0.8% of total cellular proteins both in yeast and mammalian cells 
(Ferrari and Soling, 1999). It is a member of the thioredoxin (TRX) family that has a 
common motif of WCGHCK in its two active sites (Martin, 1995) (Fig. 5A). The two 
amino acids positioned between the two cysteines in the characteristic CXXC catalytic 
motif of the thioredoxin family members usually determine the redox potential (Ellgaard 
and Ruddock, 2005). The thioredoxin protein family also includes other ER residents, 
namely Erdj5, PDIp, Erp57, Erp44, Erp72, PDIR, and P5 in mammals and Eug1, Mpd1 
and Mpd2 in yeast (Fig. 4). 
The recently reported crystal structure of the yeast PDI shed light on oxidative 
folding in more details (Tian et al., 2006). The four thioredoxin domains in the yeast and 
mammalian PDI are arranged in a bent ‘U” shape (a, b, b’, a and c, where the a, a’ and b, 
b’ domains contain the thioredoxin sites) (Fig. 5B). The catalytically active regions are 
located in a and a’ domains with a pKa around 4.5  (the free cysteine is has a pKa near 
8.5) that makes them a highly reactive thiol-group (Freedman et al., 1994) (Figs. 5A and 
B). The redox potential of PDI usually determines the type of reactions it catalyzes 
(Wilkinson and Gilbert, 2004).  
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Figure 5. The domain organization of PDI and the oxidative protein folding apparatus in the 
eukaryotic ER. (a) On the basis of various models of human PDI and the crystal structure of yeast PDI (S. 
cerevisiae, PDB ID code 2B5E), the architecture of PDI consists of five domains and one linker organized 
in the order abb′xa′c. Residues are numbered according to mature human PDI (H. sapiens, SwissProt code 
P07237). Domain boundaries are based on the yeast crystal structure, and border residues and the two 
active-site domains (shown in detail in the boxes) are aligned for human (top) and yeast (bottom) PDI. 
Domains a  (orange) and a′ (yellow) are homologous to TRX and contain the catalytic CxxC motif (green). 
Domains b (dark blue) and b′ (light blue) also adopt a TRX fold, but do not share high sequence similarity 
with each other or with domains a or a′. The flexible linker region x (black) is located between domains b′ 
and a′. The link between domains a and b is only one residue. The C-terminal extension (red) contains a 
(K/H)DEL retention signal for the ER. (b) Ribbon diagram based on the crystal structure of yeast PDI 
showing the active-site cysteines in green space-filling representation (prepared with Molscript. Colors of 
the domains are the same as in (a). This figure is reprinted with permission from Elsevier (2007) (Gruber 
et al., 2006)   (c) PDI with oxidized disulfide bonds (ii. bottom, only one of the PDI active sites is shown) 
participates in the oxidative folding of a reduced substrate (i, bottom). Then the reduced PDI (ii. top) can 
act as an isomerase to reshuffle the disulfide bonds of the substrate in order to form the correct ones (i. 
top). PDI becomes oxidized again via the Ero1 cascade (iii. and iv.). Electrons are donated from the 
reduced PDI (ii. middle, iii. top) to Ero1 flexible loop, which is located outside of Ero1. Subsequently 
these electrons flow through the rigid loop of Ero1 (located in the interior of Ero1) and the cofactor flavin 
adenine dinucleotide (FAD) to eventually molecular oxygen. This figure was adapted from (van Anken 
and Braakman, 2005). 
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Figure 5. Continued. 
 
The reactive thiol groups are solvent-exposed, and the reaction begins by a 
nucleophilic attack on the cysteine residue of the unfolded protein to form mixed 
disulfide bonds between PDI and the substrate (Fig. 5C). Thioredoxins must have their 
two active sites in close proximity of each other to exert isomerase activity. This way the 
conformational constrains are minimal when the two active sites simultaneously break 
the incorrect disulfide bonds to create a correct one. 
 It has been shown that PDI binds to unfolded proteins preferentially, due to its 
continuous hydrophobic surface on b and b’ domains (Freedman et al., 2002; Klappa et 
al., 1998; Noiva et al., 1993) (Fig. 5B). This hydrophobic patch can accommodate a 
wide variety of unfolded proteins, regardless of the position of their disulfide bonds. For  
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Figure 6. The bacterial machinery for oxidative protein folding. Oxidized DsbA (light blue with 
yellow active site, PDB accession code 1FVK) catalyzes the formation of disulfide bonds in newly 
secreted proteins by transferring its active-site disulfide. The resulting reduced DsbA (light blue with red 
active site, PDB 1A2L) is reoxidized by the inner membrane protein DsbB (green), which then passes its 
electrons on to quinones. Terminal cytochrome oxidases the reduced quinones and transfer electrons to 
molecular oxygen. In proteins with more than one pair of cysteines, DsbA can introduce incorrect 
disulfide bonds, thereby trapping proteins in non-native conformations. The isomerase DsbC corrects non-
native disulfide bonds by catalyzing disulfide shuffling (dark blue with yellow active site, oxidized DsbC, 
PDB 1EEJ; dark blue with red active site, reduced DsbC, PDB 1TJD). DsbC is maintained in an active 
reduced form by the inner membrane protein DsbD (consisting of α, β and γ domains). This protein uses 
NADPH as a source of reducing power: electrons flow successively from NADPH via TRX (gray with red 
active site, PDB 2TIR) to the DsbD domains β (black), γ (gray-blue with red active site, PDB 1L6P) and 
then α (gray-blue with red active site, PDB 1L6P). This figure is reprinted with permission from Elsevier 
(2007) (Gruber et al., 2006). 
 
the PDI to be catalytically active, it has to bind many different folding intermediates 
with low to moderate affinity and be able to release them after the catalytic cycle has 
been completed.    
When proteins with newly-formed disulfide bonds leave the ER, an equal number of 
electrons remain in the ER. These electrons pass first to PDI and in yeast, eventually to 
the ER oxidoreductin 1 protein (Ero1p) (Fig. 5C) (Tu and Weissman, 2004). Ero1p 
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shuffles electrons from its cofactor FAD, which becomes reduced to FADH2 (Tu et al., 
2000). These electrons eventually pass to molecular oxygen and create a reactive oxygen 
species (ROS). There are two different Ero1 [Ero1α (Cabibbo et al., 2000) and Ero1β 
(Pagani et al., 2000)] in mammalian cells. These two forms may have similar roles and 
contact PDI directly (Benham, 2005). There is another yeast protein (Erv2p) that seems 
to have a function analogous to Ero1p (Gerber et al., 2001). The Ero1p crystal structure 
reveals a CXXC thioredoxin domain with a bound FAD that acts a rigid structural 
element. Ero1p has another disulfide bond motif (CXXXXC) that is on a flexible loop, 
and might transfer the electrons from PDI to the rigid CXXC motif (Gross et al., 2004).  
The formation of native disulfide bonds in the substrate is energetically more favorable, 
so mixed disulfide bonds are broken faster and reoxidized by PDI. Experimental 
evidence suggests that individual PDI domains (a or a’) are able to oxidize or reduce 
disulfide bonds, but both domains are necessary for isomerization (Darby and Creighton, 
1995). The redox activity of the catalytic domains varies within organisms (Wilkinson et 
al., 2005). 
Bacteria have also PDI analogues in its periplasmic space with very little sequence 
homology to the mammalian PDI. These proteins are called DsbA (Martin et al., 1993), 
DsbE (an oxidase) (Edeling et al., 2002) and DsbB and C (reductase and isomerase) 
(Fig. 6) (McCarthy et al., 2000). 
DsbA, a reduced soluble periplasmic protein oxidizes the newly synthesized and 
translocated proteins (Guddat et al., 1998) (Fig. 6). The oxidized DsbA is reduced back 
by DsbB, an inner membrane protein. DsbB utilizes the electron transport chain to 
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donate an electron to molecular oxygen via a quinone and cytochrome oxidases (Gruber 
et al., 2006). Under anaerobic conditions the electron is donated to either nitrate 
reductase or fumarate reductase. DsbC and DsbD together facilitate isomerization. 
DsbD, a membrane protein receives an electron from NADPH through a thioredoxin 
located in the cytoplasm (Rozhkova et al., 2004). The DsbC in turn reintroduces correct 
disulfide bonds into proteins with incorrect disulfide bonds. The bacterial DsbC bears 
structural similarity to the yeast PDI, forming a homodimer with a ‘V’ shape, where the 
active sites are located at the ends of the ‘V’. Hydrophobic residues are located inside 
the ‘V’, which can facilitate the binding of unfolded or misfolded proteins (McCarthy et 
al., 2000). 
There are differences between eukaryotic and bacterial thioredoxin, including the 
distances between the redox domains. In eukaryotic cells, the two catalytic sites are 
separated by ~26 Ǻ and gated two tryptophan residues; while in bacterial DsbC and 
DsbG these sites are 40 Ǻ and 60 Ǻ apart, respectively, and more accessible to substrates  
(Figs. 6B and 7) (Gruber et al., 2006).  
The Hsp70 family 
This heat shock protein (Hsp) family participates in many cellular processes that 
include folding and assembly of newly synthesized proteins, facilitating post-
translational translocation on both sides of the ER membrane, maintaining permeability 
barrier of the mammalian ER (Hamman et al., 1998), unfolding and refolding of 
misfolded proteins, regulating the activity of its co-chaperones [J-domain proteins, 
nucleotide exchange factors (NEF)] (Bukau and Horwich, 1998). The Hsp70 family has   
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Figure 7. Characteristics of the Hsp70 catalytic cycle. The nucleotide-binding domain (NBD) is 
depicted in light blue; the substrate-binding domain (SBD) is in yellow.  J-domain proteins stimulate ATP-
hydrolysis and thereby substrate binding by SBD. The nucleotide exchange factor (NEF) stimulates the 
exchange of ADP to ATP and the release of the substrate from SBD. This figure was adapted from (Bukau 
et al., 2006). 
 
also evolved into various distinct chaperones; such as the Hsp100 and Hsp170 (Fig. 4) 
(Bukau et al., 2000). 
Hsp70 chaperones contain a substrate-binding domain (SBD) and a nucleotide-
binding domain (NBD) (Fig. 7). SBD has a high affinity for the hydrophobic stretches 
that are usually exposed in an unfolded or misfolded protein (Bukau et al., 2006). SBD 
and NBD are allosterically coupled. ATP binds to the N-terminal NBD and thereby 
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causes the substrate-binding pocket with its helical lid to open up and interact with the 
substrate. J-domain proteins can promote ATP hydrolysis, and thus indirectly trigger the 
closing of SBD and the trapping of the substrate there (Jiang et al., 2005).  
The NBD consists of two globular subdomains that are connected via the nucleotide-
binding groove, while the SBD contains a β-sandwich with one α-helix (Helix A) on its 
side and another (Helix B) on the top to serve as a lid for the substrate binding groove. A 
ten-residues-long conserved linker (VQDLLLLDV) connects NBD and SBD the signals 
between the two domains (Jiang et al., 2005; Wei et al., 1995). The crystal structure also 
revealed that Helix A is embedded in the NBD cleft directed thereby ionic, and relays 
interactions at the C-terminal end of the Helix A and hydrophobic interactions at the N-
terminal end (Jiang et al., 2005). An additional contact between these two subunits is 
made by the β-sandwich and the NBD cleft. These interactions are probably disrupted 
upon ATP binding to NBD, and hence aid the opening of the SBD. Structural changes 
within the NBD also accompany ATP hydrolysis and probably transmitted to the SBD 
through a hydrogen-bonding network, as in the case of bacterial DnaK (Vogel, Bukau et 
al. 2006). 
By themselves Hsp70s act very slowly, thus they usually employ co-chaperones. 
Numerous J-domain proteins have been identified in yeast (Walsh et al., 2004). The role 
of these J-domain chaperones is to coordinate ATP hydrolysis and substrate binding by 
Hsp70. The affinity of Hsp70 is very high for ADP, so the dissociation is slow without a 
nucleotide exchange factor. Several NEFs have been discovered to date, and their 
functions are important to promote the release of ADP and rebind ATP (bacterial GrpE, 
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eukaryotic BAG proteins, yeast cytosolic Fes1p and lumenal Sls1p, human Hsp70 
binding protein 1). The considerable number of different Hsp70s and their interactions 
with a variety of NEF and J-domain proteins suggest a wide range of substrate 
specificity and a capability to participate in different cellular events.  
N-glycosylation in the ER 
Our understanding of the N-glycosylation process in the ER lumen has increased 
considerably during the past decade (Helenius and Aebi, 2001; Ruddock and Molinari, 
2006).  N-linked oligosaccharide moieties have various cellular functions including 
increase solubility, determine orientation of the protein respect to the membrane, and 
regulate protein turnover, control immune responses and the isoelectric point of the 
proteins (Helenius and Aebi, 2004).   
Am ER translocon-associated protein, the oligosaccharyl transferase or OST, 
transfers a carbohydrate moiety via an N-glycosidic bond to the side chain nitrogen of an 
asparagine residue on nascent chain containing a glycosylation sequence (Asn-X-
Ser/Thr) (Fig. 8) (Hebert et al., 2005). The side chains of threonine or serine thought to 
form a loop with the asparagine amine and therefore make the amine more nucleophilic. 
The yeast OST complex contains nine subunits (Ost1p, Ost2p, Wbp1p, Stt3p, Swp1p, 
Ost3p, Ost4p, Ost5p and Ost6p), homologues, which are also present in mammalian 
cells, and the first five subunits are essential for proper function (Yan and Lennarz, 
2005). The STT3 subunit contains the OST active site and photocrosslinking 
experiments showed that glycosylation occurs when the Asn-X-Thr/Ser is located about 
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Figure 8. The structure of the core N-glycan. The core glycan has fourteen saccharides: three glucoses 
(red triangles), nine mannoses (green circles) and two N-acetylglucosamines (blue squares). The three 
mannose branches are named A, B and C. The trimming sites for mannosidase I and endomannosidase are 
shown by arrows. The saccharides from A-F and I are added on the cytosolic side of the ER membrane, 
while the rest is on the lumenal side after flipping. Residues D, F, L and I contribute to the interaction of 
calnexin and calreticulin with the monoglucosylated glycans. Saccharides E, G, H and K possibly interact 
with EDEM. This figure was adapted from (Helenius and Aebi, 2004). 
 
75 residues away from the ribosomal P-site and hence in close proximity to the Sec61 
complex (no more than 5 nm) (Nilsson et al., 2003). 
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N-glycans covalently attached to the protein are subject to modifications both in the 
ER and in the Golgi apparatus, as certain saccharides are trimmed and/or added.  Why 
would a cell develop such an intricate process, and why is this process conserved among 
eukaryotes (Trombetta and Parodi, 2003)? The answer appears to be that each 
configuration during oligosaccharide processing has its own role. In the ER, these 
moieties are necessary for proper folding and to pass quality control (Helenius and Aebi, 
2004). The N-glycans go through extensive modifications in the Golgi for intracellular 
transport, and eventually they exert their effect at the final destination (lysosomes, 
extracellular space, plasma membrane etc.) (Ruddock and Molinari, 2006) (Fig. 8). 
The OST complex preferentially conjugates the complete glycan to the incoming 
nascent chain, even if it means underglycosylation (Burda and Aebi, 1999; Kornfeld and 
Kornfeld, 1985). N-glycans are located on the surface of the fully folded protein 
(Wormald et al., 2002) and protrude when hydrated about 30 Ǻ into the solvent. A 
glycoprotein can contain several glycans, each with a molecular mass of about 3 kDa. In 
some cases, glycans can be removed from the protein surface without significantly 
affecting the protein structure (Helenius and Aebi, 2004).  
The core glycan is synthesized in both the cytosol and ER through conjugation of 
individual saccharides to the lipid carrier dolichol-pyrophosphate by monosaccharyl 
transferases (Helenius et al., 2002). Seven carbohydrates are added on the cytosolic side 
followed by an ATP-independent flipping of the carbohydrate moiety to the lumenal side 
by bi-directional flippase (Hirschberg and Snider, 1987; Perez and Hirschberg, 1987) 
The final configuration is Glc3Man9GlcNAc2 (Fig. 8).  
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The affinity of carbohydrate binding chaperones (lectins) for N-glycans is generally 
low (µM range), so only transient lectin-lectin interactions occur in the already crowded 
environment of the ER lumen (Kapoor et al., 2003; Patil et al., 2000). Two lectins 
participate in the folding of glycoproteins: calnexin (CNX) (Hammond et al., 1994; 
Hammond and Helenius, 1993), a type I membrane protein, and calreticulin (CRT) 
(Nauseef et al., 1995; Peterson et al., 1995), a soluble ER resident protein . 
Glycoproteins typically go through a CNX/CRT folding cycle before they are 
secreted. In this cycle, after covalent addition of the core glycan, two glucose-cleaving 
enzymes [glucosidase I (GI) and glucosidase II (GII)] sequentially remove one glucose 
residue to create Glc1Man9GlcNAc2 (Elbein, 1983; Trombetta et al., 1996). Inhibitors of 
ER glucosidases block the interactions between CNX and the N-glycans (Hammond and 
Helenius, 1994), confirming that only mono-glucosylated species interact with either 
CNX or CRT through their carbohydrate moiety. CNX and CRT serve as molecular 
chaperones in association with a cofactor, Erp57, a protein-disulfide isomerase that 
catalyzes the formation of disulfide bonds (Frickel et al., 2004; Frickel et al., 2002).GII 
has to remove the last glucose residue for the folding intermediate to be released. If the 
protein is properly folded, then now it is ready to be secreted towards the Golgi. 
Glucosyltransferase (UGGT) identifies misfolded proteins and a glucose is added 
back to its original position to re-initiate a folding attempt by CNX/CRT (Sousa et al., 
1992). 
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Calnexin and calreticulin 
These lectins are both monomeric, bind calcium, and have ER retention signals 
(Bouvier and Stafford, 2000). They have two distinct domains; a β-sandwich, globular 
domain and a proline-rich region (P-domain) (Ellgaard et al., 2001a; Ellgaard et al., 
2001b; Schrag et al., 2001) (Fig. 9A) Calnexin (CNX) also contains a membrane 
spanning region and a cytosolic segment that can undergo phosphorylation and interact 
with the ribosome (Chevet et al., 1999). The x-ray crystal structure of CNX revealed that 
a glycosylated substrate protein could reside in a cavity between the P-domain and the 
globular domain, while its glycan could bind simultaneously to the lectin-binding site in 
the globular domain (Fig. 9B). This pocket is flexible enough to adapt to the structure of 
a folding polypeptide, and hence preventing premature aggregation. Erp57 also weakly 
interacts with the end the P-domain (Ellgaard et al., 2001b). Both CNX and calreticulin 
(CRT) have the same specificity: an α-1,3 linked glucose that is conjugated to three 
mannoses (α-chain) (Ware et al., 1995). The formation of hydrogen bonds between 
asparagine and tyrosine and the glucose hydroxyl group is the reason for the preference 
for α-1,3 linked glucose (Kapoor et al., 2004). Three of the mannoses on branch A also 
contribute to the stability of N-glycan binding within the globular domain via additional 
controversial because most of the substrate proteins do not bind when the ER 
glucosidase activity is impeded (Danilczyk and Williams, 2001). Moreover, no 
hydrophobic patch has been identified in the protein-binding cavity that could serve as a 
nonspecific-binding site (Schrag et al., 2001).  Some experimental evidence also 
 
 
  
Figure 9. The structure of the calnexin ectodomain and the calreticulin oligosaccharide-binding site.  (A) Domain structure of calnexin. The 3-D 
structure of calnexin comprises a lectin domain (blue) and an extended arm called the P-domain, which comprises four repeat modules, P1–P4 (cyan, 
green, yellow and red, respectively). Each repeats module is formed by an antiparallel interaction of two different proline-rich sequence motifs. The 
observed glucose-binding site in the lectin domain is indicated by a ball-and-stick model (green). Glc1Man9(GlcNAc)2 glycoprotein binding was 
modeled by superimposing the terminal glucose of the model glycan on the observed position of bound glucose. The resulting position of the 
polypeptide of the model glycoprotein (properly folded ribonuclease B in this example; magenta) suggests that interaction with the P-domain is likely. 
This figure is reprinted with permission from TiBS  (Schrag et al., 2003) (B) A model of the oligosaccharide- binding site of calreticulin. The 
tetrasaccharide bound is Glcα1-3 Manα1-2 Manα1-2 Man. Mutational analysis showed that several of the residues that interact with the sugar in the model 
are essential for binding.  This figure is reprinted with permission from Annual. Rev. Biochem. (Helenius and Aebi, 2004)
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suggested a possibility of ATPase activity also, although its function is not yet clear (Ou 
et al., 1995). 
Glucosidase I 
Glucosidase I (GI) is an 82 kDa single-spanning membrane protein (type II) with a 
short N-terminal cytosolic region and a substantial lumenal domain that contains the 
glucosidase activity. GI facilitates glycoprotein movement from the OST complex by 
trimming the outermost α-1,2 linked glucose, and after further trimming by glucosidase 
II (GII), passing the folding protein on to the CNX/CRT cycle (Helenius and Aebi, 
2004). 
Glucosidase II 
GII is a soluble lumenal protein composed of α and β glycoproteins chains, 107 kDa 
and 54 kDa respectively that are tightly associated with each other (Trombetta et al., 
1996). β-chain is a highly conserved protein with an N-terminal signal sequence and a 
C-terminal lectin domain with an ER retention signal. Its lectin domain is homologous to 
the mannose-6-P family receptors. The α-chain does not contain a retention signal, so it 
has been speculated that its association with the β-chain serves to localize the protein in 
the ER. Both subunits are essential for the activity, stability and solubility of this enzyme 
(D'Alessio et al., 1999; Pelletier et al., 2000).  
UDP-glucose transferase (UDP-glucose:glycoprotein glucosyltransferase or UGGT) 
UGGT is a large, soluble lumenal protein with an ER retention signal, and in 
addition to the ER lumen, it is also found at ER exit sites, and in the ER to Golgi 
intermediate compartment (ERGIC) (Parodi, 2000). The catalytic site resembles that of 
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the glycosyltransferase family members and it is located within the 300 amino-acid long 
C-terminus. The N-terminal might play a role in substrate recognition, and it is essential 
for C-terminal activity (Arnold and Kaufman, 2003; Guerin and Parodi, 2003). UGGT 
transfers a glucose residue from UDP-glucose to an N-glycan with a Man9GlcNAc2 
configuration. It has the highest affinity for those N-glycans that contain all mannoses on 
the B and C chain (Fig. 8). 
When mannoses are trimmed off, both GII and UGGT interact more slowly with a 
substrate (Sousa et al., 1992). This observation suggested that the loss of mannoses and a 
decrease in the folding speed might signal the terminal misfolding of the protein, and 
eventual targeting for degradation (Trombetta and Parodi, 2005). It was proposed that 
both glycan binding and interaction with the hydrophobic regions of the glycoprotein are 
necessary for UGGT activity (Sousa et al., 1992). UGGT has affinity for substrates such 
as molten globule-like glycoproteins, and glycopolypeptide chains that have at least 12 
amino acids in hydrophobic patches (Ritter and Helenius, 2000; Ritter et al., 2005). 
Some groups suggested that UGGT can interact with hydrophobic proteins without 
glycans, since UGGT preferentially reglucosylated glycoproteins that were present on 
misfolded regions of the protein, while leaving the ones on a fully folded domain intact 
(Helenius and Aebi, 2004).  
UDPase 
UDP-glucose is transferred from the cytosol into the ER lumen through an antiporter 
that couples its entry to the exit of UMP (Failer et al., 2002; Perez and Hirschberg, 
1987). There are three different nucleoside diphosphatases (NDP) up to date; two are 
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located in the ER and one in the Golgi. One of the ER-localized NDPs is a membrane 
protein that requires Ca2+ ions for its proper functioning. Soluble NDPs need Ca2+, Mg2+, 
or Mn2+ for activity, and they hydrolyze UDP, GDP and IDP, but not any nucleoside 
triphosphate or ADP (Helenius and Aebi, 2004).  
Lectin homologues in the secretory pathway 
ERGIC-53, a broadly-expressed type I transmembrane protein, cycles between the 
ERGIC and the cis-Golgi compartments because of its ER retention signal. It belongs to 
the leguminous protein family with mannose lectin activity that contains a β-sandwich 
domain like CNX and CRT, but no P-domain (Velloso et al., 2002a; Velloso et al., 
2002b). ERGIC-53 is responsible for transporting a certain set of glycoproteins that are 
destined for secretion or for delivery to the lysosome. It usually interacts with proteins 
that are successfully folded in the CNX/CRT cycle (Appenzeller et al., 1999). 
Vesicular integral protein 36 (VIP 36) is also a membrane protein, homologous to 
ERGIC-53 (Fiedler et al., 1994). It interacts with high-mannose containing proteins that 
are targeted to the apical plasma membrane. There are several other lectin-binding 
proteins identified in the secretory pathway, and their role involves recognition, proper 
folding, quality control and transport of glycoproteins (Schrag et al., 2003).  
Mannosidases 
The removal of an α-1,2 mannose from the B and the C chain (Fig. 8) is completed 
by Mannosidase I (ManI) and Mannosidase II (ManII), respectively, enzymes that are 
present in both mammalian and yeast (Fig. 4) (Dahms and Hancock, 2002). The 
mannose 6-phosphate binding domain forms a β-barrel structure that contains three 
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disulfide bonds. The binding groove is seated deep within this β-barrel, enclosing a Mn2+ 
ion that interacts with a phosphate group in the carbohydrate. A conformational change 
in the receptor occurs upon ligand binding. This binding event is supported by a mildly 
acetic pH (Dahms and Hancock, 2002). 
ManI belongs to a GH47 enzyme family, which consists of three subfamilies: ER α-
mannosidase (ERManI) family, Golgi α-mannosidase family (GolgiManIA, IB and IC in 
mammals, but absent in yeast), and the putative ER lectins, ER-degradation-enhancing 
α-mannosidase-like protein (EDEM 1-3 in mammals and Htmp1/Mnl1 in yeast) 
(Henrissat and Davies, 1997; Hosokawa et al., 2001). Both ERManI and GolgiManI are 
Ca2+ dependent enzymes with an (αα)7-barrel structure with the active site in the center 
of the barrel. EDEM 1 has a 35% sequence identity to the catalytic domain of Man1, but 
has no mannose cleaving activity despite its conserved domain structure. EDEM lacks 
the disulfide bond in its mannosidase-like domain that may be necessary for activity 
(Molinari et al., 2003; Oda et al., 2003). However, EDEM might still act as a 
mannosidase, because many mannosidases do not require this disulfide bond for their 
function (Karaveg and Moremen, 2005; Karaveg et al., 2005; Mast et al., 2005). EDEM 
can be inhibited by both Kif and dMNJ, and upregulation of EDEM 1 and 3 results in an 
increased de-mannosylation in the cell (Hirao et al., 2006; Olivari et al., 2006). EDEM 1 
is a type 2 membrane protein, with two soluble homologues (EDEM 2 and 3) (Oda et al., 
2003). First, it was reported that its uncleaved signal sequence anchors EDEM 1 into the 
membrane, but it was later reported that the signal sequence is cleaved off and the 
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mature EDEM 1 enters the lumen in a soluble form challenged this finding (Oda et al., 
2003; Olivari et al., 2005).  
ER quality control 
Soluble secretory proteins enter the ER lumen and membrane proteins integrate into 
the ER membrane in an unfolded state (Johnson and van Waes, 1999). Some of these 
proteins then diffuse into COPII vesicles that are directed to the Golgi apparatus where 
the proteins are sorted and trafficked to their final destination (intracellular organs, 
plasma membrane, vacuoles etc.) (Fig. 10) (Barlowe, 2002). Intracellular protein export 
occurs primarily through vesicular transport by vesicle budding off the donor membrane 
and ultimately fusing with the acceptor membrane (Barlowe, 2003). The Rab family 
proteins, which are small GTPases that cycle between membrane GTP-bound and 
soluble GDP-bound forms, assist this vesicular budding. Proteins that cannot fold 
correctly or assemble into oligomers are recognized by the ER quality control apparatus 
and eliminated before they get into the secretory pathway (Ellgaard and Helenius, 2003). 
This system ensures that only fully-folded/assembled protein complexes are 
delivered to their final destination, thereby preventing any deleterious effect. Studies 
conducted with mutated, misfolded or incompletely assembled proteins revealed that 
recognition by the quality control apparatus operates on a structural rather than 
functional basis (Romisch, 2005). ER quality control operates on several and partially 
overlapping pathways. These include retrieving misfolded proteins from the Golgi by  
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Figure 10. Secretory pathway organelles within a eukaryotic cell. Secretory proteins are translocated 
into the rough ER and properly folded by various ER resident chaperones and folding enzymes. The 
correctly folded proteins are secreted towards the Golgi apparatus through COPII vesicles (black arrow) 
and eventually to their final destination (black arrow). Terminally misfolded proteins elicit a quality 
control response that operates through multiple but partially overlapping mechanisms. These include 
retrieval from the Golgi by COPI vesicles (red arrow), or diversion towards the lysosomes/vacuoles for 
degradation (green arrow). Misfolded protein overload also can also lead to ERAD and the UPR response 
(blue arrows). 
  
COPI vesicles (Spang et al., 1998), the unfolded protein response (UPR) (Hampton, 
2000), autophagy (Levine and Klionsky, 2004), and the endoplasmic reticulum-
associated degradation pathway (ERAD) (Fig. 10) (Meusser et al., 2005). 
COPI retrieval from the Golgi-complex 
ER resident proteins are retrieved from the Golgi through COPI vesicles (Rothman 
and Orci, 1992; Spang et al., 2001). Some misfolded proteins can also escape the ER 
quality control apparatus, largely under stress conditions when proteins cannot be 
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retained in the ER or the ER apparatus does not identify the folding defect. These 
proteins are recognized in the early Golgi compartments and transported either back to 
the ER for cytosolic degradation or to the vacuole/lysosome for degradation 
(Appenzeller-Herzog et al., 2005).  
Unfolded protein response (UPR) 
The Unfolded Protein Response (UPR) is initiated when there are a large number of 
unfolded/misfolded proteins present in the ER lumen. UPR alleviates stress by 
transcriptional regulation of the synthesis of ER chaperones and folding enzymes 
synthesis and/or inhibition of secretory protein synthesis (Zhang and Kaufman, 2006).  
The effects of the UPR increase the capacity of the cell to cope with the unfolded 
proteins. If UPR signals are present for a prolonged time, the cell ultimately kills itself 
by apoptosis (Fig. 12) (Di Sano et al., 2006).The UPR signaling components were first 
identified in Saccharomyces cereviciae (Cox et al., 1993; Mori et al., 1993) (Fig. 11). 
UPR is less complex in budding yeast than in mammalian cells. 
There are three independent UPR pathways present in metazoans (Ire1, ATF6, and 
PERK) (Bernales et al., 2006) (Fig. 12). The Ire1 protein has two isoforms: Ireα and 
Ireβ in mammalian cells that are expressed cell-specifically (Fig. 11). The PERK protein 
is similar to Ire1 in its lumenal unfolded protein sensing domain, but it cytosolic domain 
contains an eIF2α kinase domain (Fig. 12ii) (Bertolotti and Ron, 2001; Zhang et al., 
2005). The lumenal domains of both Ire1 and PERK dimerize when there is a significant 
amount of unfolded protein present in the ER lumen, and in turn their cytosolic domains 
go through auto-phosphorylation (Liu and Kaufman, 2003). 
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Figure 11. Mechanism of Ire1-mediated mRNA splicing. Unfolded proteins on the lumenal side 
activate Ire1, resulting in its dimerization and autophosphorylation of the cytosolic kinase (K) domain of 
Ire1. This phosphorylation event in turn causes the activation of the endoribonuclease domain (R). The 
ribosomes on the HAC1 mRNA are stalled due to base pairing between the 5’-UTR and an intron. The R-
domain removes this intron, and the tRNA ligase splices the exons so the stalled ribosomes can continue 
the translation efficiently. The product, transcription factor Hac1, enters the nucleus to activate the target 
genes. This figure was adapted from (Bernales et al., 2006). 
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Figure 12. The metazoan unfolded protein response (UPR) consists of three branches. There are three 
different ER stress transducers: ATF6 (i), IRE1α and β (ii) and PERK (iii). These proteins recognize the 
unfolded protein content present in the ER lumen and convey this through the membrane to trigger 
transcription factors or initiate translational control. In mammalian cells, ATF6 also induces XBP1 mRNA 
expression. All the transcription factors have a combined effect on UPR target genes to cause the protein 
folding capacity of the cell to enlarge and consequently aid in restoring homeostasis. PERK also 
contributes to the decrease in overall translation in cells, thus causing less protein transport into the ER. 
Unsuccessful restoration of ER homeostasis eventually results in apoptosis . This figure was adapted from 
(Bernales et al., 2006). 
 
One underlying mechanism consists of an ER membrane RNase (Ire1p) that 
transmits a signal through the ER membrane when the concentration of unfolded 
proteins in the lumen gets too high, and this signal activates a transcriptional regulator, 
Hac1, which in turn controls the synthesis of an increasing amount of ER chaperones 
(Cox and Walter, 1996; Mori et al., 1996) (Fig.11). The Ire1 UPR pathway is present 
also in mammalian cells and is integrated into some multiple, parallel, and cross-wired 
conduits (Leber et al., 2004; Patil et al., 2004). Ire1/Hac1 transcription factors control 
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over 400 different genes, and in addition to upregulating ER chaperones, the UPR also 
codes for increased phopholipid synthesis, ERAD, and vesicular secretion (Travers et al., 
2000). The recent crystal structure of Ire1 showed homology to the peptide binding 
groove of MHC-I chains, implying that the lumenal domain of Ire1 may bind to unfolded 
proteins in the ER lumen (Credle et al., 2005). Earlier, negative regulation by BiP was 
proposed, but refuting this hypothesis, these lumenal BiP binding sites have been 
identified on Ire1, and the deletion of this region did not have any affect UPR (Oikawa et 
al., 2005). 
Another member of the UPR response family in mammalian cells is the ATF6 
protein (Fig. 12i). ATF6 is also constitutively expressed throughout the cell (Shen et al., 
2005; Ye et al., 2000). ATF6 belongs to the cAMP regulatory element-binding protein 
family. ATF6 becomes cleaved by the S1P and S2P proteases when UPR is induced. 
S1P and S2P were first identified as proteases activated by cholesterol starvation. After 
ATF6 is cleaved due to ER stress and released from the ER membrane, it travels to the 
nucleus to activate its target genes (Zhang and Kaufman, 2006). The third component of 
the mammalian UPR response is PERK (PKR-like ER kinase), an ER type I trans-
membrane protein (Fig. 12iii). Its major job is to inhibit translation in the cytosol by 
phosphorylating eIF2α, which in turn interferes with the formation of 43S translation 
initiation complex formation (Harding et al., 2000). 
If the cell is subjected to extensive ER stress, all three branches of UPR trigger 
apoptosis, which is accompanied by a large Ca2+ release from the ER. Specifically, 
preapototic genes, such as CHOP are upregulated by both the PERK and ATF6 
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pathways (Yoneda et al., 2001). CHOP decreases Bcl-2 levels and thereby sets off the 
release of mitochondrial cytochrome c and the apoptosis inducing signal cascade (Urano 
et al., 2000). Simultaneously Ire1 activates the JNK cascade via TRAF2 protein, and the 
ER resident caspase-12 and 4. Additionally, Ca2+ release has a major role in calpain 
activation, which prompts the protease cascade. It is unknown presently how the 
unfolded proteins in the ER can trigger Ca2+ release (Schroder and Kaufman, 2006).  
Autophagy 
There are conditions in vivo under which all the quality control pathways fail and the 
misassembled proteins form large aggregates. Autophagy involves the recognition and 
engulfing these species (target proteins or organelles) by autophagosome vesicles 
(Bernales et al., 2007). These membrane vesicles then fuse together with the lysosome to 
release their contents for degradation via the lysosomal enzymes (Levine and Klionsky, 
2004). Several diseases (e.g. Huntington’s, Parkinson’s) are caused by the accumulation 
of protein aggregates in intracellular compartments. Experiments showed that these large 
protein aggregates have less deleterious effect then smaller aggregates (Yorimitsu and 
Klionsky, 2007). In some cases, these aggregates can be found ubiquitinated, suggesting 
that the ubiquitin-proteasome system plays a role in the cleaning out process, even 
though these large misfolded proteins complexes may present a problem for the 
proteasome (Bennett et al., 2005). Ubiquitination of these large complexes might have a 
role in autophagy. For example, autophagy eliminates A1PiZ when it is assembled into 
aggregates (Fig. 4) (Kruse et al., 2006).   
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Endoplasmic reticulum-associated degradation (ERAD) 
The ERAD pathway, one aspect of ER quality control, ensures irreversibly misfolded 
or unassembled proteins are eliminated before secretion. The first evidence that 
misfolded proteins were retained in the early secretory pathway and degraded came from 
studies with misfolded T-cell receptor (TCRα) and mutant cystic fibrosis conductance 
regulator (CFTR) (Cheng et al., 1990; Yu and Kopito, 1999). This intracellular 
degradation was once thought to occur in the ER lumen or in a pre-Golgi compartment. 
At the same time it was hard to comprehend how such an aggressive proteolytic 
apparatus can be present in the ER lumen, where there are a large number of unfolded 
proteins present. Experiments during the last decade showed that ERAD substrates were 
transported back to the cytosol for degradation (Fig. 4) (Bonifacino et al., 1989; Meusser 
et al., 2005).  
Even though the underlying mechanisms of ERAD are not completely understood, 
the current experimental approaches have elucidated a series of events that lead to 
degradation. First, folded proteins must be distinquished from folding intermediates and 
misfolded proteins, although it is unclear how the cell recognizes the myriad of 
conformational states and classifies them. It is plausible that the unfolded proteins stay 
in the ER by default, while properly-folded proteins are sorted into COPII-coated 
vesicles for transport into the Golgi apparatus. But this type of selection would need 
specific receptors that recognize folded conformations or glycosylation states (discussed 
later). Some membrane proteins contain a dibasic motif (transmembrane domains of T-
cell receptor and µ heavy chain of IgM, or cytosolic domain of IgE, ATP sensitive K+ 
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channel, or CFTR ∆508) that serves a signal for retention in the ER. Hence, masking this 
dibasic signal upon proper assembly may induce proper secretion from the ER (Stevens 
and Argon, 1999). 
Many human diseases [(Creutzfeldt-Jakob disease (CJD)], Scrapie, bovine 
spongiform encephalopathy (BSE), or Parkinson and Alzheimer) are caused by protein 
aggregates (Boelens et al., 2007; Rutishauser and Spiess, 2002; Yoshida, 2007). Some 
others, such as cystic fibrosis and lung emphysema, result from the early degradation of 
proteins (CFTR and α-1 antitrypsin respectively)  (Fig. 13) (Jensen et al., 1995; Qu et 
al., 1996; Rutishauser and Spiess, 2002; Ward et al., 1995). Yeast genetics has been a 
powerful tool in elucidating the role of various chaperones and folding enzymes in 
ERAD, although these findings can not be applied entirely to the more complicated 
mammalian systems (Brodsky and McCracken, 1997; Plemper et al., 1997). Numerous 
experiments in yeast cells involved a soluble ERAD substrate, a mutant version of 
carboxypeptidase Y (CPY*). This protein has an active site mutation (Gly to Arg) that 
results in an altered, trypsin-sensitive structure (Finger et al., 1993). Yeast ERGIC 
(sec18, ufe1, seds5, erv29) and COPII (sec12 and sec23) mutants showed decreased 
CPY* degradation, which suggested that the ER to Golgi transport is necessary for the 
ERAD of this soluble protein (Caldwell et al., 2001; Taxis et al., 2002; Vashist et al., 
2001; Vashist and Ng, 2004). 
Experiments revealed the presence of some sub-compartments in the ER that are 
formed specifically for ERAD substrates that travel from the Golgi via retrograde  
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Figure 13.  Some ERAD substrates and their relevance in the cell. Some ERAD substrates have 
medical significance, while others are used by pathogens to invade the host system.  This figure was 
adapted from (Dalbey and von Heijne, 2002). 
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movement (Vashist et al., 2001). However, yeast genetics provide only indirect 
evidence, because these mutants also disturb ER homeostasis and mislocalize several ER 
resident proteins (Nishikawa et al., 1994; Prinz et al., 2000). Fluorescence and electron 
microscopy data showed that the Ste6p* localized in the ER to proliferated ER 
membranes, which was later named ER-associated compartments (ERAC) (Huyer et al., 
2004a). ER chaperones were also present in this ER network, which suggested that there 
is not any obstruction between the ER and ERAC. This group proposed that these 
misfolded membrane proteins may be stored in this compartment until ERAD can take 
place (Huyer et al., 2004b). 
Retrotranslocation of CPY* in yeast requires Kar2p and Der1p (Knop et al., 1996) 
several J-domain proteins (Sec63p, Scj1p and Jem1p) (Nishikawa et al., 2001), and also 
some ubiquitination factors: Ubc7p, Ubc6p, (Hiller et al., 1996),  Ubc1p (Friedlander et 
al., 2000), Hrd1p (Der3p) (Hampton et al., 1996; Plemper et al., 1998), and Hrd3p 
(Gardner et al., 2000). CPY* also contains four glycan moieties, so its degradation also 
depends on carbohydrate-sensitive ERAD components, and Htm1p (EDEM) (Hosokawa 
et al., 2003; Hosokawa et al., 2001).  
Several bacterial and plant toxins exploit the ERAD machinery. A/B toxins (e.g. 
Pertussis and cholera toxins) translocate their toxic proteins into the ER of the infected 
organism (Tsai and Rapoport, 2002; Worthington and Carbonetti, 2007), while others 
(ricin) use receptor-mediated endocytosis to reach the ER and retrotranslocate back to 
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the cytosol (Lord et al., 2003). These toxins usually have a low lysine concentration to 
avoid degradation (Lord and Roberts, 1998). 
 Proteins without glycan moieties have so far received less attention. It was 
suggested that the lumenal proteins involved in ERAD substrate selectivity include 
Hsp70 molecular chaperones that detect and associate with misfolded polypeptides. 
Specifically, the ER lumenal Hsp70 (BiP in mammals and Kar2p in yeast) and two 
Hsp40 co-chaperones assist ERAD in yeast. Hsp70 presumably functions in ERAD to 
maintain the misfolded proteins in a non-aggregated state.  Kar2p (yeast BiP) is required 
for the degradation of the mutant pro-α-factor (∆gpαf) and CPY* in yeast, but not of 
membrane proteins (Brodsky, 1996; Brodsky, 2005; Brodsky et al., 1993; Brodsky and 
McCracken, 1997; Brodsky and McCracken, 1999; Brodsky et al., 1999; Plemper et al., 
1997; Plemper et al., 1998; Plemper and Wolf, 1999).   
One proposed role for BiP is to transport the aggregation prone proteins directly or 
indirectly to another ER resident protein that might serve as the actual retrotranslocation 
channel (Nishikawa et al., 2005; Nishikawa et al., 2001). BiP also seals the translocon 
from the lumenal side, which positions it in a close proximity to the translocon. If the 
translocon also serves as a retrotranslocon, this gate-keeping function of BiP also could 
explain its proposed role in ERAD substrate targeting (Haigh and Johnson, 2002; 
Hamman et al., 1998). 
PDI (protein disulfide isomerase), a thiol-disulphide oxidoreductase has also been 
suggested to play a role in ERAD. While CPY* and Igµ chain (Fagioli et al., 2001) 
degradation was understandably inhibited in a PDI-deficient yeast mutant strain due to 
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their disulfide bonds. A cysteine free protein, ∆gpαf, was astonishingly found to require 
PDI in yeast (Gillece et al., 1999; Werner et al., 1996). This finding suggests that PDI 
can also act as a molecular chaperone. PDI also has been described as a redox-driven 
chaperone in a mammalian cell line required for unfolding the A1 chain of the cholera 
toxin before targeting it to the ER membrane (Tsai and Rapoport, 2002; Tsai et al., 2001; 
Tsai et al., 2002). This group proposed that PDI binds to the substrate in a reduced state, 
forms disulfide bonds with the substrate, and travels with the substrate to a membrane 
complex containing the oxidase Ero1. Ero1 would then oxidize PDI, which in turn would 
release its substrate, and perhaps direct it to a retrotranslocation component located in 
the ER membrane. The assertation that PDI is a redox driven chaperone   was later 
questioned by experiments that proved that substrate binding and release are not driven 
by the oxidation state of PDI (Lumb and Bulleid, 2002). Another thioredoxin, Eps1, the 
ER membrane protein version of PDI, is required for degradation of the yeast membrane 
ATPase (Pma1p) (Wang and Chang, 1999). The CNX/CRT-associated Erp57 might 
have a distinct role in the glycoprotein quality control (Farmery et al., 2000; Oliver et al., 
1999; Wang et al., 2005). 
The most characterized ERAD process to date involves glycoprotein degradation. 
Although this process is becoming increasingly well understood, there are still many 
unknowns (Helenius and Aebi, 2004; Trombetta, 2003). When N-glycosylation is 
inhibited due to mutations or inhibitors (tunicamycin), proteins that are normally 
glycosylated, are subjected to aggregation and/or misfolding (Mancini et al., 2003; 
Obinata et al., 1996), perhaps because the negatively-charged hydrophilic glycan 
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Figure 14. Processing and quality control of N-glycosylated proteins in the ER. (1) The core glycan is 
assembled partly in the cytosol and flipped to the lumenal side in an ATP-dependent manner. In the lumen 
the glycan moiety is fully assembled and loaded onto the oligosaccharyl transferase (OST) complex. (2) 
The N-glycans (Glc3Man9GlcNAc2) are co-translationally conjugated to the incoming nascent chain by the 
OST complex. (3) The carbohydrate moiety is then trimmed by glucosidase I and II (GI and GII) to a 
mono-glucosylated state and enters the calnexin (CNX) or calreticulin (CRT) folding cycle (while this 
process can occur co-translationally, it is not shown for simplicity)(4). If the substrate has thiol groups, 
Erp57 may assist the disulfide bond formation (4). (5) Trimming of the last glucose residue by GII 
promotes the release of substrate from CNX/CRT. (6) If the CNX/CRT released substrate is not properly 
folded, it may be re-glucosylated to the mono-glucosylated form by UDP-glucose: glycoprotein 
glucosyltransferase (UGGT). This causes the substrate to bind again to CNX/CRT and undergo another 
series of folding attempts. If the protein eventually reached its native conformation it becomes trimmed by 
ER mannosidases I and/or II (Man I and Man II) to obtain a high-mannose glycan conformation (M?N) 
that can bind to ERGIC-53 (7) and packed into COPII vesicles for secretions towards the Golgi (8). The 
misfolded glycoproteins that enter in and out of the CNX/CRT folding cycle ultimately become trimmed 
by ER mannosidase I (Man I) to a Man8GlcNAc2 and either (9) bind to EDEM (which can be soluble or 
membrane bound) (10) or interact with various ER-resident chaperones/folding enzymes (Yos9p, BiP, PDI 
etc.)(10). The substrate may be retained in the ER for folding and rescue attempts by these chaperones 
(10), but if the protein is still misfolded, then it is eventually relayed to the retrotranslocation apparatus 
either directly (11) or indirectly (through EDEM). (11) EDEM-bound substrates are targeted for 
retrotranslocation to the cytosol. (12) The ERAD substrate traverses the ER membrane. The AAA-ATPase 
P97 and/or 19 RP might drive the dislocation of the possibly unfolded chain via an unknown retro-
translocon. In the cytosol, various E3, deglycosylation  (Png1), deubiquitination enzymes interact with the 
glycoprotein before the proteasomal degradation. This figure was adapted from (Hebert et al., 2005). 
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facilitates the proper folding and/or prevent premature aggregation of incoming nascent 
chain. Hence, it is not surprising that proteins involved in N-glycosylation also 
participate in ERAD. These include CNX, CRT, UGGT and ManI and II (the N- 
glycosylation machinery as discussed above) (Fig. 14). Glycan moieties on misfolded 
proteins must retain a glucose residue to interact with CNX/CRT and undergo the re- 
and deglucosylation in order to fold properly (Ruddock and Molinari, 2006). UGGT has 
a major role in the CNX/CRT cycle and preferentially interacts with misfolded proteins 
(Guerin and Parodi, 2003). 
The most important job in glycoprotein quality control has been attributed to  α 1,2-
mannosidases (Suzuki et al., 2006). The first observations that mannose trimming plays 
an important role in the degradation of misfolded proteins originated from inhibition 
studies (Helenius, 1994; Molinari et al., 2002; Su et al., 1993; Wu et al., 2003). When 
specific α1,2-mannosidase inhibitors, Kif or dMNJ were used to inhibit mannose-
trimming activity or when yeast ManI was mutated, a delay in misfolded protein 
disposal was observed (Kawar and Jarvis, 2001; Kawasaki et al., 2007; Kitzmuller et al., 
2003; Lu et al., 2006). When ManI was overexpressed, the misfolded proteins were 
eliminated faster. These findings led to the theory of “mannose-timer” (Helenius and 
Aebi, 2001; Liu et al., 1999). Removal of mannose residues would decrease the affinity 
of UGGT for the folding intermediate, which in turn would not enter the CNX/CRT 
cycle and/or would fold with a reduced speed, thereby making it possible for the ERAD 
machinery to recognize and eliminate this misfolded protein. 
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Saccharomyces cerevisiae does not contain any UGGT or CRT; even its CNX 
homologue (Cne1p) is very different from the mammalian one. Although the mannose 
trimming mechanism is present in S. cerevisiae, it is a much simpler version of the 
mammalian counterpart, which is evolutionarily more developed and complex. Recent 
studies demonstrated that mannose trimming can proceed up to GlcMan5-6GlcNAc2 
(Foulquier et al., 2004; Frenkel et al., 2003; Hosokawa et al., 2003; Hosokawa et al., 
2001; Kitzmuller et al., 2003).  
The lectin, EDEM, is important for capturing the substrate after mannose removal. 
EDEMs possess the glycan-binding pocket, but with no apparent hydrolytic activities 
(Molinari et al., 2003), although the latter is debated (see above) (Olivari et al., 2006). 
Even though the role of EDEM is unknown, overexpression of either EDEM 1 or 3 
resulted in the elimination of misfolded N-glycans at a faster rate. When the EDEM gene 
was disrupted, the retrotranslocation rate decreased (Hirao et al., 2006; Hosokawa et al., 
2003; Hosokawa et al., 2001; Mast et al., 2005; Molinari et al., 2003; Movsichoff et al., 
2005; Oda et al., 2003; Oda et al., 2006; Olivari et al., 2006; Olivari et al., 2005). 
Interaction between EDEM and the misfolded N-glycans has been shown by co-
immunoprecipitation (Oda et al., 2003). Experiments also demonstrated that CNX 
transfers an ERAD substrate to EDEM (Oda et al., 2003). Mammalian Derlin-2 and 3 
has been discovered to interact with EDEM-1, which might form the putative 
retrotranslocation channel (Figs.15Aiv. and Biv.) (Oda et al., 2006). This study proposed 
that EDEM-1 might transfer the glycoprotein target to the dislocation site on the 
membrane and eventually to p97 (Oda et al., 2006). EDEM might prevent 
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Figure 15.  Different ERAD complexes aid distinct ERAD substrates. Some of the most important 
ERAD components, but not all of them identified to date are shown on panels (A) and (B). (A) The 
ERAD-C pathway. ERAD substrate with a cytosolic misfolded region (yellow star) may rely on a different 
dislocation pathway than those substrates with a lumenal or transmembrane abnormality (B). ERAD-C 
substrates may require an ubiquitin ligase, Doa10p in complex with Ubx2p. Ubx2p can recruit the 
Cdc48/p97 complex via its UBA domain (Neuber et al., 2005) (ii). The putative retrotranslocon (either the 
Sec61 channel (i) or Der1 (iii)) may associate with the E3 complex. Der1 might also form a complex with 
VIMP, (a single-spanning membrane protein that may bind Cdc48/p97) (Ye et al., 2004). The Der1/VIMP 
complex alone or in association with Der2-3 (iv) (Oda et al., 2006), or these components in different 
combinations, constitutes the putative retrotranslocon. There is evidence that Sec61 may either be the part 
of this channel or associates with some of these membrane components (Plemper et al., 1997). The nature 
of the retrotranslocon is still largely unknown. If the ERAD substrate contains a cytosolic lesion, it 
requires soluble cytosolic factors for its extraction. These proteins include CHIP (an E3 ligase)(Younger et 
al., 2006), cytosolic Hsp70 (Meacham et al., 2001), or Hsp104 (Taxis et al., 2003). Ubiquitin-conjugation 
enzymes Ubc7p and Ubc1p (not shown) may also play a role. The membrane extraction of an ERAD-M 
substrate may be facilitated by either the Cdc48/p97 complex (Ye et al., 2003), the 19S RP (Wahlman et 
al., 2007) or a combination of both. (B) ERAD-L and ERAD-M substrates with the misfolded region in 
either the lumen or in the membrane, respectively. It has been proposed that either the Sec61 channel (i) or 
the Hrd1 E3 complex (ii) or Der1 (iii) in combination with (i) or (ii) or (iv) form the retrotranslocon pore. 
How this ERAD substrate crosses the membrane is still largely unknown. On the lumenal side they 
interact with soluble lumenal chaperones like PDI/BiP and/or the N-glycosylation machinery. On the 
cytosolic side, they might be extracted by Cdc48/p97 or 19S RP, which was reported to interact with the 
translocon (Ng et al., 2007). Usa1 is thought to recruit the AAA complex and may connect Der1 to the 
Hrd1 complex (Carvalho et al., 2006). Hrd3 (an E2 enzyme) has a large lumenal domain, which can gather 
the ERAD-L substrates on the lumenal side for retrotranslocation (Gardner et al., 2000; Mueller et al., 
2006; Plemper et al., 1999a). There could be still many unidentified components in both (A) and (B). 
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Figure 15. Continued. 
 
premature aggregation and disulfide bond formation. One research group claimed that 
chaperoning activity was not linked to the mannosidase-like activity, because EDEM 
mutants that were defective in their catalytic domain could still interact with the 
substrate similar to wild type EDEM (Olivari et al., 2006). 
Yos9p, another lectin in the yeast ER lumen, has been reported by three different 
groups simultaneously to participate in a retrotranslocation associated process 
(Bhamidipati et al., 2005; Kim et al., 2005; Szathmary et al., 2005). Co-
immunoprecipitation established a direct interaction between Yos9p and a misfolded 
ERAD glycoprotein substrate that contains either GlcMan8GlcNAc2 or 
GlcMan5GlcNAc2. These three independent studies disagreed on several issues, 
primarily the contribution of EDEM-1 to the Yos9p-mediated interactions and the 
deciding factor in substrate recognition. These groups all agreed on the important role of 
Yos9p in glycoprotein ERAD. Yos9p has a mammalian homologue, OS-9 (Carvalho et 
al., 2006). 
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An ERAD-L substrate must traverse the ER membrane to degrade in the cytosol. The 
soluble ERAD substrates must exit the ER, presumably through an aqueous pore-
complex; similar to the translocon which promotes the forward translocation. It was 
proposed, based on data with yeast translocon mutants, that both soluble and membrane 
proteins are exported from the ER through the Sec61 translocon (Ali et al., 2005; Pilon 
et al., 1997; Plemper et al., 1999b; Plemper et al., 1999a; Sommer and Wolf, 1997) 
(Figs. 15Ai and Bi).  It is conceivable that the translocon has several operational modes 
(Johnson and Haigh, 2000), and several translocon associated proteins facilitate the 
putative switch between retro- or forward translocation. However, the data are not 
completely convincing, because it was not clear in the studies done to date whether the 
substrate molecules were on their way out to the cytosol or into the lumen. The human 
cytomegalovirus (HCMV) produces a membrane-anchored protein, called US2. US2 
causes the class I major histocompatibility complex (MHC) to retrotranslocate from the 
ER to the cytosol, and US2 was found in association with the Sec61 translocon (Wiertz 
et al., 1996a; Wiertz et al., 1996b).  
It is unclear whether the same route is utilized by all glycosylated ERAD substrates 
and also how these substrates are targeted to the retrotranslocation site (Fig 15). It has 
also not been determined to date whether ERAD substrates exit the ER in an unfolded 
state, and if so, whether one end moves through the membrane preferentially. Newly-
synthesized proteins enter the ER lumen in an unfolded state, so when they may exit 
through the ER membrane they also need to be unfolded. Consistent with this idea, 
cholera toxin is unfolded by PDI before dislocation from the ER (Tsai and Rapoport, 
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2002; Tsai et al., 2001; Tsai et al., 2002). Yet some fully-folded domains (DHFR and 
GFP) conjugated to an ERAD substrate also retrotranslocated, implying that unfolding is 
not necessary for retrotranslocation (Fiebiger et al., 2004; Fiebiger et al., 2002; Tirosh et 
al., 2003; Tirosh et al., 2005). If folded proteins are retrotranslocated, the 
retrotranslocation pore has to be large in diameter, because DHFR and GFP have 
diameters of 40 and 24 Ǻ diameters respectively. Glycosylated substrates also return to 
the cytosol with a complete set of glycosylation moieties where they are removed by de-
glycosylation enzymes (Petaja-Repo et al., 2001).  
The crystal structure of a Sec61 homologue (archaeal SecYEG) indicated that the 
translocon has a 10 –12 Ǻ diameter, which would be inconsistent with its proposed 
retrotranslocation function (Osborne and Rapoport, 2007; van den Berg et al., 2004). But 
the crystal structure is unable to provide data on the flexibility and dynamic nature of the 
translocon (Hamman et al., 1997; Johnson and van Waes, 1999; Wirth et al., 2003). In 
contrast, fluorescence quenching experiments indicated that a translocon engaged with 
the translating ribosome has a pore diameter of a 40-60-Ǻ (Hamman et al., 1997).   
  It is also possible that another integral ER membrane protein with an unknown 
function may facilitate the export of ERAD substrates through the membrane (Hitt and 
Wolf, 2004; Knop et al., 1996) (Figs. 15Aiii and Biii). For example, it has been recently 
discovered that Derlin-1 (Der1 or Der1p in yeast) with four transmembrane domains in 
the ER membrane may have such role in ERAD (Ye et al., 2004). An interaction of Der1 
with class I MHC upon US11-dependent degradation has been detected by co-
immunoprecipitation, a finding that led to suggested that Der1 may be a part of the 
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retrotranslocation channel (Lilley and Ploegh, 2004), yet Der1p does not seem to be 
required for all the ERAD substrates in yeast (Taxis et al., 2003). Other likely candidates 
are some ubiquitin ligases (Hrd1p and Doa1p) that span the membrane several times 
(Fig. 15Aii and 15Bii). This would provide an opportunity to link retrotranslocation to 
ubiquitination at the same time (Deak and Wolf, 2001; Gardner et al., 2000; Kota et al., 
2007; Kreft et al., 2006).  
 The next question is how polypeptides are released into the cytosol. 
Retrotranslocation probably requires a driving force to facilitate unidirectional 
movement of an ERAD substrate from the lumen. Most, but not all ERAD substrates are 
polyubiquitinated, and ubiquitin conjugation might serve as a 'ratchet', if 
polyubiquitination (discussed later) and export are coupled (Biederer et al., 1997; de 
Virgilio et al., 1998; Shamu et al., 2001). It has been proposed that cytosolic molecular 
chaperones might assist polypeptides in exiting the ER. During post-translational 
translocation into the ER and mitochondria, BiP and mitochondrial Hsp70, respectively, 
power the translocation of polypeptides. Hence, retrotranslocation may be similar to 
post-translational translocation, except in the opposite direction.  
Experiments in the presence and absence of impaired 26S proteasomes showed that 
ERAD substrates with both integral membrane spanning and cytosolic regions had their 
cytoplasmic regions degraded more rapidly than the membrane spanning domains 
(Mayer et al., 1998; Walter et al., 2001). This finding suggested that the proteasomal 19S 
cap might play a role in the extraction of the integral membrane segments  (Fig. 15). If 
true, the 19S cap of the 26S proteasome may power the ATP-dependent extraction of the 
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substrate while the 20S proteolytic subunit degrades the substrate (Hirsch and Ploegh, 
2000). Using a yeast in vitro assay, it was shown that yeast cytosol can be substituted by 
purified yeast or mammalian proteasomes to fulfill the requirements for degradation of 
an ERAD substrate (Lee et al., 2004). When the proteasomal degradation activity was 
inhibited, most of the ERAD substrates can be located in the cytosol (Lee et al., 2004). 
These results suggest that extraction and degradation were uncoupled, and the substrate 
is retrotranslocated through the membrane by either another protein (e.g. Cdc48/p97; see 
below) or only the 19S cap of the proteasome (Jarosch et al., 2002; Johnston et al., 1998; 
Wiertz et al., 1996b).  
Consistent with this model, the Cdc48 (p97)/Ufd1/Npl4 complex on the cytosolic 
side of the membrane may aid the retrotranslocation and extraction of some 
ubiquitinated ERAD substrates (Bays et al., 2001a; Bays et al., 2001b; Braun et al., 
2002; Hitchcock et al., 2001; Jarosch et al., 2002; Rabinovich et al., 2002; Ye, 2006; Ye 
et al., 2001). The first evidence that Cdc48/p97 was involved in degradation came from 
studies that examined an unfolded substrate with an N-terminal ubiquitin conjugation 
(Ghislain et al., 1996).  
Cdc48/p97 could also act after the ERAD substrate was extracted from the 
membrane, as was shown by work done with the Spt23p precursor protein proved this 
hypothesis (Hitchcock et al., 2003; Hitchcock et al., 2001; Rape et al., 2001). This 
protein is an integral membrane protein that forms a homodimer called p120 (120 kDa). 
It becomes cleaved upon activation to a membrane bound and a soluble fragment, p90 
(90 kDa), and this proteolysis step takes place after ubiquitination of the p120. Since this 
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ERAD substrate accumulated on the cytoplasmic face when mutant yeast cells had 
defective Npl4 and Ufd1, p97/Npl4/Ufd1 appear to be involved (Bays et al., 2001b; 
Jarosch et al., 2002). These data implied that Cdc48/Npl4/Ufd1 removed the 
ubiquitinated p90 from the membrane-bound p120. A recent study also suggested that 
Cdc48/Npl4/Ufd1 might bind to a monomeric or very short ubiquitin chain on p90 
(Richly et al., 2005). These short ubiquitin chains were then further elongated by Ufd2p 
and eventually passed on to Rad23p/Dsk2p from Cdc48/Npl4/Ufd1, which then 
delivered p90 to the proteasome (Chen and Madura, 2002; Funakoshi et al., 2002). This 
process was named the “escort pathway” that hands over the ERAD substrate to a set of 
proteins with affinities for different ubiquitin chains (Richly et al., 2005). Rad23p was 
also found to interact with a deglycosylation enzyme, Png1p (Fig.14) (Elsasser et al., 
2004; Medicherla et al., 2004; Suzuki et al., 2001).  
Cdc48 [p97 or VCP (valosin-containing protein) in mammals] belongs to the AAA-
ATPase family. Both Sec18p and Cdc48 contain a SRH-motif (Second Region of 
Homology) and have duplications in the their ATP-binding domain (Frohlich et al., 
1991; Lee and Wickner, 1992). X-ray structures elucidated the conformational changes 
that p97 goes through during the ATP hydrolysis cycle (DeLaBarre and Brunger, 2003; 
DeLaBarre and Brunger, 2005; DeLaBarre et al., 2006). This catalytic nucleotide-
dependent structural change is responsible for its substrate unfolding activity (Dreveny 
et al., 2004; Yuan et al., 2004).  
Cdc48 and the proteasome might interact directly with each other as well. Cdc48 
preferentially works on proteins with a Ubx domain (similar to the structure of ubiquitin) 
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via its N-terminus (Decottignies et al., 2004; Schuberth and Buchberger, 2005; 
Schuberth et al., 2004). There have been seven Ubx-domain proteins identified in yeast 
to date (including Ubx1p/Shp1, the yeast p47 homologue). A Ubx-motif protein, 
specifically Ubx2p, is required for the degradation of several ERAD substrates such as 
CPY* (Neuber et al., 2005), and an artificial ubiquitin-containing protein by recruiting 
Cdc48/Ufd1p/Npl4p, Doa1p and Hrd1p (Fig. 15Aii and 16Bii). Ubx2p also interacts 
with Der1p and Dfm1p (a Der1p homologue in yeast), perhaps to form a putative 
retrotranslocation pore (Guerra et al., 2005; Lilley and Ploegh, 2004; Lilley and Ploegh, 
2005; Schuberth and Buchberger, 2005; Ye et al., 2004). According to another group 
(Romisch, 2006), Cdc48 may bind directly to Der1p and causes Der1p to interact with 
the membrane-bound UBX domain of Ubx2p, while the UBA motif of Ubx2p contacts 
the Sec61 channel through ubiquitin ligases.  
Ufd1p was discovered through screening for ubiquitinated mutants with decreased 
degradation (Johnson et al., 1995). The NMR structure showed separate binding sites for 
mono and polyubiquitin (Park et al., 2005). The N-terminal domain of Ufd1p is very 
similar to that of Cdc48, suggesting that Ufd1p also can bind to Ubx2p. The other co-
chaperone of Cdc48, Npl4p, plays an important role in nuclear pore function and nucleus 
structure (DeHoratius and Silver, 1996). Npl4p mutant yeast strains showed no 
detectable impairment in cytosolic protein degradation, but some ERAD substrates 
accumulated in an ubiquitinated form in the cytosol, suggesting a role in 
retrotranslocation (Bays et al., 2001). Npl4p-Ufd1p heterodimer adaptors bind to Cdc48p 
via the Npl4p ubiquitin fold domain (UFD) (Hitchcock et al., 2001). This suggests that 
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Npl4p and Upd1p play a role in retrotranslocation after ERAD substrate ubiquitination, 
but before proteasome degradation (Bruderer et al., 2004; Hitchcock et al., 2001).  
Another protein, Ufd2p, also binds to Cdc48p, but this interaction is inhibited by the 
membrane bound ubiquitin-ligase Doa1p (also called Ufd3p), which competes for the 
same binding site (Ghislain et al., 1996; Rumpf and Jentsch, 2006). A deubiquitination 
protein in yeast, Otu1p also utilizes the same docking site on Cdc48 (Rumpf and Jentsch, 
2006). These interesting findings suggested that Cdc48 acts in the ubiquitination 
pathway as a core regulator, and its preference for different ubiquitin interacting 
proteins/adaptors determines the fate of its substrate. Unfortunately, currently there are 
no data available that would show whether specific chaperones, polyubiquitination, or 
the proteasome were itself aid retrotranslocation for ubiqutinated substrates.  
Another uncertainty is whether the retrotranslocated proteins are degraded 
exclusively by 26S proteasome in the cytosol. Although the 26S proteasome is a major 
player in ERAD, alternative pathways are present in mammalian cells and can play an 
important role in the disposal of both glycoproteins and non-glycoproteins.  It has been 
demonstrated that at least two ERAD substrates utilized both a proteasome-dependent 
and a proteasome-independent degradation pathways simultaneously (CPY* and A1PiZ 
in mammalian cells) (Brodsky et al., 1999; Kruse et al., 2006; Mancini et al., 2003; 
Marcus and Perlmutter, 2000; McCracken et al., 1996; Palmer et al., 2003; Qu et al., 
1996; Teckman et al., 2001; Teckman and Perlmutter, 1996). RNA interference 
experiments identified the protease of the latter pathway as insulin degrading enzyme 
(IDE), which belongs to the M16 metalloprotease family (Schmitz and Herzog, 2004; 
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Schmitz et al., 2004). Similarly, experiments with ApoB revealed that proteasomes were 
responsible for only part of its degradation (Pariyarath et al., 2001).  
It is likely that individual ERAD substrates will exhibit differential requirements for 
degradation since no two ERAD substrates to date were found to have identical 
requirements for their degradation. This is not surprising since ERAD substrates are 
either soluble in the lumen or integrated in the ER membrane (Fig. 15) where their 
domains are located in the cytosol, lumen, or ER membrane. As a result, a single 
pathway is perhaps inadequate to accommodate all substrates.  
Experiments with the single-spanning α-subunit of the T-cell receptor (TCRα) 
membrane protein showed that the retrotranslocation of this protein is initiated from the 
lumenal side (Yu and Kopito, 1999), and its degradation depends on the Hrd1p ubiquitin 
ligase (Kikkert et al., 2004). This study also suggested that the degradation of both 
lumenal and membrane proteins depends on lumenal factors. Additionally, class I MHC 
degradation seems to be independent of cytoplasmic lysine residues that could be 
ubiquitinated (Furman et al., 2003; Shamu et al., 1999). 
It has been proposed (Vashist et al., 2001) that most soluble ERAD substrates require 
lumenal, but not cytoplasmic, chaperones, while the degradation of most ER membrane 
proteins involves cytoplasmic, but not lumenal chaperones. A membrane protein, Ste6p 
was examined to identify what factors were involved in its retrotranslocation. The two 
halves of this protein each contain six transmembrane segments and a large cytosolic 
domain. Ste6p is rapidly degraded if this protein lacks its last 52 residues (Ste6p*) 
(Loayza et al., 1998). Ste6p* requires only cytosolic chaperones (Huyer et al., 2004a). 
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The cytosolic Hsp70 chaperone, Ssa1p, and its two co-chaperones (Ydj1p and Hlj1p) are 
involved, but not the lumenal Kar2p. Ydj1p is attached to the ER membrane by 
prenylation, while Hlj1p is a signal-anchor membrane protein. Its degradation also 
depends on Doa10p ubiquitin ligase that associates normally with Ubc6p and Ubc7p, 
and directly or indirectly to Cue1p (Swanson et al., 2001). It was also shown that Hrd1p 
contributes to Ste6p* degradation, and not through the yeast Sec61 channel, but a 
homologue (Ssh1p) (Wittke et al., 2002). Another ER membrane protein that contains 
misfolded cytosolic domains is the mutant plasma membrane protein ATPase [(Pma1p 
(D378N)], and its degradation requires a disulfide-isomerase (Eps1p) (Wang and Chang, 
1999; Wang and Chang, 2003).  
Interestingly, when membrane proteins contain a misfolded lumenal region, they 
require lumenal chaperones (Fig. 15B). For example, the misfolded ABC multidrug 
transporter protein (Pdr5p*) (Plemper et al., 1998) needs Htm1p (EDEM) (Gnann et al., 
2004; Jakob et al., 2001; Plemper et al., 1998) and Der1p, but not Kar2p. Studies with 
CPY* have taken this finding further, by fusing CPY* on the lumenal side through a 
Pdr5p transmembrane segment to cytoplasmic GFP the obtain CTG* (Taxis et al., 2003). 
Degradation of this chimera depends on the proteasome and cytosolic Dsk2p, Rad23p, 
and Hsp70 with its co-chaperones (Hlj1p, Cwc23p, and Jid1p), but is independent of 
Der1p and Kar2p. The authors proposed that the misfolded lumenal domain might signal 
through the GFP domain to recruit cytoplasmic chaperones.  
Another protein chimera that has been constructed is signaling protein Wsc1p, with a 
single transmembrane segment fused to a KHN domain in place of the Wsc1p, N-
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domain (Vashist et al., 2001) (KHN is a Kar2 signal peptide fused to simian virus5 HA-
Neuraminidase ectodomain). This fusion protein, KWW, has a misfolded lumenal 
domain, and its degradation depends on Cue1p, Htm1p, Der1p, Hrd1p, and on ER-Golgi 
trafficking. When a different chimera (KSS) contained misfolded domains on both sides 
of the ER membrane, (Ste6p* in the cytosol and KHN in the lumen), the degradation 
required all of the components were necessary for degradation of Ste6p* protein (Huyer 
et al., 2004b). Thus, the use of modular substrates has elucidated some important 
features of the degradation of membrane proteins (Huyer et al., 2004a; Huyer et al., 
2004b; Schulze et al., 2005; Taxis et al., 2003).  
Another group used a systematic approach in yeast to identify the retrotranslocation 
factors for both soluble and membrane-bound ERAD substrates (Carvalho et al., 2006). 
They found that the retrotranslocation of soluble (ERAD-L) substrates usually involved 
Hrd1p ubiquitin ligase, Hrd3p, Der1 and Usa1p (Hrd1/gp78; Sel1; Der1, 2,3; Herp in 
mammals respectively) (Fig. 15B). ERAD substrates with misfolded transmembrane 
segment utilize ERAD-M pathway, while ERAD-C pathway involves Doa10 also (Teb4 
in mammals).  The ERAD-L pathway is generally the more complex of these three. 
 An ER membrane complex may be associated with both Yos9p (Os-9) on the 
lumenal side through the Hdr3 domain and with Cdc48 on the cytosolic side through 
Ubx2p (Richly et al., 2005; Schuberth and Buchberger, 2005). Some co-
immunoprecipitation experiments obtained these data via sucrose gradient centrifugation 
of digitonin-solubilized membranes. It was proposed that the Hrd1 complex might 
receive substrates from different sources (Fig.15Bii), since the Hrd3 mutant cells were 
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still able to degrade CPY* when Hrd1 was over-expressed (Gauss et al., 2006; Plemper 
et al., 1999a). A newly discovered protein; Usa1 perhaps provides the link between Der-
1 and Hrd1 (Figs. 15Bii and iii). Usa1 seemed to associate with all ERAD-L substrates 
tested in this study and also with Hrd1p (Gauss et al., 2006). Interestingly ERAD-M 
substrates do not require either Usa1 or Der1 that has been implicated in forming the 
channel (Carvalho et al., 2006). These results are consistent with other experiments 
based on yeast mutant strains and the membrane protein version of CPY* (Taxis et al., 
2003). ERAD-M substrates might become ubiquitinated by the Doa10 complex that 
recruits Cdc48 (Neuber et al., 2005; Ravid et al., 2006; Swanson et al., 2001) (Fig. 
15Aii). 
 In summary, the hypothesis is that ERAD substrates undergo both lumenal and 
cytosolic checkpoints. The first is the cytosolic, and if the protein found misfolded on 
this side, it becomes ubiquitinated and degraded by the Doa10 machinery. Hence, the 
cytosolic quality control presumably predominates over the lumenal one. If a membrane 
protein contains a lumenal or transmembrane misfolded region, the degradation pathway 
shares similarities with the degradation patterns of soluble ERAD substrates. These 
observations may result, at least in part, to cytoplasmic chaperones inhibiting the 
aggregation of the cytoplasmic domains of integral membrane ERAD substrates, while 
lumenal chaperones may maintain the lumenal ERAD substrates and domains in a non-
aggregated state, so that they successfully exit the ER lumen. Everything considered, all 
of these apparently contradictory findings highlight the need for further experiments 
(Carvalho et al., 2006) in more well-defined systems. 
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ERAD of the ubiquitin-proteasome system at the ER membrane 
The ubiquitin (Ub) protein exists in all eukaryotic cells in a structurally conserved 
form as the name entails (Hershko, 1983; Smalle and Vierstra, 2004). Ub has a globular 
final structure, with five beta-sheet strands forming a cleft into which an α-helix can 
insert. Free Ubs are conjugated in an ATP-dependent manner to E1 (Ub-activating 
enzyme) (Hershko, 1983; Hershko et al., 1983) by forming an acyl-phosphoanhydrate 
bond first between AMP (adenosine monophosphate) and the C-terminal carboxyl group 
of glycine on the Ub, and later between a thioester bond between E1 and this glycine 
residue (Hatfield et al., 1997; Kornitzer and Ciechanover, 2000). Transesterification 
occurs upon transferring Ub from E1 to E2 (Ub-conjugating enzyme). Several isoforms 
of E2 exist in a cell, but they all have a common domain with a 150-residue region that 
encloses the active site cysteine. Each E2 has a distinct function in the cell by interacting 
with a specific E3 (Ub ligating enzyme) (Fang and Weissman, 2004).  In the final step, 
with the help of the E3, the Ub is attached to a lysine ε-amino group on the substrate by 
an isopeptide bond to the carboxyl group of glycine on the Ub (Fig. 16A). There are at 
least four different E3 families (Ardley and Robinson, 2005). These include the HECT 
(homology to E6AP C-terminus) (Huang et al., 1999; Wang and Pickart, 2005), 
RING/U-box (Real interesting new gene) (Hatakeyama and Nakayama, 2003), APC 
(anaphase-promoting complex) (Hershko, 2005), and SCF (F-box) protein families (del 
Pozo and Estelle, 2000; Lechner et al., 2006). 
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Figure 16.  The ubiquitination pathway 26 proteasome and organization and structure. (A) Ubiquitin 
(Ub) is activated in an adenosine triphosphate (ATP)-dependent manner via the Ub-activating enzyme 
(E1). Ub is subsequently transferred to an Ub-conjugating enzyme (E2), and ultimately Ub is attached to a 
lysine in the target protein with by an Ub-ligating enzyme (E3). In some cases another Ub is added to the 
previous ubiquitin by of the above enzymes in collaboration with E4. Once the polyUb-protein conjugate 
is ready, it is degraded by the 26S proteasome in an ATP-dependent manner. Individual Ub monomers are 
released by deubiquitinating enzymes (DUBs) that dismantle the polyUb chain to regenerate both the 
target protein and Ubs. (b) The possible structure of the 19S regulatory particle (RP) predicted from its 
individual subunit interactions. The two components, the lid and the base are depicted in pink and light 
blue, respectively. All six AAA subunits (T) are shown in green, while the other non-ATPase subunits are 
shown in yellow (N). The lid non-ATPase subunits are in red (N), and all the subunits in the 19S RP are 
numbered (c) Illustration of the 26S proteasome and its two components, the 20S core protease (CP) and 
the 19S regulatory particle (RP). (d) The operation of the 20S core protease (CP) postulated from the 
crystal structure of the yeast 20S CP. The active-site threonines are portrayed in the middle of the CP. The 
possible functional stages of the 26S are shown throughout the degradation of ubiquitinated proteins. This 
figure was adapted from (Vierstra, 2003). 
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Figure 16. Continued. 
 
The substrate and its conjugate E2 and E3 complexes to determine whether 
additional Ubs are added to the first Ub conjugated to the substrate to form a 
polyubiquitinated substrate. Substrates with only one ubiquitin attached are targeted to 
the lysosome/vaculole. All seven lysines of the Ub can be used to conjugate additional 
Ub. The most common one is the lysine 48 conjugation, which is recognized by the 26S 
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proteasome (Kostova and Wolf, 2003; Kruger et al., 2001; Pety de Thozee and Ghislain, 
2006). 
The first indication that the ubiquitin-proteasome system is involved in the 
degradation of misfolded ER lumenal and membrane proteins came from studies 
conducted with a CFTR mutant, CFTR∆F508. Inhibition of the proteasomal 20S subunit 
resulted in accumulation of CFTR at the ER membrane (Jensen et al., 1995; Ward et al., 
1995). Experiments with yeast mutants revealed the presence of five genes [Ufd1p-
Ufd5p (Ubiquitin fusion degradation)] that play an important role in ubiquitin-dependent 
degradation (Johnson et al., 1995). Ufd2p, an E4 multiubiquitination enzyme can further 
extend the length of the ubiquitin chains (Jentsch and Rumpf, 2007; Rumpf and Jentsch, 
2006) (Fig. 16A).  
Yeast genetic experiments with temperature-sensitive mutations indicated that Ub-
conjugating enzymes Ubc6p and Ubc7p were involved in ERAD (Biederer et al., 1996; 
Sommer and Jentsch, 1993). Ubc6p is an integral membrane protein, while Ubc7p is a 
soluble cytoplasmic protein recruited to the ER membrane by an ubiquitin ligase, Cue1p  
(Fig. 15; cytosolic side) (Biederer et al., 1997). 
 Substrates degraded via the Ub-proteasome pathway in the ER, include the 
HMGCoA reductase (3-hydroxy 3-methylglutaryl coenzyme A), which is involved in the 
mevalonate pathway (Hampton, 2002a; Hampton, 2002b). Hmg2p is one of the ER 
bound isoforms of this protein, and it is rapidly degraded when a large amount of 
mevalonate is present.  
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Hrd1p/Der3p is a complex found in association with the translocon and belongs to 
the RING-domain Ub-ligase family (Bays et al., 2001a; Deak and Wolf, 2001; Hampton 
et al., 1996). This complex not only plays a role in Hmg2p degradation, but also in the 
misfolded carboxypeptidase Y (CPY*) (Bordallo et al., 1998). The Hrd1p/Der3p 
complex also has at least two Ub-conjugating enzyme partners, Ubc7p and Ubc1p. 
 A cofactor, Hrd3p has a large lumenal domain that may participate in recruiting 
ERAD substrates for retrotranslocation (Gardner et al., 2000). Its mammalian 
homologue, Sel1l, had also been identified and implicated in the degradation of the 
US11-mediated dislocation of the class I MHC heavy chain. Another Ub-ligase complex 
in the yeast ER membrane was named Doa1p, and it interacts with both membrane-
bound Ubc6p and Cue1p/Ubc7p (Shearer and Hampton, 2004; Shearer and Hampton, 
2005).  
Since different ERAD substrates require different Ub-ligase/conjugating enzyme 
complexes, it is very likely that there are several different ERAD pathways present 
within the ER (Vashist and Ng, 2004). While most of the yeast proteins can also be 
found in metazoan, there are additional Ub-ligases that participate in mammalian ERAD 
(Fang et al., 2001; Kikkert et al., 2004; Lenk et al., 2002) . For example CHIP, a soluble 
U-box Ub-ligase has been found to play a role in CFTR degradation (Ballinger et al., 
1999; Connell et al., 2001; Cyr et al., 2002; Dai et al., 2005; Jiang et al., 2001; Meacham 
et al., 2001; Qian et al., 2006; Younger et al., 2006; Younger et al., 2004).  
Additional examples are Parkin, a RING-finger containing Ub-ligase, and the Skp1-
Cullin1-F-box (SCF) complex (Imai et al., 2002; Imai et al., 2001; Imai et al., 2000). 
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The latter associates with F-box adaptor proteins (Fbs1, Fbs2) that recognize N-
glycosylated proteins that have been dislocated from the ER and targets them for 
degradation after removal of the N-glycans (Yoshida et al., 2005; Yoshida et al., 2007; 
Yoshida et al., 2003). 
The 26S proteasome 
Proteasomes are large (2 MDa), multi-catalytic enzyme complexes in the cell that 
can be found in the cytosol, attached to the ER membrane, or in the nucleus (Peters, 
1994; Peters et al., 1994; Smith et al., 2006; Voges et al., 1999) (Fig. 16C). The 
complete 26S proteasome is composed of 20S core particle that facilitates degradation, 
and the 19S regulatory particle (RP) cap that recognizes substrates for degradation 
(Glickman and Maytal, 2002; Glickman et al., 1998a; Glickman et al., 1998b; Glickman 
et al., 1999; Rubin et al., 1998). Electron microscopy data revealed that the proteasome 
is around 15 nm in length and 11 nm in diameter (Hase et al., 1980; Hough et al., 1987), 
cylindrical in shaped, and capped on one or both sides of the 20S core particle by the 
19S cap.  
The proteasome has a role in several cellular functions, including cell cycle control, 
metabolic adaptation, and stress response (Finley et al., 1987; King et al., 1996). 
Proteasomes also have an important role in the cellular immune response. The peptides 
released from its core chamber after degradation are transported into the ER lumen 
where they are loaded onto major histocompatibility complexes (MHC)-class I proteins. 
The resulting MHC-I•peptide complexes are then transported to the cell surface where 
 
 
 66
they can be recognized by the cytotoxic T lymphocytes (Belich and Trowsdale, 1995; 
Koopmann et al., 1997; Pamer and Cresswell, 1998; Rivett and Hearn, 2004).  
The 20S proteasome is highly conserved among eukaryotes, archaea, and some 
eubacteria. Prokaryotes have a homologue, called HslV that forms a 240 KDa 
homododecamer, which becomes a core of the ATP-dependent protease, HslVU 
(Bochtler et al., 2000; Goldberg et al., 1997; Rohrwild et al., 1997). In arhaea, the 20S 
core particle is comprised of two different gene products (α and β), and two rings of 
seven β-subunits are sandwiched between two rings of α-subunits (α1−7β1−7β1-7α1−7) 
(Dahlmann et al., 1986; Hegerl et al., 1991) (Fig. 16D). The α-subunits are not active 
proteolytically, and they fold as heptamers to serve as a folding template for back-to-
back assembly with the seven β-subunits. In yeast, α and β-subunits are all different 
with their own nomenclature. Four of the seven β-subunits are inactive in yeast, while in 
archaea all of them are active (Lupas et al., 1995; Wenzel and Baumeister, 1995). The 
three active β-subunits in yeast recognize different substrate features and have 
peptidylglutamyl-hydrolyzing (PGPH), trypsin-like, and chymotrypsin like, which 
explains the broad specificity of the proteasome (Kisselev et al., 2000; Wenzel et al., 
1994). Similarly there are at least five different activities in a mammalian proteasome. 
The opening of the assembled proteasome does not allow even a 1.4 nm gold particle 
through, so it is highly restricted, in terms of size. When the protein for degradation 
eventually enters the main chamber, it is degraded to at least a 4-25 residue long 
polypeptide, but with the average length of 7-9 residues (Bochtler et al., 1999).  
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The assembly of the 20S proteasome is a complex process, and passes through 
several precursor stages over several forms with the help of folding assistants/maturation 
factors (Hendil et al., 2002; Jager et al., 1999; Mayr et al., 1998; Rodriguez-Vilarino et 
al., 2000). The 20S proteasome can be activated and inhibited by various molecules. 
Among the inhibitors are peptide aldehydes (reversible), dipeptidyl boronic acids, 
peptidyl vinyl sulfanes, and the fungal irreversible inhibitor, lactacystine (Bogyo et al., 
1997a; Bogyo et al., 1997b; Fenteany et al., 1995; Kisselev et al., 2006; Klinger and 
Schubert, 2005; Tsukamoto and Yokosawa, 2006). Polycations, sodium dodecyl sulfate 
(SDS).  
PA28 is an ATP-independent activator of the 20S core particle with about a 200 kDa 
oligomeric weight (Dick et al., 1996; Groettrup et al., 1996; Ma et al., 1992). PA28 
exists in a heterohexameric or heteroheptameric form, composed of two different 
subunits (α and β). The crystal structure has shown that the central pore of PA28 aligns 
with the central pore of the 20S, and its C-terminus displaces the Ν−terminal 
interdigitating side-chains of the 20S that obstruct its opening (Knowlton et al., 1997). It 
was also proposed that the PA28 operates in concert with the 19S proteasome cap to feed 
the substrate into the 20S (Hendil et al., 1998).  
The 19S proteasome regulator (PA700 or 19S RP) has a molecular weight of 843 
kDa (Etlinger and Goldberg, 1977) (Fig. 16B). One or two 19S can form a higher 
molecular weight complex with the 20S proteasome in an ATP-dependent manner, to 
create the 26S proteasome (Rubin et al., 1998). The 19S cap has a ‘V’ shape with 
dimensions of 15 nm by 20 nm (Peters, 1994; Peters et al., 1993). It is composed of 17  
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Figure 17.  Models depicting the association of PAN with the α ring of the 20S proteasome and how 
PAN’s C-termini induce gate opening. (A) The C-termini (yellow) of PAN (orange) dock into the 
intersubunit pores in the top of the 20S. The HbYX motif in PAN’s C-termini is colored red. When PAN 
associates with the 20S proteasome (upon binding ATP), the translocation channel gate in the 20S is 
opened. (B) Seven-residue peptides that correspond to PAN’s C-termini dock to the intersubunit pockets 
in the α ring and induce gate opening by themselves. (C) The multiple ATP-dependent steps in protein 
degradation and the requirement for nucleotide binding and hydrolysis. This figure is reprinted with 
permission from Journal of Structural Biology  (Smith et al., 2006).  
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different subunits with the molecular masses of 12-112 kDa (Glickman and Maytal, 
2002; Glickman et al., 1998a; Glickman et al., 1998b). The six highly homologous 
ATPase subunits form a hexameric ring. 19S RP belongs to the AAA (ATPases 
Associated with a variety of cellular Activities) protein family (Ogura and Tanaka, 
2003). The members of this protein family all contain a Walker motif, which is a 
conserved ATP-binding domain of 200-250 residues (Confalonieri and Duguet, 1995). 
Most of these AAA protein complexes are involved in ATP-dependent 
assembling/disassembling, an unfolding/folding protein complexes (Smith et al., 2006). 
The 19S proteasome can also be divided into two subcomponents called the base and the 
lid. The base is composed of the six ATPase subunits (Rpt 1-6) and two non-ATPases 
subunits (Rpn 1-2), while the lid has nine non-ATPase subunits (Rpn 3-12) (Voges et al., 
1999). The crystal structure of the 19S complex is not yet known, but the base shares 
similarity with the Methanococcus ATPase [PAN (proteasome activating nucleotidase)] 
(Benaroudj and Goldberg, 2000; Zwickl et al., 1999). The PAN complex and the 20S CP 
together degrade proteins in most archaea in an ATP-dependent manner (Fig. 17A) 
(Navon and Goldberg, 2001). Elucidation of the structure of PAN by mass spectroscopy 
and electron microscopy (EM) has revealedsome functionally significant insights into 
the operation of the eukaryotic 19S RP (Smith et al., 2005).   
Mutagenetic studies (Glickman et al., 1998b; Glickman et al., 1999) showed that all 
the six ATPases have distinct and important functions. The Rpt2 (S4) subunit had the 
most pronounced effect on cell growth and on the opening the gate of the 20S CP 
(Kohler et al., 2001). It was shown that the association between PAN and the 20S CP 
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requires ATP, but not ATP hydrolysis (Figs. 17A and C) (Smith et al., 2005). EM 
studies also revealed that the association between PAN and 20S CP is very similar to the 
19S RP and 20S CP without the lid (Benaroudj and Goldberg, 2000). These EM images 
have shown not only a larger inner ring, but also an outer ring that corresponds to the 
non-ATPase subunits (Rpn1-2) (Figs. 17A and B) (Kajava, 2002). Perhaps this smaller 
outer ring of PAN actually corresponds to the coiled-coil domains in both PAN and 19S 
RP that are thought to play a role in substrate binding and recognition (Gorbea et al., 
1999; Zwickl and Baumeister, 1999; Zwickl et al., 1999). PAN binding to the 20S CP 
was stimulated by the presence of ATP, ATPγS, or AMPPNP, but not by ADP (Smith et 
al., 2005). Gate opening is the consequence of this binding, and is the key step in 
activating the 20S CP (Figs. 17A and C). Interestingly, a deletion of the C-terminal 
HbYX sequence that is present in four of the six 19S RP ATPases, and on all of the PAN 
subunits, inhibited binding to the 20S CP and subsequent gate opening (Smith et al., 
2006). Astonishingly, small peptides containing these seven residues have also been 
found to facilitate gate opening on their own by inserting themselves into the small 
pockets between the α-subunits of 20S CP (Fig. 17B) (Smith et al., 2005). It was also 
established that protein unfolding by 19S RP is distinct mechanistically from 
translocation into the 20S CP (DeMartino and Slaughter, 1993). These experiments 
showed that unfolding requires ATP-hydrolysis, but not the translocation (Liu et al., 
2006). This finding implied that a protein enters the main chamber passively.  
When the directionality of the translocation process was examined, it was found that 
certain substrates entered the proteasome with the C-terminus, while others entered with 
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the N-terminus, and some with either end first (Goldberg, 2007). The 20S proteasome 
can also make peptide cleavages in a polypeptide loop (Liu et al., 2003). The 20S 
proteasome alone showed no directional bias, so this preference results from an 
interaction between the substrate and the ATPase subunits (Goldberg, 2007; Navon and 
Goldberg, 2001). Ubiquitination can also influence the direction by which the substrate 
enters into the 20S CP (Goldberg et al., 2001).  
AAA protein family: Cdc48/p97 
The AAA protein family belongs to a large and diverse AAA+ protein family that 
participates in many cellular activities, hence its name: ATPase Associated with various 
cellular Activities (Erdmann 1991). The AAA+ family includes AAA proteins with 
protease activity, and includes transcription regulators, activators, and helicases, 
peroxisomal biogenesis (Pex1, Pex6), vesicle-mediated transport (Sec18/NSF), control 
of cell division (Cdc48/p97), proteolysis (FtsH), endosome biogenesis (Vps4), and 
microtubule-separation (katanin) (Aravind et al., 1999; Neuwald, 1999; Neuwald et al., 
1999; Volker and Lupas, 2002). AAA proteins contain a well-conserved region, termed 
second region homology domain (SRH) (Tomoyasu et al., 1993a; Tomoyasu et al., 
1993b), and only those proteins that have a homologous region are considered members 
of the AAA family.  
The family has five major subtypes: proteasomal proteins, metallproteases, D1 
domains, D2 domains and meiotic proteins (Frohlich, 2001). AAA proteins consist of an 
N-terminal non-ATPase domain that was proposed to play a role in substrate 
recognition, and one or two ATPase domains (Fig. 18A). Structures of p97 and NSF (N-  
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Figure 18. Location of mutated residues lining the pore of p97/VCP. (A) The p97/VCP ADP hexamer 
is shown in a space-filling view with one of the protomers shown as cartoon (nucleotide as spheres). A 
side-on view (left panel) is shown with two of the protomer subunits cut away to reveal the central pore. 
The protomer is colored as follows: N domain, brown; D1 and D2 α/β, blue; D1α, purple; D2α, green. All 
of the Walker A/B and the SRH residues are near the nucleotide and not near the pore. Loops are 
highlighted by circles, (I) Arg586/Arg599, (II) Trp551/Phe552, and (III) His317 loop, and are colored red 
in the space-filling view. The arrow near loop (II) indicates the p97/VCP-SytI crosslinked region. The 
right panel shows a view looking down from the D2 end of the molecule. The location of the 
Arg586/Arg599 pair is colored red, and a cartoon protomer is given for reference. (B) Detailed views of 
the pore loops shown both for the protomer (left panels) and the molecular hexamer (right panels). In the 
hexamer views, protomers are uniquely colored and one of the protomers labeled. This figure is reprinted 
with permission from Molecular Cell (DeLaBarre et al., 2006) Elsevier (2007).  
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ethylmaleimide-sensitive factor) have been solved and representing D1 and D2 ATPase 
domain proteins, respectively (Fig. 18). When these two structures are superimposed on 
each other they display remarkable similarity, although only D1 is active catalytically 
(Lenzen et al., 1998; Yu et al., 1998; Zhang et al., 2000). 
D1 domain is composed of two regions, one the N-terminal nucleotide-binding site 
and the other the C-terminal helical domain. The N-domain consists of three αβα 
structures, with a five-stranded parallel β-sheet in the middle. The difference between 
the AAA ATPase domain and other P-loop NTPases is the intercalation of the forth β-
strand between strand one and three. As a result, β4 introduces a polar residue between 
the Walker B motif and the P-loop. This polar amino acid side chain can interact with 
the γ-phosphate group of either ATP or ADP to distinguish the ADP and ATP-bound 
states (Hattendorf and Lindquist, 2002a; Hattendorf and Lindquist, 2002b; Karata et al., 
1999). The C-terminal helical domain of this family has more freedom in terms of 
structural variety than the N-terminal domain, but it is found in a similar position with 
respect to the nucleotide perpendicular to the ATP/ADP base. An arginine residue of the 
C-terminus was proposed to interact directly with the nucleotide, but one study reported 
that its most important function in Hsp104 is to supply energy rather than differentiate 
between ATP and ADP (Hattendorf and Lindquist, 2002b) (Fig. 18B). 
AAA proteins are usually assembled into hexameric rings, and each individual 
subunit of the ring might contain an ATPase domain. The ATP/ADP binding regions are 
arranged in a way that one of the five β-strands (β5) extends towards the ATP/ADP in 
the adjacent subunit. Hence, an arginine from each subunit interacts with the preceding 
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subunit. This arrangement is the so called arginine finger motif (Ahmadian et al., 1997) 
that is necessary for complete nucleotide hydrolysis. When ATP is hydrolyzed, an 
interaction between the γ-phosphate and the polar amino acid is passed on from one ring 
to another by a movement of the helix between the polar residue within the N-domain 
and the arginine finger (Schmidt et al., 1999). In some cases, the assembly of the AAA 
protein is dependent on nucleotide binding and/or interactions with the substrate 
(Hartman and Vale, 1999). Some AAA proteins have subunits that promote this 
oligomerization, while a second subunit has only hydrolytic activity (Sec18/NSF and 
peroxisomal AAA proteins). 
 The primary question is how these AAA proteins can accomplish their unfolding 
activity. Presumably the substrate binds to the N-termini of the AAA protein rings. ATP 
hydrolysis followed by a conformational change in the AAA subunits facilitates the 
unfolding of the substrate. After this remodeling activity, the AAA protein might release 
its substrate or transfer it into a central pore of the 20S proteasome or metalloproteases. 
If the substrate is a membrane protein, AAA proteins appear to first recognize the 
folding status and length of a soluble, exposed domains of the membrane protein. Then a 
membrane-spanning segment of the substrate is extracted via the central pore of the 
AAA protein accompanied by ATP hydrolysis (Chiba et al., 2000; Karata et al., 1999; 
Kihara et al., 1999; Leonhard et al., 2000; Navon and Goldberg, 2001).  
Cdc48/p97 was uncovered over two decades ago while searching for mutants that 
played a role in cell cycle arrest in yeast. The structure of Cdc48/p97 follows the general 
theme of AAA proteins. It is composed of a 200 residue-long N-terminal adaptor domain  
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Figure 19. Schematic picture of the ATP hydrolysis-dependent conformational change in p97. (i) 
When there is not any nucleotide bound to the complex [D1-red, D2-blue, N-yellow, and the pore is gray 
(from the top) or dark blue (from the bottom). The color of D2 changes during the graph, which represents 
structural changes in the D2 ring. The tilted side and bottom of p97 are shown (ii). When ATP binds, the 
N domain (yellow) moves beneath the level of the D1 ring, the cavity of the D2 ring partly contracts, 
while the D2 domain turns approximately 20° clockwise. (iii) After ATP is hydrolyzed, the N domain 
moves back to the plane of the D1 ring as the D2 ring pore opens more (green) with an extra 10° 
clockwise movement of the D2 ring. (iv) Then the D2 domain turns counter-clockwise about 15° with the 
narrowing of the D2 hole to the ATP-bound state due to the discharge of the inorganic phosphate from p97 
as projections become visible in the middle of the structure (red). This figure was adapted from (Davies et 
al., 2005). 
 
(N), two 230-250 residue-long ATPase domains (D1 and D2) connected by a short loop, 
and a C-terminal helical subdomain (C). Six of these proteins are assembled into a 
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hexameric, double-stacked ring with a small central channel (DeLaBarre and Brunger, 
2003; Huyton et al., 2003) that has the N-domain projecting outward.  
Cdc48/p97 goes through a large conformational change upon ATP hydrolysis, similar to 
that of other members of AAA family, and this structural flexibility is responsible for the 
mechanical force (Fig. 19). During the non-nucleotide bound state, the N-domain 
protrudes in the plane of the D1 ATPase domain, while the opening of the ring formed 
by D2 is in its most open state (~70 A°, widest central pore). When ATP binds to both 
D1 and D2 sites, the N-domain shifts downwards, below the plane of the D1 ring. 
During this time, the D2 central pore constricts to half its diameter and undergoes a 20° 
clockwise rotation. After ATP hydrolysis, the N-domain returns to its original position 
(non-nucleotide bound state), and the D2 central pore opens up again with rotating an 
additional 10° clockwise rotation. After release of inorganic phosphate, the D2 central 
pore narrows back again with rotating 15° counterclockwise. When ADP is released, a 
less compact, but more flexible non-nucleotide bound form is observed (Davies et al., 
2005). 
There are two important loops lining the central pore that also undergo 
conformational change during ATP hydrolysis. The first one contains two arginines 
(Arg586 and Arg599) (Fig. 19B) located at the entrance of the D2 ring that form a 
double ring facing the central pore in activated ADP-bound state, but not in the ATP-
bound and apo state. These may contribute a substrate binding site that is concealed in 
the ATP-bound state. These two arginines are capable of denaturing any secondary 
structures and are responsible for protein unfolding activity. These two arginines are also 
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present in 19S cap of the 26S proteasome, which suggests similar roles for this group in 
the 19S RP. The second group contains two hydrophobic residues (Phe552 and Trp551) 
at the interface of D1 and D2 in the center of the pore. A tryptophan mutant of 
p97showed decreased affinity for the substrate without any effect on ATP kinetics, 
suggesting that this residue is a part of a putative hydrophobic patch responsible for 
substrate binding within the pore. One study proposed (DeLaBarre et al., 2006) that the 
substrate does not pass through the D1 ring, but only enters D2, and from there it is 
either removed by the 26S proteasome or exits between D1-D2.  
Cdc48/p97 participates in large variety of cellular functions that apparently specified 
by its abundant cofactors (Richly et al., 2005). These cofactors typically interact with the 
N-terminal domain (except for Ufd2). Both Cdc48/p97 and some of its cofactors 
apparently bind simultaneously to the substrate, as shown by their binding to a 
polyubiquitin chain conjugated to the substrate (Ye, 2005; Ye, 2006; Ye et al., 2001).
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CHAPTER II 
MATERIALS AND METHODS 
Preparation of canine pancreatic microsomes (RM) 
Dogs were sacrificed and each pancreas was removed essentially as described earlier 
(Walter and Blobel, 1983). Pancreas tissue was homogenized and centrifuged for 10 min 
in an SW34 rotor for 3300 rpm. The fat was removed and the supernatant was 
centrifuged again for 10 minutes at 10400 rpm in the same rotor. The supernatant was 
collected and re-centrifuged on a sucrose cushion [50 mM TEA (pH 7.5), 50 mM KOAc, 
5 mM Mg(OAc)2, 1.3 M sucrose, 1 mM dithiothreitol (DTT), and  0.5 mM 
phenylmethylsulfonyl fluoride (PMSF)] in a Ti50.2 rotor for 2.5 hr at 40000 rpm. The 
pellet was resuspended in Buffer AR [50 mM TEA (pH 7.5), 250 mM sucrose, and 1 
mM DTT] to a 50 A280 units/ml concentration. These microsomes are termed rough 
microsomes (RMs). 
Preparation of column-washed rough microsomes (CRM) 
RMs were used to prepare CRM, KRM and SRP as before (Walter and Blobel, 
1983). CRMs were prepared by equilibrating Sepharose Cl-2B columns (40 cm length 
and 5 cm diameter) with Buffer AC [50 mM TEA (pH 7.5), 1.5 mM Mg(OAc)2, 1 mM 
ethylenediamine tetraacetic acid (EDTA) (pH 7.5), 0.5 mM PMSF, 1 mM reduced 
glutathione (GSH)] and loading RMs on the top of this column. The microsomes were 
eluted at a flow rate of 15 ml/hr and 80 drops/tube, collected and centrifuged in a Ti50.2 
rotor for 15 min at 23500 rpm at 4 ˚C. The CRMs were resuspended in Buffer AR with 1 
mM GSH. The CRMs were nuclease treated with 20 units/µl Staphylococcus aureus 
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nuclease and 1 mM CaCl2 at 23 ˚C for 10 min. The reaction was stopped by the addition 
of 2 mM glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA) (pH 7.5). 
The CRMs were centrifuged at 34000 rpm for 30 min in a Ti50.2 rotor at 4 ˚C and 
resuspended in Buffer AR to a final concentration of 4 equivalent/µl (1 equivalent/µl has 
an A280 of 50).  
Preparation of salt-washed rough microsomes (KRM) 
KRMs were obtained after removing the SRP and ribosomes from RM. RMs (8000 
equivalents) were thawed and mixed with an equal volume of Buffer AA [50 mM TEA 
(pH 7.5), 2 mM Mg(OAc)2, 1 mM EDTA, 1 mM DTT. 1 mM PMSF, 2% (v/v) 
aprotonin, and 250 ng/ml protease inhibitor mix]. These RMs were centrifuged in a Type 
35 rotor for 30 min at 35000 rpm at 4 ˚C. The pellets were resuspended in Buffer BB [50 
mM TEA (pH 7.5), 1 mM Mg(OAc)2, 1 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 1% 
(v/v) aprotonin, and 250 ng/ml protease inhibitor cocktail] with a Dounce homogenizer. 
This homogenate was centrifuged again in a Type 35 rotor as before and resuspended in 
80 ml of Buffer BB. Then 20 ml of high salt buffer [50 mM TEA (pH 7.5), 20.5 mM 
Mg(OAc)2, 0.5 mM EDTA (pH 7.5), 1 mM DTT, 2 M KOAc (pH 7.5), 1% (v/v) 
aprotinin, 100 ng/ml protease inhibitor mix] was added to the 80 ml of washed RMs. The 
solution was stirred for 15 min and then 17 ml of this was overlayed on a 7 ml sucrose 
cushion [50 mM TEA (pH 7.5), 5.5 mM Mg(OAc)2, 0.5 mM EDTA, 1 mM DTT, 500 
mM KOAc, 350 mM sucrose, 1% (v/v) aprotonin, 100 ng/ml protease inhibitor mix] to 
centrifuge in a Ti50.2 rotor for 1 hr at 40000 rpm at 4 ˚C. The pellet was resuspended to 
a final concentration of 2 equivalent/µl in Buffer AR after Dounce homogenizing it 
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twice and flash freezing aliquots of the preparation in liquid N2 (these membranes are 
called KRM). 
Preparation of reconstituted microsomes (RRM) and microsomes lacking soluble 
lumenal proteins (XRM) 
Extraction of soluble lumenal proteins was performed by high pH treatment as 
described earlier (Bulleid and Freedman, 1988; Haigh and Johnson, 2002; Hamman et 
al., 1998; Nicchitta and Blobel, 1993). Basically, 200 µl of 1 M concentration of Bicine 
(pH 9.5-10.0) was added to 200 µl of 2 eq/µl KRMs and the volume was adjusted to 1 
ml with double distilled water (ddH2O). The microsomes were incubated on ice for 30 
min, and then layered on 200 µl of sucrose cushion with 50 mM Hepes/50 mM CAPS 
(pH 9.5) and 0.5 M sucrose. The microsomes were collected by centrifugation with a 
Beckman TLA 100.2  rotor at 60,000 rpm for 20 min at 4°C. Microsomes were 
reconstituted by resuspending them in 310 µl Solution A. Solution A was prepared by 
mixing of the appropriate volume of purified ∆gpαf-BOF or ∆gpαf to obtain a final 
concentration of 5–15 µM with 3.5 mg/ml soluble lumenal proteins or 10-50 µM final 
concentration selected lumenal proteins in Buffer B [50 mM Hepes (pH 8.0) and 0.25 M 
sucrose],  2 mM ATP (pH 7.2), and 50 mM of Bicine (pH 10.0) to a final volume of 310 
µl, and kept on ice for at least 10 min. The reconstituted microsomes were incubated on 
ice for 5 min, and the pH was reduced to 7.5 by the addition of 100 µl of 1 M 
Pipes/Hepes (pH 6.5) using pH paper to ensure the pH was 7.5 +/- 0.1. After 10 min 
incubation on ice, the microsomes were layered on a 1 ml Buffer A cushion [50 mM 
Hepes (pH 7.5), 40 mM KOAc, 5 mM MgCl2 and 0.5 M sucrose] and centrifuged for 20 
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min at 60000 rpm in a TLA 100.2 rotor. The resulting pellet was thoroughly resuspended 
in 500 µl Buffer A [50 mM Hepes (pH 7.5), 40 mM KOAc, 5 mM MgCl2] with 0.25 M 
sucrose. The microsomes were purified by gel filtration chromatography using a 
Sepharose Cl-2B column (0.7 cm x 50 cm) equilibrated and run in Buffer A using 
gravity flow and a flow-rate of 0.1 ml/min. Fractions (500 µl) were collected and the 
microsome-containing fractions were pooled. Fractions containing reconstituted ER 
microsomes (RRMs) were detected using light scattering (λ ex = 405, λ ex = 420). 
Preparation of yeast microsomes for in vitro translation 
Yeast microsomes were prepared by growing yeast [single colony from YPD (20 g 
peptone, 10 g yeast extract, 20 g dextrose in 1 liter H2O) plate] in YPD media to OD600 = 
2-6/ml at 30 ˚C. The cells were harvested by centrifugation at 5000 rpm in a YA-10 rotor 
for 5 min. Yeast cells were washed in water and resuspended in 10 ml of Buffer YA 
[100 mM Tris-HCl (pH 9.4), 10 mM DTT]. After an additional spin at 5000 rpm in a JA-
10 rotor for 5 min, the pellet was resuspended in 10 ml Buffer YA, incubated at room 
temperature for 10-20 minutes, centrifuged as above. The pellet was resuspended to an 
A600 of 100 in 0.7 M sorbitol, 10 mM Tris-HCl (pH 7.4), and 0.5% (w/v) glucose in the 
presence of 10-20 U lycticase/optical density unit of cells. The lysing efficiency was 
monitored by mixing 1:200 cells in water and measuring the A600 until it was less then 
5% of the initial value, at which point the cells were placed on an equal volume of 
sucrose cushion in 1:1 [0.8 M sucrose, 1.5% Ficoll 400, and 50 mM Hepes (pH 7.4)] and 
centrifuged for 10 min at 6000 rpm in a JA-10 rotor. The spheroplasts were collected 
after removal of the supernatant and resuspended in lysis buffer [20 mM Hepes/KOH 
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(pH6.8), 50 mM KOAc, 100 mM Sorbitol, 2 mM EDTA and 1 mM sorbitol and DTT] to 
A600 of 100-150. The spheroplasts were homogenized using a Dounce homogenizer (15 
times up and down). The lysate was centrifuged again in Corex tubes in JA-17 rotor at 
5000 rpm for 10 min. The supernatant was removed and transferred to a polycarbonate 
tube. The supernatant fractions were centrifuged again at 5000 rpm for 10 minutes in JA-
17 rotor at 4 °C and homogenized again using a Dounce homogenizer (15 times up an 
down). The supernatant was spun in JA-17 rotor at 15000 rpm for 10 min at 4 °C and the 
pellet was resuspended in 2 ml Buffer 88 [20 mM Hepes (pH 6.8), 150 mM KOAc, 250 
mM sorbitol, 5 mM MgOAc]. Then the samples was layered on a two step-sucrose 
gradient [20 mM Hepes (pH 6.8), 50 mM KOAc, 1 mM PMSF, 1mM DTT, 2 mM 
EDTA and either 1.5 M or 1.2 M sucrose) centrifuged at 40000 rpm in SW 50.1 rotor at 
4 °C. The microsomes were removed from the interface with a Pasteur pipette.The yeast 
rough microsome (yeast RM) concentration was determined by mixing 5 µ of yeast RMs 
(yeast microsomes) with 2% (w/v) SDS in ddH2O, and the adjusting volume of the 
sample with Buffer 88 until the final yeast RM A280 was 40 (10-12 mg/ml protein 
concentration). The yeast RMs were quick-frozen and stored in aliquots at –80 ˚C. 
Expression and purification of ∆gpαf 
The yeast mating pro-α-factor (∆gpαf) used here lacked a signal sequence, contained 
a C-terminal hexameric histidine tag, and mutations to prevent glycosylation (N23Q, 
N57Q, N67Q), and had a dye attachment site (Y165C or T25C). The NdeI to SalI 
fragment encoding the entire sequence of ∆gpαf was cloned into a heat-inducible 
expression vector (pJLA603) (Bush et al., 1991; Schauder et al., 1987). The primers 
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used for ligation into the vector were GCGCCATATGGCTCAGTCCAACTAC (5’ end) 
and GCGCGTCGACTTTGTTACATCTACACT (3’ end). Ligation was carried out 
according to the quick ligation protocol (New England Biolabs, M2200S).  
E. Coli BL21 (DE3) cells transformed by this vector were grown at 30°C overnight 
with shaking to saturation in 100 ml of Luria-Bertani Media (LB) (1 liter LB has 10 g 
bactotryptone, 10 g yeast Extract, 5 g NaCl) with ampicillin (100 µg/ml). This culture 
was added the next day to 3 liter LB with ampicillin (100 µg/ml) and grown at 30°C to 
an A600 of 0.6, at which point the expression of ∆gpαf was induced at 42°C for 4 hr. 
Cells were harvested by centrifugation at 4000g for 20 min and then lysed by shaking at 
room temperature for 1 hr in Buffer AP [8 M urea, 50 mM Hepes (pH 8.0), 100 mM 
NaCl]. After sedimentation (10000g, 15 min), the supernatant was filtered (Nalgene 
syringe filter, 0.2 µm; 25 mm) before being loaded on an XK 16/10 Chelating Sepharose 
Fast Flow column (GE) equilibrated with Co2+ and equilibrated in Buffer AP. The 
column was transferred to a Pharmacia FPLC apparatus and washed with 65 ml of 
Buffer AP at room temperature. Following another wash with 95% Buffer AP/5% Buffer 
BP [50 mM Hepes (pH 8.0), 1 M imidazole], ∆gpαf was eluted from the column with 
300 mM imidazole (55 ml of 70% Buffer AP/30% Buffer BP). A peristaltic pump 
maintained a flow rate of 3 ml/min during these procedures. The ∆gpαf solvent was 
changed to Buffer CP [50 mM Hepes (pH 8.0), 2 mM EDTA, 1 mM DTT] containing 2 
M urea by gel filtration through Sephadex G-25  (30 cm x 2.5 cm i.d.) pre-equilibrated in 
Buffer CP. This approach for exchanging the solvent was used throughout because the 
dilution and rapid solvent exchange of this method both reduces the aggregation of 
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∆gpαf and increases its labeling efficiency when compared to ∆gpαf that has been 
dialyzed. 
 ∆gpαf was further purified by ion exchange chromatography on an FPLC Mono Q-
Sepharose column by loading the protein in Buffer CP plus 2 M urea, washing the 
column with 30 ml of Buffer CP, and then eluting ∆gpαf with a 50-ml linear salt 
gradient (100 - 1000 mM NaCl in Buffer CP). ∆gpαf eluted in a single peak near 300 
mM NaCl. After ∆gpαf was transferred into 20 mM Hepes (pH 8.0), 50 mM NaCl, and 
2 mM EDTA by gel filtration to remove DTT prior to labeling, a 4-fold molar excess of 
4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-S-indacene-3-propionyl)-N'-
iodoacetylethylenediamine (BODIPY-Fl or BOF, Invitrogen) (Fig. 20) dissolved in ~ 
500 µl DMSO was added dropwise to ∆gpαf (10-20 µM; ~ 30 ml) at 4°C while stirring. 
The reaction proceeded for at least 12 hr in the dark at 4°C before it was quenched (30 
min, 4°C) by the addition of 10 mM DTT. Removing unreacted dyes and transferring the 
protein into Buffer B [50 mM Hepes (pH 8.0), 250 mM sucrose] was accomplished by 
first loading a volume of Buffer AP equal to the protein reaction volume on a Sephadex 
G-25 gel filtration column (25 cm x 2.5 cm i.d.) equilibrated in Buffer B. After the 
buffer AP had fully entered the resin, the reaction mix was loaded on the column so that 
the protein was eluted through the urea-containing Buffer AP, thereby releasing any non-
covalently bound dye as the protein was finally eluted in Buffer B. The resulting ∆gpαf-
BOF (5-15 µM) was stored at –80°C in 420 µl aliquots appropriate for reconstitution. No 
non-covalently bound BODIPY-Fl (BOF) dyes were detected in these preparations by 
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Figure 20.  Structures of BODIPY-Fl IA, BODIPY-Fl SE, and ANB. 
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fluorescence detection in sodium dodecyl sulfate polyacrylamide gel electrophoresis 
gel s (SDS-PAGE) using the BioRad FX phosphorimager.  
BOF labeling of BiP, PDI, and GSH 
BiP and PDI were reacted with BOF using the same procedures used for labeling 
∆gpαf and were purified by gel filtration from the unreacted dye. GSH (1 mM) was 
reacted with 10 µM BOF reagent in the same way, but unreacted glutathione was not 
separated from glutathione-BOF. 
Determining the BOF labeling efficiency  
Analytical HPLC using a C1 column (Poros perfusion chromatography R1/10 4.6 
mm diax100mmlength) was employed to separate the unlabeled and BOF-labeled ∆gpαf 
proteins and to quantify the labeling efficiency. The protein was loaded in Buffer AH 
[50 mM TEAA [triethylammonium acetate])] and eluted with a gradual increase with 
Buffer BH (7mM TEAA/ 28 mM CH3CN) (0-80% buffer B in 30 min). The unlabeled 
protein eluted first followed by the labeled ∆gpαf , and the ratios of the two peaks were 
~ 1:1, thus 48-50% of the ∆gpαf was found to be labeled with BOF. Since purifying 
∆gpαf-BOF from ∆gpαf proved difficult, the ∆gpαf-BOF used here was only about half-
labeled. 
The absorbance of the labeled ∆gpαf after removal of the unincorporated dye offered an 
alternative, although less precise way to determine labeling efficiency. The extinction 
coefficient of ∆gpαf was calculated by a the number of trypthophan, tyrosine and 
cysteine residues to be 50640 M-1 cm-1l at 280 nm (Pace et al., 1995), while the 
published extinction coefficient is of BODIPY-Fl IA is 81000 mol-1 cm-1l  in methanol at 
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503 nm (Invitrogen). The absorbance of ∆gpαf-BOF was measured at 280 nm and 503 
nm, and this fraction labeled was determined using extinction coefficiencies at these 
wavelengths to obtain the concentrations of ∆gpαf and BOF. The ratio between [∆gpαf] 
and [BOF] multiplied by a hundred represented the labeling efficiency. 
Purification of BiP and PDI 
Human intein-tagged PDI was purified using a chitin column according to Novagen 
specifications, while hamster BiP with C-terminal His tags was purified as before (Alder 
et al., 2005), except using Chelating Sepharose FPLC columns loaded with Co2+. PDI 
and BiP were each then additionally purified on a Q-Sepharose (GE Healthcare) column 
using a linear salt gradient. BiP, PDI, and ∆gpαf are each stored in Buffer B; the BiP 
solution also contained 1 mM ATP. Before use, PDI was incubated at 30°C for 30 min in 
Buffer A [50 mM Hepes (pH 7.5), 40 mM KOAc, and 5 mM MgCl2] containing either 5 
mM DTT or 5 mM oxidized glutathione (GSSG). 
Preparation of hemoglobin-free reticulocyte lysate 
A 5 ml HisTrap HP (17-5248-01, GE) column was equilibrated with Buffer A at 4 
°C using a peristaltic pump with a flow rate of 3 ml/min. Reticulocyte lysate (2 ml) was 
passed through the column at 0.5 ml/min flow rate (generous gift of Dr. William Skach 
and prepared according to (Carlson et al., 2005). The hemoglobin in the 2 ml lysate 
normally binds throughout the entire 5 ml column volume without eluting into the flow 
through. All proteins except hemoglobin were eluted in Buffer A. The hemoglobin was 
eluted separately in Buffer A plus 1 M imidazole to regenerate the column. The eluted 
cytosol (8 ml) was filtered (Nalgene syringe filter, 0.2 µm; 25 mm), and 1 mM final 
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GSH (1M stock) and 1 mM EDTA (pH 7.5) concentration was added. The removal of 
EDTA is important, because the presence of a chelating agent affects the 
retrotranslocation of the ERAD substrate. The hemoglobin free cytosol was dialyzed 
overnight at 4 °C with at least two buffer exchanges against Buffer A with 1 mM GSH. 
Following dialysis, A280/A260 was determined, and either 4 µl of the cytosol without or 1 
µl of cytosol with hemoglobin was mixed with 2X SDS PAGE sample buffer to evaluate 
the globin content. The cytosol without hemoglobin was frozen in 250 µl aliquots and 
stored at - 80 °C.  
Preparation of wheatgerm 
Nuclease-treated wheat germ was prepared by Yiwei Miao and Yuanlong Shao 
according to protocols by Erickson and Blobel (Erickson and Blobel, 1983), but the 
wheat germ was further purified by chromatography using a Sephadex G-25 column and 
stored in 40 mM HEPES (pH 7.4), 100 mM KOAc (pH 7.5), 5 mM Mg(OAC)2, 2 mM 
GSH or 2 mM DTT and 100 µM EGTA. The gel filtration step removed any endogenous 
amino acids that would compete with εANB-Lys-tRNALys and [35S]Met for 
incorporation into the translation product. Wheat germ extract containing glutathione 
was used in photocrosslinking experiments to reduce the chemical inactivation of the 
azide, because the DTT is a stronger reducing agent. 
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Purification of 26S and 19S proteasome 
The 26S and 19S proteasomes used in this study were provided by Dr. George 
DeMartino and were as described elsewhere (DeMartino, 2005; DeMartino et al., 1994). 
Preparation of lumenal proteins 
β-Octylglucoside (0.4 M in ddH2O) was added drop-wise to a final concentration of 
20 mM to 4000 equivalents of KRMs ((Walter and Blobel, 1983) in Buffer C [50 mM 
Hepes (pH 7.5), 0.25 M sucrose, and 1 mM DTT)]with gentle stirring on ice. The 
detergent-saturated membranes (10 ml) were layered on a 10 ml sucrose cushion [50 
mM Hepes (pH 7.5), 0.5 M sucrose] and sedimented (Ti 50.2, 40,000 rpm, 2 hr, 4°C). 
The supernatant fraction and the upper 2 ml of the sucrose cushion (22 ml) were 
removed and re-sedimented (Ti 50.2, 40,000 rpm, 5 hr, 4°C). The detergent was 
removed by extensive dialysis of at least 4 buffer exchanges at 4 °C over 24 hr against 1 
liter of Buffer C without DTT each time. The first buffer contained 5 g SM-2 Bio-beads 
(BioRad) outside the dialysis bag, and was changed after 3 hr The second buffer 
exchange also contained Bio-beads outside the dialysis bag, and was dialyzed overnight. 
The following two exchanges did not contain Bio-beads; only Buffer A without DTT 
and was allowed to equilibrate for at least 4 hr each. Then the 22 ml of buffer from the 
dialysis tube containing all lumenal proteins was sedimented again (TLA100.2, 100,000 
rpm, 30 min, 4°C). The resulting supernatant (22 ml) containing all of the lumenal 
proteins was concentrated using Centricon YM-3 filters (Amicon) to 4 ml of ~10 mg/ml 
being stored at –80°C in 50 µl aliquots and analyzed by SDS-PAGE. 
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Purification of tRNA and labeling with ANB-NOS and BOF 
Purification, aminoacylation and characterization of E.coli tRNALys was performed by 
Y.Shao and Y.Miao as described previously (Flanagan et al., 2003). HPLC-purified Lys-
tRNALys was chemically modified using then-hydroxysuccinimide ester of  N-5-azido-2-
nitrobenzoic acid (ANB-NOS; Pierce Chemicals) or BODIPY-Fl (Invitrogen) (Fig. 20) 
to yield εANB-Lys-tRNALys  (Krieg et al., 1986) or εBOF-Lys-tRNALys . 
Cell-free translation, translocation, and retrotranslocation 
The ppαf gene was cloned by using S. cerevisiae genomic DNA as a template (from 
Dr. M. Kladde) with PCR primers (5’ end, GCGCGGATCCATGAGATTTCCTTCA 
ATTTTTACTGC; 3’ end, GCGCGAATTCATGAGATTTCCTTCAATTTTTACTGC) 
into pRSET A vector at the BamHI and EcoRI restriction enzyme sites. p∆gpαf  was 
generated after in vitro mutagenesis of the ppαf DNA (N23Q, N57Q, N67Q).  
Full-length mRNA encoding the p∆gpαf was transcribed in vitro using SP6 RNA 
polymerase with PCR-produced DNA fragments (primers: PAGE-purified 5’ end, 
GATTTAGGTGACAC TATAGAATACCACCATGAGATTTCCTTCAATTTTTAC 
TGCAGT; 3’ end, CTATTAATGATGATGATGATGATGGTACATTGGTTG (with 
6XHis tag)) from the pRSET vector containing full-length ppαf or p∆gpαf.  
In vitro translations (350 µl, 26°C, 60 min) contained 140 mM KOAc, 20 mM 
HEPES (pH 7.5), 2.8 mM MgCl2, 200 µM spermidine, 8 µM S-adenosylmethionine, 1.2 
mM ATP, 1.2 mM GTP, 9.6 mM phosphocreatine, 3.5 units of creatine phosphokinase, 
30 µM of each of eighteen amino acids (no Met or no Lys), protease inhibitors (0.1 
µg/ml final concentration for antpain, pepstatin A, leupeptin, chymostatin; 0.01% (w/v) 
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for aprotinin; 70 units of RNase inhibitor (Promega), 175 µCi [35S]Met, 70 µl wheat 
germ cell-free extract, 40 nM canine SRP, 112 equivalents of KRMs, and 210 pmoles of 
εBOF-Lys-tRNALys or Lys-tRNALys (Crowley et al., 1993). 
 After translation, the microsomal vesicles containing ∆gpαf were isolated by 
centrifugation at 100,000 rpm for 8 min in a TLA 100.2 rotor at 4°C through a 700 µl 
cushion containing 0.5 M sucrose in Buffer A. The sedimented microsomes were 
washed and resuspended in 350 µl of Buffer A containing 2 mM ATP, 2 mM GTP, 
protease inhibitors as above, 16 mM phosphocreatine, 5 units of creatine phosphokinase, 
and either 60 ml of reticulocyte lysate, 240 ml of reticulocyte lysate without hemoglobin, 
or no lysate. Samples were then incubated at 30°C and 100 µl aliquots were removed at 
the indicated times for analysis by SDS-PAGE on a 10-20% gel. Each aliquot was 
layered on a 100 µl of 0.5 M sucrose cushion in Buffer A, sedimented for 3 min in a 
TLA 100 rotor at 4°C at 100,000 rpm, and the pellet was resuspended in 40 µl of sample 
buffer and analyzed by SDS-PAGE on a 10-20% gel. Where indicated, lactacystin [10 
mM stock (Sigma) in ddH2O] or epoxomicin [1 mg/ml stock (Calbiochem) in 100% 
ethanol] was added to the cytosol to a final concentration of 20 µM or 50 µM, 
respectively, and incubated at 0°C for 30 min before being added to the RRMs. Two 5-
µl aliquots of each 50 µl sample were removed at various times and precipitated in hot 
TCA to determine the amount of [35S]Met in polypeptides by collecting the precipitated 
material on filters and counting the radioactivity in a liquid scintillation counter. A 
portion (20 µl) of the 50 µl sample was mixed with sample buffer, and analyzed by SDS-
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PAGE on a 10-20 % gel. The remaining 20 µl of sample were layered on a 100 µl 
cushion of Buffer A with 0.5 M sucrose, sedimented for 4 min with TLA 100 rotor at 
4°C at 100,000 rpm, and the pellet was resuspended in 25 µl of SDS-PAGE sample 
buffer. The supernatant and the sucrose cushion were combined, precipitated in hot 
TCA, and resuspended in 25 µl sample buffer for electrophoresis as above.  
The same approach was used with A1PiZ. The A1PiZ cDNA was a generous gift 
from Dr. J. Brodsky and was cloned into a yeast pYES2 vector. The mRNA was 
generated from PCR products (primers: PAGE-purified 5’end, 
GATTTAGGTGACACTATAGA ATACCACCATGCCGTCTT CTGTCTCGTG 
GGGCATC and 3’ end, TTATTTTTGGG TGGGATTCACCAC) that contained the SP6 
polymerase sites.  
Immunoprecipitations 
KRMs were isolated by sedimentation prior to immunoprecipitation with affinity-
purified antibodies raised against the C-terminal 14 residues of Sec61α (αSec61α; 
Research Genetics, Huntsville, AL). The membrane pellet was resuspended in 50 µl of 
resuspension buffer [2% (w/v) SDS, 100mM Tris-HCl (pH 7.5)] by heating at 55°C for 
30 min. The samples were completely mixed, added to new 1.5 ml microfuge tubes, and 
then washed to 500 µl with Buffer AI [140mM NaCl, 10mM Tris-HCl (pH 7.5), 2% 
(v/v) TritonX-100 (TX-100)] for αSec61α. Individual samples were pre-cleared by 
adding 40 µl of protein A-Sepharose (Sigma) and rocking at room temperature for 1 hr 
before the Sepharose beads were removed by sedimentation. The antibodies (5 µg) were 
added to each sample and rocked at 4°C overnight. On the following day, 40 µl of 2x-
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diluted protein A-Sepharose in Buffer AI was added to each sample and the incubation 
was allowed to continue for another 3 hr at 4°C. The immunoprecipitate was recovered 
by sedimentation, washed twice with Buffer AI plus detergent, and then washed a final 
time with the same buffer containing no detergent. Immunoprecipitated material was 
separated by SDS-PAGE as before (Do et al., 1996) and visualized using a Bio-Rad FX 
phosphorimager.  
For immunoprecipitations using affinity-purified antibodies raised against the C-
terminal 13 residues of TRAM (Research Genetics, Huntsville, AL), the C-terminal 50 
residues of αDer-1 (Novus Biologicals, Littleton, CO), αPDI, αBiP or αCNX 
(Calbiochem), the membrane pellet was solubilized in 50 µl of resuspension buffer [1% 
(w/v) SDS, 100 mM Tris-HCl (pH 7.5)] by heating at 55°C for 30 min. Each sample was 
diluted to 500 µl with Buffer BI [150mM NaCl, 50mM Tris-HCl (pH 7.6), 2% (v/v) 
Triton X-100, 0.2% (w/v) SDS] and rocked overnight at 4°C after the addition of 
specific antibodies (5 µg). On the following day, 40µl of 2x-diluted protein A-Sepharose 
in buffer BI was added to each sample and the incubation was allowed to continue for 
another 3 hours at 4°C. The immunoprecipitate was recovered by sedimentation, washed 
twice with Buffer BI, and then washed a final time with the same buffer containing no 
detergent. The immunoprecipitated material was separated by SDS-PAGE, and 
visualized using a BioRad FX phoshoimager.  
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Steady-state fluorescence spectroscopy 
Steady-state fluorescence measurements were conducted in an SLM 8100 photon-
counting spectrofluorometer using a 450 W xenon lamp light source. The instrument had 
a double monochromator in the excitation light path, a single emission monochromator, 
and a Peltier-cooled PMT housing. The quartz cuvettes (Starna Cells, Inc) used in this 
study were 4 mm x 4 mm. For single wavelength experiments, BOF was excited at 490 
nm and the emission was monitored at 513 nm with a band-pass of 4 nm for both 
excitation and emission. For emission scans, 5 sec integrations of emission intensity 
were recorded at each specific at 1 nm intervals. The time-dependent emission intensity 
change was monitored after first thoroughly mixing the sample on ice 20 times using a 
magnetic stir bar outside the cuvette (Dell et al., 1990). After the cuvette was placed into 
the temperature equilibrated cuvette-holder in the fluorometer. F0 (zero time-point) was 
measured immediately. In order to prevent photo-degradation of the fluorescent dyes, the 
shutters automatically closed and opened before and after data were acquired (every 40 
seconds up to typically 2000 second time length). 
Static quenching by antibody binding to a fluorophore 
This type of quenching occurs when a fluorophores binds to a dye-specific antibody 
and forms a non-fluorescent complex. When such a dye-antibody complex absorbs light, 
the dye instantaneously returns to the ground state without the emission of a photon. To 
ensure that all dyes in the sample were bound to antibodies, the amount of antibody 
needed to saturate the sample was determined by titration. 
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Steady-state anisotropy to examine macromolecular association 
Anisotropy (r) was measured in Buffer A using BOF-labeled protein, Glan-
Thompson prism polarizers in L-format as before using a single emission 
monochromator and a double excitation monochromator (Mutucumarana et al., 1992). 
The emission intensity was measured at 513 nm by sample excitation at 490 nm through 
the vertically polarized light and detected via horizontal polarizer as IVH. The other 
parameters (IVV, IHV, and IVV) were determined similarly to IVH after changing the 
orientation of the polarizers. A blank sample contained the same components as the 
fluorescent sample, but the BOF dye was omitted from it. The net anisotropy was 
determined by subtracting the blank intensity (e.g., IVH) from sample intensity. The 
anisotropy was calculated r = (IVV – G * IVH)/(IVV + 2 * G * IVH), where G is the grating 
coefficient and equals IHV/IHH. 
In the anisotropy experiments, 0.5 µM of ∆gpαf-BOF was typically incubated in 
column buffer and gradually titrated with a protein without the fluorescent tag to detect 
any associations between the fluorescent-labeled and the non-fluoroscent-labeled species 
at 4 °C. 
To detect the degradation of ∆gpαf-BOF by the 26S proteasome, the anisotropy of 
the full-length substrate was compared to that of the digested substrate at 30 °C. 
 
 
 
 
 
 96
SDS-PAGE 
Translations, photocrosslinking experiments, immunoprecipitation analysis, western 
blots and purified proteins were analyzed on a 14 cm x 19 cm x 0.8 mm (height x width 
x thickness) gel via SDS-PAGE. The wells were 2 cm x 0.5 cm x 0.8 mm (depth x width 
x thickness) and 20-25 µl of samples were loaded into each. The stacking gel was 
prepared using 4%  (w/v) polyacrylamide, 60 mM Tris-HCl (pH 6.8), 0.1%  (w/v) 
sodium dodecyl sulfate (SDS), 0.05% (v/v) N,N,N’,N’-tetramethylethylenediamine 
(TEMED), and 0.08% (w/v) ammonium persulfate (APS). The resolving gel was 
prepared by 400 mM Tris-HCl (pH 8.8), 0.08% (w/v) SDS, 0.02% (v/v) TEMED, and 
0.08% (w/v) APS and either 15%, 10% or 20% (w/v) acrylaminde/bisacrylamide 
(30:0.8) mixture to obtain a 10-15% or 10-20% gradient gel. The sample was normally 
mixed with SDS-PAGE running buffer [274 mM Trizma base, 34% (v/v) glycerol, 8.2% 
(w/v) SDS, 17 mM EDTA] and the samples were heated at 95˚C for 5 min unless 
otherwise specified. The gel was run under constant current (15 mA) for 40 min through 
the stacking gel and at 32 mA for 2.5 hours for the resolving gel. The wet gel was 
washed briefly in ddH2O if the gel contained fluorescent-labeled samples that were 
required to be visualized by BioRad phophoimager immediately after electrophoresis. 
Otherwise, the gel was placed in a stain solution tp detect purified proteins without 
fluorescent-label or antibodies in the case of immunoprecipitations for at least 10 min 
[10% (v/v) acetic acid, 50% (v/v) methanol, and 0.125% (w/v) coomassie brilliant blue 
dye (Sigma)], followed by destaining the gel [10% (v/v) acetic acid, 35% (v/v) 
methanol] for at least 30 min. The gel was rinsed thoroughly in water and dried on a 
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3MM Whatman paper for 40 min on a BioRad gel-drier. The gel was then exposed to a 
Kodak phophorimaging screen overnight or longer, and visualized using the BioRad FX 
Molecular Imager and its Quantity One software. 
Western transfer and immunoblotting 
Following SDS-PAGE, gels transferred to PDVF membrane (Amersham, catalog # 
RPN303F) using the tank transfer method. Blots were treated with blocking solution [3% 
non fat dried milk, 50mM Tris-HCl (7.4), 150mM NaCl, 0.05% (v/v) Tween-20] for 30 
min at room temperature, then incubated with primary antibody (diluted in blocking 
solution) for either 2 hr at room temperature, or overnight at 4°C. Then the blots were 
washed three times (10 min per wash, room temperature) with TBS-T [50mM Tris-HCl 
(pH. 7.4), 150mM NaCl, 0.05% Tween-20], followed by incubation with the secondary 
antibody conjugated to horseradish peroxidase (HRP) (1:10000, blocking solution, 1 hr, 
room temperature). The blots were washed three times with TBS-T, and developed using 
the ECL+Plus chemiluminescence reagent kit (GE healthcare, RPN2132) according to 
instructions and the blot was detected using the BioRad phophoimager. 
Hot TCA assays 
Radioactive proteins were translated in vitro (next section) whenever conditions for 
translation and translocation were optimized, and also when degradation of a protein 
over time was assessed. To quantify the amount of acid-precipitable radioactivity in a 
sample, aliquots were incubated in hot acid (protein precipitated in hot acid, while DNA 
and RNA are chemically degraded). In general, 2 µl of a translation/translocation 
reaction was removed and mixed with 1 ml of 10% (w/v) trichloroacetic acid (TCA), and 
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3 % (w/v) casamino acids (CAA) in a 13 x 100 mm glass tube. The samples were heated 
at 85 ˚C for 10 min and then cooled on ice for 2 min. The heating hydrolyzed all the 
RNA molecules, but precipitated the proteins. The samples were vortexed and then 
filtered under vacuum through a 25 mm Metrical membrane filter (0.45 µm pore size, 
Gelman Sciences), which has been wetted previously with 3 ml of ice cold 5% (w/v) 
TCA. The samples on the filter were also washed with 5% TCA three times and then 
dried under an infrared heat lamp for 10 min, resuspended in PPO/POPOP/toluene 
scintillation cocktail and counted in a Beckman scintillation counting apparatus.  
TCA precipitation was also used to recover proteins prior to SDS-PAGE. When a 
translation was completed, an equal volume of  25% (w/v) cold TCA was added to the 
tube, left on ice for 30 min, and sedimented at 15000 rpm for 10 min at 4 ˚C in a 
microcentrifuge tube. The supernatant was removed by aspiration, and the pellet was 
washed with 1 ml of acidic acetone (19:1 acetone: 0.1 M HCl), followed by 
recentrifugation for 5 min at 15000 rpm. The pellet was dried by vacuum centrifugation 
on the Speed-Vac and mixed with SDS-PAGE sample buffer. 
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CHAPTER III 
RETROTRANSLOCATION OF AN IN VITRO TRANSLATED ERAD 
SUBSTRATE FROM CANINE PANCREATIC AND YEAST MICROSOMES 
Background and experimental design 
The ultimate goal of this project was to create a retrotranslocation assay that was 
based on the well-established protocol for reconstituting canine pancreatic microsomes 
with selected proteins or small molecules (Alder et al., 2005; Bulleid and Freedman, 
1988; Haigh and Johnson, 2002; Hamman et al., 1998; Nicchitta and Blobel, 1993). 
The yeast mating pheromone prepro-α-factor (ppαf) is composed of a 19 amino-acid 
long N-terminal cleavable signal sequence, a 64 amino-acid long pro-region that 
contains three consensus N-glycosylation sites and a carboxyl-terminal domain with four 
13 amino-acid repeats (see later). This protein obtains modified N-glycans in the yeast 
Golgi apparatus, characteristic to yeast glycoproteins, when high mannose chains are 
added to its three core glycans. Later in this pathway, the basic spacer residues between 
the four repeat segments serve as cleavage sites for specific proteases (KEX2, STE13, 
KEX1), which separate them to form four fully matured α-factors for secretion from the 
cell. The proregion of ppαf might direct this protein to the proper compartment within 
the secretory pathway and facilitates the proteolytic processing by KEX2 of this protein 
(Kurjan and Herskowitz, 1982). As all other secretory proteins are, ppαf is targeted to 
the ER membrane post-translationally in yeast and co-translationally in mammalian cells 
(Garcia and Walter, 1988; Hansen et al., 1986). This finding suggests that this yeast 
protein translocates across the ER membrane by a different mechanism in mammalian 
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and yeast cells, which may also be the case during its retrotranslocation. These ppαf 
targeting and translocation differences between yeast and mammalian systems might be 
attributable to the SRP dependence of ppαf trafficking in mammalian cells. Other yeast 
secretory proteins used in this study did not translocate through the mammalian 
membrane post-translationally, even in the presence of SRP (Hansen et al., 1986), an 
observation that contrasted with ppαf translocation. Another interesting observation 
made in this paper was that the fully glycosylated version of pαf (3gpαf or gpαf) 
translocated into canine RMs had a slower mobility on an SDS-PAGE gel did those 
translocated into yeast RMs.  
Experiments conducted in a rat pituitary cell line that also expressed a mammalian 
homologue of the KEX2 enzyme presented some very interesting findings regarding the 
secretion of this protein in a mammalian system (Su et al., 1993). The wild-type protein 
(pgpαf) was targeted properly to the mammalian ER membrane in vivo, but never 
reached the Golgi apparatus. Further examination of the differently glycosylated ppαf as 
using various inhibitors revealed the fate of this protein in mammalian systems 
compared to yeast. In this study, the authors concluded that both gpαf and ∆gpαf 
degraded in vivo in the early secretory pathway in mammalian cells, proposing the 
interesting possibility that this yeast protein was recognized as a non-native substrate in 
a heterologous system even of the wild-type configuration, and eliminated. This group 
revealed that pαf interestingly did not interact with the mammalian BiP or Grp94 
because they did not co-immunoprecipitate together. These data were contrary to several 
findings in yeast (Kabani et al., 2003) that demonstrated the dependence of pαf on 
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Kar2p (yeastHsp70) either for translocation into the yeast ER or for degradation of its 
mutant form (Matlack et al., 1999).  
In yeast, both in vivo and in vitro experiments demonstrated that if glycosylation of 
pαf is prevented, pαf becomes an ERAD substrate (∆gpαf) (Brodsky et al., 1993; 
Nishikawa et al., 2001; Pilon et al., 1998) and is retrotranslocated to the cytosol for 
degradation. However, currently there are no data that would suggest that a mammalian 
in vitro system would support the retrotranslocation of ∆gpαf, one of the most studied 
ERAD substrates. It was suggested that a portion of ∆gpαf (m∆gpαf) could become O-
glycosylated in the ER lumen in yeast, which might inhibit its retrotranslocation from 
the lumen (Harty et al., 2001; Nakatsukasa et al., 2004).  
 A number of other potential ERAD substrates are currently available. The mutant Z 
variant of α-1-proteinase inhibitor (A1PiZ, also known as α-1-antitrypsin-Z or AT-Z) is 
one of the soluble substrates for ERAD that degraded both in ubiquitination dependent 
and independent manner. The mutated form of yeast carboxypeptidase Y (CPY*) is 
another favored ERAD substrate. CPY* uses an ubiquitination-dependent degradation 
pathway and might use different degradation routes to exit from the mammalian ER 
(Mancini et al., 2003). A number of toxins have been shown to exploit the 
retrotranslocation machinery of their target cells to gain entry into the cytosol, but avoid 
subsequent degradation, e.g. protein ricin, a member of the AB-toxin family (Hazes and 
Read, 1997; Simpson et al., 1999). 
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Retrotranslocation of S35- labeled ∆gpαf from KRMs in the presence of cytosol  
Before a more complicated reconstitution experiments with canine microsomes were 
examined, it was necessary to determine whether ∆gpαf retrotranslocated in vitro from 
intact KRMs and also whether the experiments with yeast RMs were reproducible 
(Gillece et al., 1999; McCracken and Brodsky, 1996). The previous procedure for 
analyzing retrotranslocation of radiolabeled ∆gpαf lacking the three consensus 
glycosylation acceptor sites (N23Q, N57Q, and N67Q) was therefore modified, using 
both canine KRMs and yeast RMs with mammalian cytosol in our system.   
First, KRMs were used in a wheat germ in vitro translation system that synthesized 
full-length ∆gpαf. This protein was translocated into these microsomes in the presence 
of mammalian SRP. The vesicles were sedimented at the end of the translation, washed 
with standard buffer (SB) [50 mM Hepes (pH 7.5), 40 mM KOAc, 5 mM MgCl2] and 
resuspended in SB either with cytosol or without [in the presence or absence of 
proteasome inhibitors] to initiate retrotranslocation. The samples were mixed and kept 
on ice until retrotranslocation was initiated at 30 ˚C. An energy-generating system 
(EGS), which contains ATP, creatine phophokinase and phosphocreatine and protease 
inhibitors (which do not have any effect on the proteasomes) were also added to the 
ERAD assay, unless the dependence on ATP was investigated. These experiments 
determined how much ∆gpαf has remained in the microsomes, after various times of 
retrotranslocation to the cytosol (Fig. 21). When ∆gpαf is translocated into the ER 
lumen, its signal sequence is cleaved off. This yields a higher mobility radioactive 
species on the SDS-PAGE gels (Fig. 21; lower band). Signal sequence cleavage also 
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Figure 21. Retrotranslocation of S35-labeled ∆gpαf in a mammalian cell-free system. Cytosol- and 
ATP-dependent degradation of ∆gpαf was accomplished by the retrotranslocation and processing of 
p∆gpαf. Translation reactions containing KRMs and [35S]Met synthesized radiolabeled ∆gpαf, and 
degradation of ∆gpαf was then monitored by  0’, 10’, 30’, and 60’ min chase incubation of the resulting 
KRMs after sedimentation and resuspension in the presence or absence of cytosol, ATP (lanes 1-12 and 
21-24) or apyrase (13-20), or proteasome inhibitors (21-24). All lanes show the microsomal fractions from 
the total reactions. The radioactive samples were run on a SDS-PAGE gel and visualized by BioRad FX 
phophorimager. 
 
indicates the fraction of proteins that is translocated into the microsomes. Signal 
sequence cleavage does not occur if hydrophobic p∆gpαf associates with the cytosolic 
side of the ER membrane in vitro and is not translocated, as often the case. Also, some 
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full length p∆gpαf that may have been translocated but not signal cleaved because of 
inefficient signal peptidase activity (Fig. 21; upper band). 
After microsomes were resuspended and incubated in the presence or absence of 
cytosol, aliquots were removed at various time-points.  These aliquots were then used to 
assess the amount of ∆gpαf present still in the KRMs or alternatively retrotranslocated 
into the cytosol, where ∆gpαf was either degraded or stabilized if the proteasome 
function was impaired.  ∆gpαf was retrotranslocated in the presence mammalian cytosol 
(hemin-free rabbit reticulocyte lysate) (Fig. 21; lanes 1-4) and EGS, because the amount 
of full length ∆gpαf decreased over time. The presence of a small amount of DMSO (the 
solvent for the proteasome inhibitor, MG132) did not affect ERAD, but it was a 
necessary control to show the effect of MG132 was not due to the solvent (Fig. 21; lane 
5-8). In the absence of cytosol, retrotranslocation did not occur and ∆gpαf was not 
extracted from the microsomes (Fig. 21; lanes 13-16). When apyrase was present in two 
different concentrations (15 U/ml or 30 U/ml), very little retrotranslocation was 
observed. The small quantity of retrotranslocated and degraded ∆gpαf might be due to 
some ATP still present in the microsomes or bound to some cytosolic ATPases. These  
data suggest that ∆gpαf is retrotranslocated from mammalian microsomes in a cytosol- 
and ATP-dependent manner. 
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Retrotranslocation of S35- labeled ∆gpαf from yeast RMs in the presence of 
mammalian cytosol 
Yeast RMs were also tested for ERAD activity (Fig. 22), but with mammalian 
cytosol instead of yeast cytosol (McCracken and Brodsky, 1996). The data obtained 
showed ∆gpαf was retrotranslocated from yeast RMs in the presence of mammalian 
cytosol (Fig. 22; lanes 1-3), but that this ERAD substrate remained in the microsomes in 
the absence of cytosol (Fig. 22; lanes 4-6).   
 
 
Figure 22. Retrotranslocation of S35- labeled ∆gpαf from yeast RMs in the presence of mammalian 
cytosol and EGS. Cytosol-dependent retrotranslocation of ∆gpαf from yeast RMs in the presence of 
mammalian cytosol was accomplished by translocating the full length protein in wheat germ extract 
without the addition of any SRP, but in the presence of yeast RMs. After translocation, these vesicles were 
washed SB and resuspended in +/- cytosol. Aliquots were removed at the designated time points and TCA 
precipitated to assess the retrotranslocation and degradation of ∆gpαf. A cytosol dependent 
retrotranslocation was observed (lane 1-3) time period concluded from the disappearance of the lower 
band over 20’. Some non-translocated or p∆gpαf that was translocated but not cleaved by signal peptidase 
was also present in these reactions (upper band). In the absence of cytosol, retrotranslocation did not occur 
(lanes 4-6). The radioactive samples were run on a SDS-PAGE gel and visualized by BioRad FX 
phophorimager.  
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Figure 23. Retrotranslocation and degradation of ∆gpαf-BOF in the presence of lactacystine. 
p∆gpαf was translated in vitro in wheat germ with εBOF-Lys-tRNALys and [35S] Met, and translocated 
into KRMs. The washed vesicles were resuspended into cytosol (panels A and B; lanes 4-6), cytosol 
treated with lactacystine (panels A and B; lanes 7-9), or cytosol containing Hb in (panels A and B; lanes 1-
3), or SB (lanes panels A and B; lanes 10-12). At the designated time-points, aliquots were removed and 
TCA precipitated to assess degradation by detection with radioactivity (A), or fluorescence (B). Only the 
cytosolic fraction is shown in C, which was prepared by removing a fraction from the total samples, 
sedimenting the microsomes and precipitating the supernatant in TCA. The radioactive and fluorescence 
samples were run on a SDS-PAGE gel and visualized by BioRad FX phophorimager. 
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Figure 23. Continued. 
 
Retrotranslocation of a fluorescent-labeled ERAD substrate in the presence of 
proteasome inhibitors 
 A similar approach was used as discussed previously in this chapter (Fig. 21) to 
evaluate the effect of lactacystine (an irreversible proteasome inhibitor) on degradation 
of the retrotranslocated ∆gpαf (Fig. 23). Samples were TCA-precipitated after removing 
aliquots at different times and to evaluate the extent of degradation. These ∆gpαf had 
also a BOF dye incorporated because εBOF-Lys-tRNALys was added to the translation 
mixture. These experiments demonstrated that the presence of a BOF dye did not 
detectably affect or alter the rate of ∆gpαf retrotranslocation (Figs. 23 and 24). The 
∆gpαf degradation was almost fully inhibited (Fig. 23; lanes 7-9) when the cytosol was 
treated with lactacystine (an irreversible proteasome inhibitor), as detected by both 
radioactivity (Fig. 23A) and fluorescence (Fig. 23B). ∆gpαf also remained stable in the 
absence of cytosol, as it was observed with only in the microsomal fractions (Fig. 21; 
lanes 10-12). When the samples were sedimented at each time point to separate the 
cytosolic and microsomal fractions, the presence of retrotranslocated, and nondegraded 
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Figure 24. Retrotranslocation and degradation of ∆gpαf and ∆gpαf-BOF in cytosol with or without 
hemoglobin. The mRNA for p∆gpαf was translated in the presence of wheat germ extract, [35S] Met, SRP 
and either εBOF-Lys-tRNALys (lanes 1-9) or only Lys-tRNALys (lanes 10-12). Reticulocyte lysate (cytosol, 
lanes 1-3), lysate that lacked hemoglobin (cytosol-Hb, lanes 4-6 and 10-12), or no cytosol (lanes 7-9) were 
compared. The average percentages of ∆gpαf-BOF and ∆gpαf are shown below and normalized to zero 
time point after quantification by detection either radioactivity (A) or BOF fluorescence (n=7 and standard 
errors are 2-7%). 
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∆gpαf was apparent in the cytosolic supernatant fraction (Fig. 23C; lanes 4-6). The 
lower band in Fig. 23C is the signal cleaved ∆gpαf, while the top band is the non-
translocated p∆gpαf that remained in the cytosol. These results revealed that ∆gpαf was 
retrotranslocated back into the cytosol for degradation, but that this degradation step can 
be prevented if the 20S subunit of the proteasome is inhibited. This data are consistent 
with previous experiments (Fig. 21; lanes 16-18), although a less potent and reversible 
inhibitor was used.The effect of BOF was also investigated (Fig. 24). When ∆gpαf was 
translocated into KRMs with or without a BOF dye attached (Fig. 24A; lanes 4-6 and 
10-12) the retrotranslocation and degradation rates were very similar for ∆gpαf and 
∆gpαf-BOF. This implies that the presence of fluorescent BOF dye did not alter ERAD 
rate. 
Retrotranslocation of wild type 3gpαf from KRMs, but not from yeast RMs 
One interesting aspect of pαf secretion in a mammalian system that this protein is 
recognized as an ERAD substrate not only in the mutant, non-glycosylated structure 
(∆gpαf), but also in its glycosylated, wild type form (3gpαf). Experiments were 
conducted as described earlier (Fig. 21) with the in vitro translated, wild type ppαf 
mRNA. When KRMs that contained 3gpαf were incubated with cytosol and EGS, a 
time-dependent retrotranslocation was observed (Fig. 25; lanes 1-6). On the contrary, 
yeast RMs recognized 3gpαf as a properly folded and processed protein, not an ERAD 
substrate, and it was therefore not retrotranslocated (Fig. 25; lanes 7-9). Most of the 
translocated pαf had all three glycans on (3gpαf), but some possessed either two (2gpαf)  
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Figure 25. Retrotranslocation and degradation of gpαf. The ppαf mRNA was translated and 
translocated into KRMs (lanes 1-6) or yeast RMs (lanes 7-9). These vesicles were sedimented and 
resuspended in EGS and mammalian cytosol (Ret, reticulocyte lysate) (lanes 1-3 and 7-9) or in the 
absence of cytosol (lanes 4-6).  After incubation at 30 ˚C, aliquots were removed at the indicated times, 
sedimented, and pellets were resuspended in SDS-PAGE running buffer. The gel was visualized by 
radioactivity with BioRad phophorimager. 
 
or one glycans (1gpαf). The non-glycosylated pαf is also detectable on this gel (Fig. 25; 
lanes 1-6, black triangle) and showed a cytosol-dependent degradation over-time, which 
consistent with the data depicted earlier (Fig. 21). 
Yeast RMs and KRMs have different glycan processing machineries 
In order to further investigate why the wild 3gpαf is recognized in the mammalian 
system as an ERAD substrate, the glycosylation patterns of the 3gpαf in both yeast RMs 
and KRMs were examined. The translocation products were run on an SDS-PAGE gel 
beside each other, using two different batches of yeast and KRM to show that the results 
were not batch specific (Fig. 26; Lanes 1-4) 
 
 
 111
 
 
 
Figure 26. Differential trimming of 3gpαf in yeast and mammalian microsomes. The ppαf mRNA 
was translated and translocated into yeast RMs (lanes 1-2) or KRMs (lanes 3-4). After translocation, the 
membranes were resuspended in SDS-PAGE running buffer and run on a 10-20% SDS-PAGE gel. The gel 
was visualized by radioactivity with BioRad phophorimager. Experiments in lanes 1 and 2 were done with 
two different batches of microsomes (in lane 1 the yeast RM was purified in this lab as described in the 
methods section; in lane 2 the microsomes were generously provided by Dr. Brodsky), but the two batches 
show the same glycan processing. Mammalian microsomes in lanes 3-4 were used from different 
microsomal preparations, made in this lab. 
 
The SDS-PAGE results revealed that 3gpαf had different mobilities in KRMs versus 
yeast RMs (Fig. 26; lanes 1-2 vs. 3-4). This discovery implied that the three glycans on 
3gpαf were processed or trimmed in the mammalian ER differently compared to the 
yeast ER. This glycan processing difference between these two systems is probably the 
result of an extra glucose residue that is added back to or not removed from branch A on 
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any of the three carbohydrate moieties via UGGT (Fig. 8). UGGT preferentially 
reglucosylates hydrophobic, unfolded proteins in the CNX/Calcreticulin (CRT) cycle 
and is absent in yeast RMs. 
Retrotranslocation of S35- labeled ∆gpαf from reconstituted RMs (RRMs) in the 
presence of cytosol and EGS  
After the investigation of retrotranslocation of ∆gpαf from intact microsomes 
(KRMs), the retrotranslocation competence of RRMs was investigated. RRMs have a 
fully functional forward translocation activity and they are resealed in the correct 
orientation after lowering the pH back to 7.5. Ultimately, a purified ERAD substrate was 
going to be encapsulated into these microsomes, so it was crucial to show that RRMs 
were able to carry out retrotranslocation. 
RRMs reconstituted with total with lumenal content (Fig. 27; lanes 1-6) or without 
any soluble proteins (XRMs) (Fig. 27; lanes 7-9) were used for in vitro translocation of 
the wheat germ translated p∆gpαf. This ERAD substrate was retrotranslocated from 
RRMs (Fig. 27; lanes 1-3, bottom band) in a cytosol dependent manner (Fig. 27; lanes 4-
6, bottom band). The XRMs that did not contain soluble lumenal proteins did not 
support retrotranslocation as had the RRMs with a full set of soluble lumenal proteins 
present (Fig. 27; lanes 7-9 bottom band). On the other hand, p∆gpαf was translocated 
into RRMs and XRMs to similar extents. 
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Figure 27. Retrotranslocation of p∆gpαf from reconstituted microsomes. The p∆gpαf mRNA was 
translated and ∆gpαf translocated into RRMs (lanes 1-6) or XRMs (lanes 7-9). These vesicles were 
sedimented and resuspended in mammalian cytosol (Ret, reticulocyte lysate) (lanes 1-3 and 7-9) or in the 
absence of cytosol (lanes 4-6), EGS and incubated at 30 ˚C. Aliquots were removed at the indicated time-
points, sedimented, and the pellet was resuspended in SDS-PAGE running buffer. The gel was visualized 
by radioactivity with BioRad phophorimager.  
 
Can another ERAD substrate retrotranslocate from KRMs? 
An alternative ERAD substrate is the mammalian misfolded α1-antitrypsin inhibitor, 
which has several misfolded variants, but in this study the Z-variant (A1PiZ) was 
examined. A1PiZ has a mutation at position 342 where a negatively charged glutamic 
acid has been replaced by a positively charged lysine residue. This mutation causes 
misfolding, retention in the ER and eventually degradation in the cytosol. A1PiZ has 
three glycosylation sites and no disulfide bonds. When pA1PiZ mRNA was translated 
and translocated into KRMs, the largest fraction of A1PiZ became glycosylated 
completely (three carbohydrate moieties), but there were also double, single and  
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Figure 28. Retrotranslocation of A1PiZ from KRMs.  A1PiZ was translated in the presence of wheat 
germ extract and [35S] Met and KRMs. The sedimented microsomes were resuspended with (lanes 4-6 and 
10-15) or without (lanes 1-3 and 7-9) cytosol (Ret) and with EGS (lanes 1-6, 7-9, and 13-15) or apyrase 
(lanes 10-12). Fractions were removed at the indicated times and either further purified by sedimentation 
to remove the cytosolic part (Lanes 1-6). The complete samples, including cytosolic proteins were TCA 
precipitated to assess degradation (Lanes 7-15). A non-glycosylated pA1PiZ and A1PiZ were run in lane 
16 as controls. The samples were resuspended in SDS-PAGE running buffer. The gel was visualized by 
radioactivity with BioRad phophorimager. 
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nonglycosylated species present (Fig. 28; lanes 1-16). These KRMs with A1PiZ inside 
(1-3gA1PiZ and the signal cleaved A1PiZ) were washed and resuspended in cytosol and 
EGS to assess whether retrotranslocation of this protein occurs in vitro. When both the 
pellet and the total (pellet and supernatant together) fractions were examined 
individually for degradation during 60 minutes time-course, it was found that the amount 
of A1PiZ and especially the single glycosylated form (1gA1PiZ) decreased. The triple, 
double and nonglycosylated species also appeared to be degraded (Fig. 28; lanes 13-15). 
This degradation was cytosol and ATP-dependent, because in the absence of these two 
components no proteolytic activity was observed (Fig. 28; lanes 7-12). When the 
microsomal (pellet) fractions were examined alone after separating the cytosol from the 
pellet by sucrose gradient centrifugation, a cytosol-dependent decrease was observed in 
the amount of A1PiZ present in the microsomes. This finding showed that 0-
3gA1PiZwas retrotranslocated from the KRMs only in the presence of cytosol (Fig. 28; 
lanes 1-6), perhaps in an ubiquitination-independent manner. 
Retrotranslocation of an in vitro translated ERAD substrate from KRMs detected 
by fluorescence spectroscopy 
The retrotranslocation of ∆gpαf was also examined in the fluorometer. These 
experiments were necessary to establish the viability of the approach before doing more 
complex experiments with the purified ∆gpαf-BOF. The ∆gpαf mRNA was translated in 
the presence of KRMs, SRP, and either εBOF-Lys-tRNALys, or Lys-tRNALys as a dye 
free background sample. KRMs were then purified on a gel-filtration column to separate 
the microsomes from the non-translocated p∆gpαf-BOF and from εBOF-Lys-tRNALys. 
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Figure 29. Retrotranslocation of the in vitro translated ∆gpαf-BOF from KRMs detected by 
antibody quenching. The mRNA for p∆gpαf was translated in the presence of wheat germ extract, [35S] 
Met, SRP and either εBOF-Lys-tRNALys for the fluorescent sample or only Lys-tRNALys for the blank 
samples. The KRMs containing the in vitro translated ∆gpαf-BOF were purified by gel-filtration and 
resuspended in cytosol-Hb. The net emission intensities of samples with and without αBOF were recorded 
as a function of time and then normalized (F = F+αBOF / F-αBOF). F0 is the initial net normalized intensity at 
t0, while F is the net normalized intensity at any time t. The average F at each time point for three separate 
experiments is plotted; error bars show the standard error for each point and dictate line thickness. 
 
 
The microsomes were collected and placed into a fluorescence cuvette in the absence or 
presence of cytosol, BOF-specific antibodies (αBOF) and EGS for fluorescence 
experiments. The emission intensity was recorded in the presence and absence of αBOF 
for 500 seconds (Fig. 29). The magnitude of the αBOF-dependent intensity change was 
then given by the ratio of intensities with and without αBOF (F = F+αBOF / F–αBOF * 100 
or % F/F0). Only the αBOF-dependent intensity is shown here. A cytosol dependent 
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decrease in fluorescence intensity was observed over time (Fig. 29; circles) without 
subtraction of the non-retrotranslocation dependent decrease in fluorescence intensity 
(explained later in Chapter IV). These data suggested that some ∆gpαf-BOF was 
transported from the ER lumen into the cytosol where the dye was bound by αBOF and 
quenched. The reduction in intensity totaled 10% by the end of the 500-second period; 
while no significant quenching was observed in the absence of cytosol (Fig. 29; 
triangles). 
Discussion 
Several important conclusions can be drawn from these experiments. First, the 
mammalian system recognizes the misfolded ∆gpαf as an ERAD substrate and 
retrotranslocates it back to the cytosol. Second, a BOF dye covalently conjugated to 
∆gpαf does not alter its retrotranslocation rate (Figs. 23 and 24). Third, ∆gpαf, 3gpαf 
and A1PiZ were degraded in the cytosol by the proteasome, because their degradation 
was not affected by protease inhibitors, only by proteasome inhibitors.  Fourth, 
retrotranslocation also was an ATP-dependent process, because the addition of apyrase 
that eliminates any ATP present by hydrolyzing ATP into AMP and pyrophosphate 
(Figs. 21, 23, 24, 28) prevented ERAD to occur in at least two substrates. 
The wild-type 3gpαf was also recognized by the quality control system in the 
mammalian ER, but not by the yeast ER (Fig. 25). One can easily detect differences in 
the mobilities on the SDS-PAGE gel between 3gpαf present either in KRMs or yeast 
RMs. Moreover, the glycosylation patterns of 3gpαf in either a mammalian or a yeast 
ER showed some differences (Fig. 26). The same observation was made earlier by a 
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group that was investigating the post-translational translocation of ppαf into yeast RMs 
versus canine RMs (Hansen et al., 1986). These distinctions in glycan processing 
between yeast and canine ER may result from a lag in the glycan processing within the 
mammalian ER. During this time period, the newly translated/translocated protein goes 
through a refolding attempt by the CNX/CRT cycle in which glucose is added back to 
the A-chain by UGGT (Fig. 8). The presence of extra glucoses on all three of the N-
linked carbohydrate moieties of 3gpαf may account for the different mobility in the 
SDS-PAGE gel. Since Saccharomyces cereviciae does not contain UGGT or its 
homologue, it is quite likely that 3gpαf avoids this type of a quality control in yeast. In 
contrast, the unglycosylated ∆gpαf appears to take similar routes in both yeast and 
mammals, because both systems recognized ∆gpαf as an ERAD substrate.  
The degradation of 3gpαf was also noted in an in vivo study (Su et al., 1993) that 
tried to use a mammalian system [rat pituitary cell line] to investigate the biogenesis of 
ppαf. A mammalian system seemed ideal to examine the movement of 3gpαf from the 
ER to the plasma membrane, since trafficking through the mammalian secretory 
pathways takes much longer than in yeast. These in vivo experiments also showed that 
3gpαf becomes stabilized in mammalian cell lines that contained mannosidase 
inhibitors, while these inhibitors had naturally no affect on the retrotranslocation of 
∆gpαf (Su et al., 1993). This observation is consistent with the hypothesis that proposes 
that mannose trimming is very important in the quality control of glycoproteins in a 
mammalian system (Yoshida, 2003). This so-called “timer” mechanism would allow 
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improperly folded glycoproteins to go through extensive refolding cycles to reach the 
correct conformation. If these attempts fail, a mannose residue is removed from the B-
chain of the carbohydrate moiety (Fig. 8), which may facilitate the interactions with 
mannosidase-like chaperones (Fig. 14) (Hirao et al., 2006). If folding is unsuccessful, 
eventually these glycoproteins are targeted for degradation (Helenius and Aebi, 2004).  
Interestingly, some of the ∆gpαf was found to become O-mannosylated in yeast 
RMs in vitro, supposedly to escape retrotranslocation (Harty et al., 2001). O-
mannosylation starts with the addition of dolichol-phosphate mannose to a serine or 
threonine residue on the protein by one of the seven-mannosidase transferase (Pmt1-7p). 
This research group also found a set of O-mannosylated forms (m∆gpαf) crosslinked to 
the Sec61 channel, which led them to conclude that the translocon also acts as a 
retrotranslocon. It was suggested that there is a limited time-window for this protein to 
be degraded in yeast ER and to start acquiring these O-mannosylations. It is not very 
clear from these experiments why the m∆gpαf would be associated with the translocon 
if it becomes stabilized in the lumen by O-mannosylation and not retrotranslocated. They 
proposed that ∆gpαf might be engaged with the translocon for retrotranslocation while 
the O-mannosylation occurs, so this misfolded protein can be retained in the yeast ER. 
O-mannosylation was proposed to occur post-translationally in yeast ER by a slow and 
inefficient process (Nakatsukasa et al., 2004).  O-mannosylation was suggested to 
maintain the proteins in a chaperone-independent, soluble form. In our in vitro 
retrotranslocation assay using mammalian microsomes, O-mannosylation of ∆gpαf was 
 
 
 120
not detectable, so perhaps it is limited to yeast microsomes or occurred in a small, 
undetectable fraction of translocated ∆gpαf (Fig. 21).  
A1PiZ is another widely used ERAD substrate that was investigated in this study 
(Fig. 28). This protein is the only soluble ERAD substrate beside ∆gpαf that has been 
demonstrated to retrotranslocate in an in vitro assay up to this day (Qu et al., 1996).  The 
abnormally folded A1PiZ causes several serious diseases in humans. The wild type α-1-
proteinase inhibitor (A1PiM, α1-antitrypsin inhibitor M-form) is synthesized by the liver 
and normally passes through the secretory pathway. A1PiM has three glycosylation sites 
and traffics through the ER very quickly. Its Z-form has a mutation E342K, which 
causes the salt bridge between K290 and E342 to be disrupted. This form accumulates in 
the ER lumen and is eventually degraded in the cytosol. This degradation was shown to 
be inhibited by 10 µM lactacystine and A1PiZ completely disappeared within 2-4 hours 
without proteasome inhibitors in vivo (Qu et al., 1996). A cell-free system developed by 
this research group used proteasome-treated reticulocyte lysate for in vitro translation of 
A1PiZ mRNA and translocation into KRMs. The microsomes were sedimented and 
resuspended it into reticulocyte lysate without proteasome inhibitors. The reaction was 
run up to 16 hours while aliquots were removed about every hour, run on an SDS-PAGE 
gel, and quantified. This system supported the degradation on A1PiZ, while A1PiM 
remained stable. This approach was used in this dissertation (Fig. 28). When A1PiZ 
mRNA was translated in wheat germ extract, neither degradation nor retrotranslocation 
from KRMs occurred. The KRMs were sedimented and resuspended in reticulocyte 
lysate cytosol; aliquots were removed then during an hour incubation period (Fig. 27). It 
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was demonstrated that A1PiZ could be retrotranslocated in a reticulocyte cell-free 
extract (Fig. 28; lanes 1-6), because the amount of A1PiZ decreased over time in an 
Adenosine 5'-triphosphate (ATP)- and cytosol-dependent process (Fig. 28; lanes 7-15). 
In this respect, the degradation of ∆gpαf was very similar to the degradation of A1PiZ, 
but ∆gpαf was degraded in a faster rate.  
The next task was to examine whether the in vitro translated and translocated ∆gpαf-
BOF retrotranslocation was detectable spectroscopically. Some εBOFLys was 
incorporated into ∆gpαf, and the microsomes were purified by gel-filtration before the 
spectroscopic measurements. The results showed that the antibody in the cytosol 
quenched BOF when the in vitro translated ∆gpαf-BOF was transported from the ER 
lumen to the cytosol. There was a 10% decrease in the fluorescence intensity of the 
sample containing cytosol and EGS compared to the no cytosol sample over a 500 
second time period. These preliminary results confirmed that ∆gpαf-BOF was 
retrotranslocated back to the cytosol, although the conditions to maximize the rate still 
needed to be optimized by future experiments (Fig. 29). 
These in vitro experiments revealed that the dependence on ATP and cytosol for the 
retrotranslocation of ERAD substrates is universal, but may involve different individual 
cytosolic and lumenal components for various ERAD substrates. The identification of 
these factors/proteins in the ER lumen, membrane and cytosol was the goal of this 
project. 
 
 
 
 122
CHAPTER IV 
CYTOSOLIC REQUIREMENTS FOR  
THE RETROTRANSLOCATION OF A FLUORESCENCE-LABELED ERAD 
SUBSTRATE* 
Background and rationale 
ERAD quality control machinery must distinguish misfolded proteins in the ER 
lumen from proteins that are on the way to folding properly, and ERAD substrates must 
be targeted to a retrotranslocation site in the ER membrane, transported through the 
membrane, and directed to sites of proteolysis (Johnson and Haigh, 2000). Proteins in 
and on both sides of the ER membrane are thus essential to work in concert to complete 
this procedurally difficult task. Since ERAD was first identified (Hampton et al., 1996; 
Hiller et al., 1996; McCracken and Brodsky, 1996; Sommer and Jentsch, 1993; Ward et 
al., 1995), a number of proteins have been shown to be involved directly or indirectly in 
ERAD. While the specific roles of some proteins have been determined, the functions of 
others are either unknown or controversial. The confusing and sometimes contradictory 
data about the involvement of specific proteins in retrotranslocation result in part from 
limitations in the experimental approaches currently available to examine this process, 
especially in mammalian systems. First, in most in vivo and in vitro studies, ERAD 
                                                 
* Part of the data reported in this chapter is reprinted with permission from “Real-Time 
Fluorescence Detection of ERAD Substrate Retrotranslocation in a Mammalian In Vitro 
System” by Wahlman et al., 2007. Cell, 129 (5). 943-955. Reprinted in accordance with 
Copyright © Elsevier (2007)  
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substrates are synthesized in the cytoplasm and co-translationally translocated into the 
ER lumen concurrent with ongoing retrotranslocation and degradation. Thus, approaches 
to study retrotranslocation are complicated by the inability to discriminate between 
substrates on their way into the ER lumen and those on their way out. Even the presence 
of a lumenal or cytosolic-specific covalent modification (e.g., signal sequence cleavage, 
glycosylation, ubiquitinylation) cannot distinguish between proteins that were 
completely translocated and those that were trapped at some stage prior to complete 
translocation. These realities interfere with accurate quantification of the extent of 
retrotranslocation. Second, the kinetics of retrotranslocation are difficult to quantify 
accurately, both for the above reasons and because retrotranslocation cannot be 
synchronized in most experiments. Since translocation and retrotranslocation proceed 
simultaneously both in vivo and in vitro at unknown and perhaps variable rates, there is 
currently no way to prepare samples in which all substrates are in the same state at a 
specific time. Hence, synchronous initiation of retrotranslocation for all substrates in a 
sample has been impossible. Third, the role of a particular protein in retrotranslocation is 
difficult to ascertain in many approaches. For example, the mutation of a particular gene 
may alter in vivo retrotranslocation activity, but it is difficult to know whether the 
observed change in activity is a primary or secondary effect. Interpretations are further 
complicated if the loss of a specific protein is obscured by the presence of another 
protein that is partially or wholly redundant.  
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Experimental design 
To overcome these limitations, a mammalian in vitro system was developed that 
allowed us to monitor retrotranslocation synchronously and in real time in the absence of 
concurrent translocation (Fig. 30).  Fluorescent-labeled ERAD substrate molecules and a  
 
 
 
Figure 30. Reconstitution of canine pancreatic microsomes with various soluble lumenal contents.  
KRMs (i. gray) release their soluble lumenal contents when subjected to high pH (ii). These open 
microsomes are purified from the soluble contents (ii. pink, orange, and purple, blue) by sedimentation. 
These microsomes are resuspended in a solution containing a BOF-labeled ERAD substrate with purified 
soluble lumenal components (all, some or none) and resealed by lowering the pH to 7.5 (iii). The 
microsomes with lumenal content (RRMs) or without any lumenal content (XRMs) are resealed in the 
proper orientation and are fully functional. RRMs are further purified by gel-filtration to remove any non-
encapsulated proteins and directly used for fluorescence experiments. 
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known selection of lumenal components is encapsulated inside ER microsomes using the 
procedures summarized in Fig. 30. The lumenal contents of ER microsomes were 
extracted by exposure to pH 9.5-10.0 and separated from membranes by sedimentation 
(Alder et al., 2005; Bulleid and Freedman, 1988; Haigh and Johnson, 2002; Hamman et 
al., 1998; Nicchitta and Blobel, 1993). After the membranes were resuspended in a 
solution containing the components to be encapsulated (e.g., ∆gpαf-BOF, ATP, BiP), 
the solvent pH was reduced to 7.5 to re-seal the microsomes in their original orientation 
(lumen inside) without any detectable loss of ribosome-binding activity. Following gel 
filtration to separate the microsomes from any nonencapsulated material, the 
reconstituted rough microsomes (RRMs) had a defined lumenal content. When such 
microsomes are added to a solution containing a known selection of cytosolic 
components, the resultant sample is well-defined biochemically, with the desired 
molecular species on each side of the ER membrane. The retrotranslocation of 
fluorescent-labeled substrates from the lumenal to the cytosolic side of the membrane is 
detected because the cytosol also contains fluorescence-quenching agents (Fig. 31). The 
rate of substrate retrotranslocation is therefore monitored directly in real time by the 
reduction in sample emission intensity as the dyes that are covalently attached to the 
substrate move through the ER membrane and are exposed to the quenchers. As all 
substrate molecules are initially encapsulated inside microsomes and retrotranslocation 
is initiated by increasing the temperature, substrate retrotranslocation is synchronized 
and reproducible. Moreover, by varying the lumenal and cytosolic components in 
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Figure 31. Basis of fluorescence-detected retrotranslocation. (A) (i) RRMs (gray) containing ∆gpαf-
BOF (cyan with yellow dye), ATP, and a selection of lumenal proteins (? = all, some or none) are mixed 
on ice with ATP, αBOF (anti-BOF antibodies; red), and some selection of cytosolic proteins (? = all, 
some, or none). (ii) Retrotranslocation is initiated at t0 by incubating samples at 30°C. (iii) 
Retrotranslocation of ∆gpαf- BOF from the inside to the outside of the microsomes allows αBOF to bind 
the BOF dye and quench its emission intensity. (iv) A direct real-time measure of the rate and extent of 
∆gpαf-BOF retrotranslocation is therefore given by the time-dependent decease in BOF intensity as more 
∆gpαf-BOF molecules are exposed to αBOF. 
 
parallel samples, the requirement for individual factors during retrotranslocation may be 
revealed by even subtle changes in the kinetics of substrate retrotranslocation.  
The ERAD substrate used in this study was ∆gpαf, a non-glycosylated derivative of 
the yeast pro-α-factor mating pheromone (Fig. 32). Because both yeast (Caplan et al., 
1991; McCracken and Brodsky, 1996) and mammals (Su et al., 1993) recognize and 
degrade ∆gpαf, it is a valid model ERAD substrate. Furthermore, ∆gpαf is soluble, is 
not ubiquitinylated, and lacks disulfide bonds, carbohydrates, and transmembrane 
sequences. Since these structural features may complicate retrotranslocation and require 
additional or different mechanisms and/or components, ∆gpαf was used to establish the 
minimal requirements for retrotranslocation and characterize the system with in this 
dissertation. 
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Figure 32. The structure of the wild type and mutant pro-α-factor. The wild type yeast prepro-α-
factor mating pheromone (ppαf) is shown in the upper panel. The three potential glycosylation sites are 
shown on the wild-type protein. The mutant, unglycosylated (∆gpαf) protein without the signal sequence, 
which is an ERAD substrate, is shown in the bottom panel. A single cysteine was substituted at either 
position 25 or 165 if the protein and then covalently modified by the attachment of a fluorescent dye as 
shown with a yellow star (either Y165C or T25C). Data presented in this dissertation were obtained with 
the construct that had the dye attached to the C-terminal end (Y165C), unless specified otherwise. 
 
∆gpαf-BOF and microsomes with defined lumenal contents 
One advantage of the spectroscopic approach is that a substrate from a single prep of 
∆gpαf-BOF can be encapsulated and compared with parallel samples that have different 
combinations of lumenal and/or cytosolic components. This approach also eliminates 
substrate heterogeneity (Fig. 30). A recombinant ∆gpαf derivative was over-expressed 
and purified with a C-terminal hexameric histidine tag and four single-site mutations: 
N23Q, N57Q, and N67Q to prevent glycosylation, and Y165C for dye attachment (Fig. 
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32). Since no targeting to the translocon was required, no signal sequence was present. 
This ∆gpαf derivative was then covalently modified with BOF and gel filtered to 
remove unreacted dye, thereby yielding ∆gpαf-BOF. To assess whether ∆gpαf-BOF 
adsorbs to the outer surface of RRMs after the reconstitution procedures, microsomes 
were subjected to mock encapsulation procedures in the absence of ∆gpαf-BOF and then 
incubated with ∆gpαf-BOF to allow adsorption. After gel filtration, the BOF intensity of 
mock RRMs was ~10% of that seen with RRMs that contained ∆gpαf-BOF. Since any 
cytosol-exposed ∆gpαf-BOF was quenched before retrotranslocation was initiated, the 
molecules absorbed to the outer microsomal surface did not contribute to the spectral 
changes shown below. An independent, although less accurate, determination of ∆gpαf-
BOF absorbed to the outside was carried out by proteinase-K (PK) digestion (Fig. 33). 
The ∆gpαf-BOF was visualized by fluorescence and quantified. PK only digested 
∆gpαf-BOF absorbed to the outside microsomal surface, and this was about 10% of the 
original signal after quantification (compare Fig. 33; lanes 1 and 2). The ∆gpαf-BOF 
almost completely disappeared after addition of TX-100 to solubilized the membranes. 
These experiments confirmed that the majority of ∆gpαf-BOF was within the RRMs, but 
one must emphasize that proteinase experiments are clearly not as accurate as 
determination of the amount of ∆gpαf-BOF outside of the microsomes by antibody 
quenching (only ~5% of the initial signal was quenched after addition αBOF to the 
RRM with ∆gpαf-BOF encapsulated, but αBOF quenches BOF conjugated to a protein 
by 50% efficiency) or by mock reactions (~10%). 
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Figure 33. Fluorescence-detected protease protection assay with reconstituted ∆gpαf-BOF. ∆gpαf-
BOF was reconstituted into canine pancreatic microsomes and separated by gel filtration over Sepharose 
CL-2B from any non-encapsulated ∆gpαf. Proteinase K (0.1 mg/ml final concentration) or proteinase K 
and TX-100 [(v/v) 1% final concentration] were added to purified, reconstituted vesicles and samples were 
incubated on ice for 30 min. Reactions were terminated by addition of 1 mM PMSF. Samples were 
analyzed by SDS-PAGE and the bands were quantified using the BioRad phophorimager by BODIPY 
fluorescence. 
 
Fluorescence-detected retrotranslocation 
In initial retrotranslocation experiments, microsomes contained ∆gpαf-BOF, ATP, 
and a full set of lumenal proteins that had been extracted, concentrated, and then 
reconstituted back into RRMs (complete RRMs). To obtain a full set of cytosolic 
proteins, rabbit reticulocyte lysate was first chromatographed to remove hemoglobin 
because its presence interfered with fluorescence measurements. The resulting 
hemoglobin free lysate, here termed “cytosol or cytosol-Hb” (Figs. 23 and 24), was 
diluted ~4-fold from the original lysate, but still supported retrotranslocation (Fig. 21) 
 
 
 130
 
 
 
Figure 34. The retrotranslocation of ∆gpαf-BOF is spectroscopically detectable. Complete RRMs 
containing ∆gpαf-BOF with total lumenal proteins, and ATP were purified by Sepharose CL-2B and 
resuspended in cytosol, an EGS and +/- αBOF. Sample fluorescence intensity was monitored with mixing 
in the fluorometer for 2000 seconds.  A time-dependent decrease in fluorescence intensity can be observed 
over this time-period, which is due to the quenching of the BOF dye when ∆gpαf-BOF is transported out 
of the microsomes and into cytosol containing ATP. 
 
and was used in all fluorescence experiments. A solution containing cytosol and ATP is 
designated “complete cytosol”. The concentrations of ATP, cytosol, and lumenal 
proteins required for maximal retrotranslocation were determined and used throughout 
this study. To detect substrate retrotranslocation, BOF-specific antibodies (αBOF) were 
added to the cytosol. Since no retrotranslocation occurs at 0°C (Fig.53), RRMs were 
mixed with the cytosolic components and αBOF on ice before retrotranslocation was 
initiated by raising the temperature to 30°C. Besides allowing complete mixing, the 0°C 
incubation allowed αBOF to quench any residual non-encapsulated ∆gpαf-BOF before 
the reaction was initiated (t0). Since αBOF binding to BOF strongly quenches its 
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emission, any retrotranslocation of lumenal ∆gpαf-BOF into the cytosol should result in 
a significant reduction in sample emission intensity (Fig. 34). The magnitude of the 
spectral change depends on the initial state of BOF in the sample because BOF emission 
is partially quenched in the full-length polypeptide, and proteolysis of ∆gpαf-BOF 
causes a 65% increase in BOF intensity (see later). To focus solely on αBOF-dependent 
intensity changes, parallel samples with or without αBOF were examined in each 
experiment. The magnitude of the αBOF-dependent intensity change was then given by 
the ratio of intensities with and without αBOF (F = F+αBOF / F–αBOF). Only the αBOF-
dependent intensity is shown here. When complete RRMs were added to complete 
cytosol, a substantial αBOF-dependent decrease in BOF intensity was observed (Fig. 
34). Maximal αBOF-dependent quenching averaged 46 ± 1% of the initial intensity after 
2000 sec (Fig. 34). 
Cytosol- and ATP-dependent substrate retrotranslocation 
When complete RRMs were incubated in the absence of cytosolic proteins, the initial 
sample intensity was reduced by 9 ± 1% after 2000 sec (Fig. 35; red trace).  When 
apyrase, an enzyme that hydrolyzes ATP, was included in both the lumenal and cytosolic 
solutions, the rate and extent of ∆gpαf-BOF quenching were reduced to the same extent 
(10 ± 3%) (Fig. 36; green trace). 
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Figure 35. Cytosol is required for the retrotranslocation of ∆gpαf-BOF. Complete RRMs 
encapsulating ∆gpαf-BOF and all soluble lumenal proteins were incubated in the presence (blue) or 
absence (red) of cytosol, an EGS and +/- αBOF. Retrotranslocation was monitored in the fluorometer for 
2000 seconds. 
 
 
 
 
Figure 36. ATP is required for the retrotranslocation of ∆gpαf-BOF. The αBOF-dependent quenching 
is shown for complete RRMs encapsulating ∆gpαf-BOF upon incubation in complete cytosol (blue; n = 
48), ATP in the absence of cytosolic proteins (red; n = 21), and cytosol lacking ATP (green; n = 7; 30 
units/ml apyrase was included in both the lumen and the cytosol). 
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Thus, both cytosolic proteins and ATP are required for ∆gpαf-BOF retrotranslocation, as 
observed in yeast systems (McCracken and Brodsky, 1996; Pilon et al., 1997; Lee et al., 
2004). 
Origin of background fluorescence quenching 
The fluorescence approach utilized here measures the kinetics of ERAD substrate 
exposure to the cytosol continuously at a time resolution much higher than that 
achievable by other methods. 
 
 
 
Figure 37. Cytosol-dependent retrotranslocation of ∆gpαf-BOF during a longer time period.  
Complete RRMs containing ∆gpαf-BOF were incubated for a longer time with complete cytosol (red) or 
without cytosolic proteins (blue). 
 
There was a small steady decrease in ∆gpαf-BOF intensity observed in the absence 
of either cytosol or ATP (Figs. 35 and 37). Is the slow, steady increase in αBOF-
dependent quenching in the absence of cytosolic proteins or ATP caused by 
encapsulated material leaking from the microsomes? 
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Figure 38. Retrotranslocation-independent exposure of BOF-labeled polypeptides to cytosol. (A) 
Complete RRMs containing ATP, total lumenal proteins, and either glutathione-BOF (red), PDI-BOF 
(blue), or BiP-BOF (orange) were incubated in complete cytosol. RRMs containing glutathione-BOF were 
also incubated in the absence of cytosol (cyan). n = 3 to 5 independent experiments. The small steady 
decrease in ∆gpαf-BOF intensity observed in the absence of either cytosol or ATP (Fig. 36) was nearly 
identical to the decrease observed with RRMs containing BODIPY-labeled glutathione, heavy chain 
binding protein (BiP) or protein disulfide isomerase (PDI). Since BiP and PDI are ER resident proteins 
and are not retrotranslocation substrates, this αBOF-dependent quenching appears unrelated to 
retrotranslocation.  
 
RRMs were reconstituted with ATP, total lumenal proteins, and BOF-labeled 
glutathione to determine if the release of a small molecule occurs spontaneously from 
the RRMs over time. Other RRMs were prepared with ATP and either BOF-labeled BiP 
or BOF-labeled PDI because these abundant ER lumenal proteins should not be 
substrates for retrotranslocation (Fig. 38). When incubated in full cytosol, the rates and 
extents of quenching, and hence BOF exposure to αBOF in the cytosol, were the same 
for both large (BiP-BOF, PDI-BOF) and small (glutathione-BOF) encapsulated 
molecules. Thus, any openings in the RRMs had to be large enough to release PDI and 
BiP at the same rate as glutathione. Yet we showed previously that microsomal 
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membranes are impermeable to iodide ions for more than 4 hours at 4°C (Crowley et al., 
1994). Thus, holes large enough to release PDI or BiP from microsomes are unlikely, 
and the slow increase in αBOF-dependent quenching in the absence of retrotranslocation 
apparently does not occur due to either glutathione-BOF or ∆gpαf-BOF leakage from 
RRMs. Instead, this signal loss most likely results from a low constant rate of RRM 
breakage at 30°C that simultaneously exposes glutathione-BOF and the larger ∆gpαf-
BOF, PDI-BOF, and BiP-BOF to αBOF. Whatever its origin, this αBOF-dependent 
emission intensity decrease appears to constitute a “background” signal change because 
it is observed under conditions in which retrotranslocation does not occur (compare Fig. 
36 “no cytosol” and “no ATP” traces with Fig. 38). Moreover, after very long time 
periods (~50 min), the rate of quenching was the same regardless of whether or not 
cytosol was present (Fig. 37). Thus, the quenching due to retrotranslocation was 
complete within ~50 min under our conditions in the sample containing cytosolic 
proteins, and the net intensity reached a plateau by 50 min (Fig. 37). Therefore the 
αBOF-dependent quenching observed with samples lacking cytosol was routinely 
subtracted to accurately portray the retrotranslocation-dependent fluorescence change 
(Fig. 39). 
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Figure 39. Corrected quenching after subtraction of the retrotranslocation-independent exposure of 
BOF-labeled polypeptides to cytosol. Complete RRMs containing ∆gpαf-BOF and ATP were incubated 
for an extended time with or without cytosol, and the net αBOF-dependent quenching (red; n = 3) was 
obtained by subtracting the non-cytosol αBOF-dependent quenching from the complete cytosol αBOF-
dependent quenching (Fig. 37). The non-cytosol dependent quenching was also subtracted from itself to 
yield the expected flat line (blue). Subtracting the background from the observed signal change yielded 
this net retrotranslocation-dependent fluorescence change. ∆gpαf-BOF retrotranslocation was complete 
when the spectral change reached a plateau, which occurred after 3000 sec under our conditions. 
 
Detection of ∆gpαf- BOF in the cytosol after retrotranslocation 
Direct biochemical evidence for lumenal ∆gpαf-BOF transport into the cytosol was 
provided by incubating complete RRMs with ATP and epoxomicin-treated cytosol in the 
absence of αBOF (Fig. 40), removing the microsomes by sedimentation, and quantifying 
the amount of ∆gpαf- BOF fluorescence in the supernatant. On average (n = 3), 30% of 
full-length ∆gpαf-BOF was found in the supernatant under conditions when the 
proteasome was inhibited by epoxomicin (Fig. 40, lane 4). Much less ∆gpαf-BOF was 
found in the supernatant when proteasomes were active (Fig. 40, lane 2), and none was 
found when no retrotranslocation occurred (Fig. 40, lane 3). 
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Figure 40.  Fluorescence-detected accumulation of ∆gpαf-BOF in the cytosol after 
retrotranslocation. Complete RRMs containing ∆gpαf-BOF were incubated (30°C, 30 min) with 
complete (lane 2), without cytosol (lane 3), or complete cytosol inhibited with 60 µM epoxomicin (lane 4); 
an equivalent amount of RRMs was loaded directly into lane 1. After microsomes and encapsulated 
∆gpαf-BOF were removed by sedimentation, the amount of full-length ∆gpαf-BOF in each supernatant 
was determined by SDS-PAGE and imager-detected BOF fluorescence. 
 
The AAA protease, p97, with its two co-chaperones (Npl4 and Ufd1) do not 
stimulate ∆gpαf retrotranslocation 
The ATPase complex containing p97 (VCP; Cdc48 in yeast), Ufd1 and Npl4 play a 
critical role in the retrotranslocation of several ERAD substrates (Bays and Hampton, 
2002; Carlson et al., 2006; Tsai et al., 2002).  To show that there  
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Figure 41. Western blot shows no detectable residual p97 bound to RRMs after the high pH 
treatment. Isolated p97 (VCP) and the p97/Npl4/Ufd1 complex each have ATPase activity, and the 
p97/Npl4/Ufd1 complex binds to polyubiquitin chains (G. DeMartino, personal communications). These 
p97 were incubated with 10 eq/µl KRMs or RRMs, or these microsomes were incubated with only buffer 
at 4 ˚C for 20 minutes and then 30 ˚C for 10 minutes. The resulting microsomes were sedimented and the 
pellet was resuspended in SDS-PAGE running buffer. The bands were detected by chemifluorescence on 
BioRad phophorimager with antibodies to p97. 
 
was not any residual p97 present on the ER membrane, western blotting was done (Fig. 
41). While the KRMs contained residual p97 (although some might have sedimented 
independently of the microsomes due to its size), the Western blot shows no detectable 
residual p97 bound to RRMs after the high pH treatment. Isolated p97 (VCP) and the 
 
 
 
 139
 
 
Figure 42. Retrotranslocation of ∆gpαf-BOF does not depend on p97-Npl4-Ufd1. Complete RRMs 
containing ∆gpαf-BOF were incubated with ATP and p97, Ufd1, and Npl4 (red; n = 4), full cytosol (blue), 
or no cytosol (cyan). The longer time-scale graph is shown on the left and the shorter time-scale is on the 
right. 
 
 
p97-Npl4-Ufd1 complex each have ATPase activity, and the p97-Npl4-Ufd1 complex 
binds to polyubiquitin chains (DeMartino, personal communication). 
To assess the involvement of this complex in ∆gpαf retrotranslocation, complete 
RRMs were incubated with purified p97, Ufd1, Npl4, and ATP, and no increase in 
αBOF-dependent quenching over background was observed (Fig. 42). 
A different approach to confirm the involvement of p97 in retrotranslocation was 
utilized when cytosol was incubated with excess antibodies to p97 (αp97) prior to 
addition to the ERAD assay. The quenching rates of the untreated and did not change 
compared to the full cytosol sample when excess αp97 was added (Fig. 43), thereby 
showing that a p97-αp97 complex prior to exposure to microsomal membranes did not 
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Figure 43. Retrotranslocation of ∆gpαf-BOF is not inhibited by antibodies to p97. Complete RRMs 
containing ∆gpαf-BOF and full cytosol were incubated separately with 3 µg/ml αp97, and then used for 
ERAD assay in the fluorometer (red, n=2). The full cytosol (black) and no cytosol (blue) samples are also 
shown. The longer time-scale graph is shown on the right and the shorter time-scale is on the left. 
 
alter the rates of retrotranslocation. Thus, ∆gpαf retrotranslocation is independent of p97 
and its cofactors in this system. 
Cytosolic requirements for ∆gpαf-BOF retrotranslocation can be replaced with 
purified 26S proteasomes 
In yeast, 26S proteasomes stimulate ∆gpαf retrotranslocation (Lee et al., 2004) and 
possibly that of other substrates (e.g., (Chillarón and Haas, 2000; Mayer et al., 1998; 
Walter et al., 2001). When complete RRMs were incubated with ATP and purified 
bovine 26S proteasomes, the maximal rates and extents of αBOF-dependent quenching 
were nearly the same for pure 26S proteasomes and for total cytosolic proteins (Fig. 44). 
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Figure 44. Cytosolic requirements for the retrotranslocation of ∆gpαf-BOF can be substituted by 
purified 26S proteasomes. Complete RRMs containing ∆gpαf-BOF were incubated with ATP and 26S 
proteasomes (red; n = 17), complete cytosol (cyan), or without cytosol (blue). The longer time-scale graph 
is shown on the left and the shorter time-scale is on the right. 
 
PA700, the 19S regulatory particle (RP) of the 26S proteasome, stimulates ∆gpαf 
retrotranslocation 
To determine whether PA700 alone could promote retrotranslocation, complete 
RRMs were incubated with ATP and purified bovine PA700. Since an increase in 
αBOF-dependent quenching was observed (Fig. 45), PA700 stimulated ATP-dependent 
∆gpαf retrotranslocation. Moreover, the ATPase activity of PA700 was required because 
pre-treating PA700 with N-ethylmaleimide  (NEM; (DeMartino et al., 1994) essentially 
blocked retrotranslocation (Fig. 46).  Continuous monitoring of ∆gpαf-BOF intensity 
revealed that the initial quenching rates were similar for samples containing either 
purified 26S or purified 19S RPs (Figs. 44 and 45, right panel), but the total 19S-
dependent increase in quenching was much less than the total 26S-dependent increase 
(Fig. 45). 
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Figure 45. PA700, the 19S proteasomal regulatory particle, stimulates ∆gpαf retrotranslocation. 
Complete RRMs containing ∆gpαf-BOF were incubated with ATP and PA700 regulatory particles (RPs) 
(red; n = 10), without cytosol (blue), or complete cytosol (cyan). The longer time-scale graph is shown on 
the left and the shorter time-scale is on the right. 
 
 
 
Figure 46. ∆gpαf retrotranslocation does not occur in the presence of NEM-treated 19S RP. 
Complete RRMs containing ∆gpαf-BOF were incubated with ATP and NEM-treated 19S proteasomes 
(red; n = 4), 19S RPs (green; n = 10), no cytosol (blue), or complete cytosol (cyan).  
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The cause of the differential quenching between 26S- and 19S-containing samples 
was revealed by incubating complete RRMs with ATP and 26S that had been pre-treated 
with the proteasome inhibitors epoxomicin or lactacystine (Gaczynska and Osmulski, 
2005). The rates and extents of αBOF-dependent quenching were nearly the same for 
samples containing PA700 (Fig. 45), epoxomicin-treated 26S (Fig. 47), epoxomicin-
treated (Fig. 48) or lactacystin-treated 26S cytosol (Fig. 49). Hence, the 26S protease 
activity was responsible for the different quenching profiles observed with 19S and 26S. 
This conclusion was confirmed by measuring the BOF intensity of intact and 
proteolyzed ∆gpαf-BOF and its sensitivity to αBOF (data not shown). 
 
 
 
Figure 47. The rate and extent of ∆gpαf retrotranslocation are similar in the presence of 
epoxomicin-treated 26S proteasome and 19S RP. Complete RRMs containing ∆gpαf-BOF were 
incubated with ATP and epoxomicin-treated 26S proteasomes (red; n = 4), 19S RPs (green; n = 10), 
without cytosol (blue), or complete cytosol (cyan). The longer time-scale graph is shown on the left and 
the shorter time-scale is on the right. 
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Since the spectral change observed in 26S-containing samples includes contributions 
from retrotranslocation and degradation, the kinetics of retrotranslocation are best 
quantified using spectral changes that are independent of substrate digestion. Thus, the 
rate of ∆gpαf-BOF exposure to the cytosol under our conditions is more accurately 
given by the t1/2 (the time required to reach 50% of maximal quenching) in 19S-
containing samples (2.2 min; Fig. 45) than by the t1/2 in 26S-containing samples (8.3 
min; Fig. 44). These data also reveal that the maximal initial rate of ∆gpαf-BOF 
retrotranslocation can be achieved solely with ATP and PA700 (Fig. 47).  
 
 
 
Figure 48. The rate and extent of ∆gpαf retrotranslocation are similar in the presence of 
epoxomicin-treated cytosol and 19S RP. Complete RRMs containing ∆gpαf-BOF were incubated with 
ATP and epoxomicin-treated cytosol (red; n = 4), 19S RPs (green; n = 10), without cytosol (blue), or 
complete cytosol (cyan). The longer time-scale graph is shown on the left and the shorter time-scale is on 
the right. 
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Figure 49. The rate and extent of ∆gpαf retrotranslocation are similar in the presence of lactacystin-
treated 26S and 19S RP. Complete RRMs containing ∆gpαf-BOF were incubated with ATP and 
lactacystine-treated cytosol (red; n = 3), 19S RPs (cyan; n = 10), without cytosol (blue), or complete 
cytosol (black).  The longer time-scale graph is shown on the left and the shorter time-scale is on the right. 
 
Figure 50. Fluorescence-detected proteolysis of ∆gpαf-BOF after retrotranslocation from RRMS.  
Complete RRMs containing ∆gpαf-BOF were incubated at 30°C in either rabbit reticulocyte lysate 
(cytosol; lanes 1-3), or rabbit reticulocyte lysate cytosol without hemoglobin (cytosol–Hb; lanes 4-6), or 
rabbit reticulocyte lysate cytosol without hemoglobin preincubated (0°C, 30 min) with 50 µM lactacystin 
(lanes 7-9). Equivalent aliquots of the total sample were removed at the times indicated and analyzed by 
SDS-PAGE. Full-length ∆gpαf-BOF was detected by BOF emission intensity.  
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Fluorescence and αBOF quenching of intact and proteolyzed ∆gpαf –BOF 
Retrotranslocated ∆gpαf-BOF was degraded when complete RRMs were incubated 
in cytosol at 30°C (Fig. 50, lanes 4-6). Since this proteolysis was prevented by 
preincubating the cytosol with the proteasome-specific inhibitor lactacystin (Fig. 50, 
lanes 7-9), ∆gpαf-BOF was degraded solely or primarily by the 26S proteasome. 
Biophysical and biochemical experiments also showed that full-length non-ubiquitinated  
∆gpαf-BOF was degraded by purified 26S proteasomes, but not by purified epoxomicin-
inhibited 26S proteasomes (Figs. 51 and 52). The reduction in BOF anisotropy (r) results 
 
 
 
Figure 51. Fluorescence-detected proteolysis of ∆gpαf-BOF. The average (n = 3) anisotropy (r) of 0.5 
µM purified ∆gpαf-BOF was monitored as a function of time at 30°C in samples containing 20 µg/ml 
purified 26S proteasomes that had not (red) or had (blue) been preincubated (0°C, 30 min) with 60 µM 
epoxomicin.  
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Figure 52. 26S proteasomes degrade ∆gpαf-BOF even though it lacks ubiquitin. Biochemical 
evidence for the degradation of free (non-encapsulated) ∆gpαf-BOF by purified 26S proteasomes is shown 
above. Purified ∆gpαf-BOF was incubated with either purified 20 µg/ml 26S proteasomes with or without 
50 µM epoxomicin pre-treatment (lanes 2-3), 0.3 mg/ml cytosol with our without 60 µM epoxomicin pre-
treatment (lanes 4-5), or no cytosol and 26S proteasomes (Lane 1).  
 
from an increase in the dye’s rate of rotation as the polypeptide to which the dye is 
attached is reduced in size by proteolysis. The amount of ∆gpαf-BOF was significantly 
decreased when free ∆gpαf-BOF was incubated with purified 26S proteasomes or 
cytosol in the absence of epoxomicin (Fig. 52). ∆gpαf-BOF was detected on an SDS-
PAGE gel by BOF-fluorescence. 
When ∆gpαf-BOF was completely degraded by the 26S proteasome (shown by a 
reduction in BOF anisotropy from 0.13 to 0.04), BOF emission intensity was increased 
by 65%. Thus, BOF emission is quenched by 40% in intact ∆gpαf. BOF emission is 
quenched upon binding to BOF-specific antibodies, and the intensity of the quenched 
 
 
 148
BOF is the same whether BOF is attached to intact or degraded ∆gpαf. Thus, the 
magnitude of antibody quenching depends upon the state of the ∆gpαf polypeptide. 
When αBOF binds to intact ∆gpαf -BOF, BOF intensity is reduced by 56%. When 
excess αBOF is added to proteolyzed ∆gpαf -BOF, BOF intensity was reduced by 72%. 
Hence, the αBOF-dependent quenching ranges between 56% and 72% when ∆gpαf-
BOF is actively degraded in a sample. Since αBOF binding to either intact or degraded 
∆gpαf-BOF is complete by the time the sample has been mixed, no detectable delay for 
αBOF binding to ∆gpαf-BOF is observed, and no correction of the kinetic data is 
necessary. This difference explains why the observed spectral change was greater (net 
F/F0 was smaller) in 26S than in 19S samples (Fig. 45), since the fluorescence quenching 
by αBOF was greater in samples in which ∆gpαf-BOF was degraded.  
Thus, there were four components to the spectral signal in our experiments: the 
∆gpαf-BOF molecules that were retrotranslocated and thereby exposed to αBOF; the 
∆gpαf-BOF molecules that were exposed to αBOF because of background microsome 
release during the incubation at 30°C; the ∆gpαf-BOF molecules that were degraded in 
the cytosol; and the few ∆gpαf-BOF molecules that were adsorbed to the outer surface 
of the microsomes after gel filtration (<10%). Clearly, it is essential to identify, quantify, 
and thoroughly characterize the biochemical origin of any spectral changes before 
interpreting them (Johnson, 2005b). The fraction of ∆gpαf-BOF that is retrotranslocated 
from RRMs in our samples can be calculated using the above intensities for different 
species. Assuming that 10% of the ∆gpαf- BOF is adsorbed to the outer surface of the 
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microsomes and that 10% of the remaining ∆gpαf-BOF (= 9%) is exposed to the cytosol 
by the background release of contents from microsomes (Fig. 35), a total intensity 
decrease of 46% (Fig. 34) in complete RRMs (when all lumenal proteins are present) 
with full cytosol under these conditions would result from 36% of the originally 
encapsulated ∆gpαf-BOF being retrotranslocated from the lumen to the cytosol and then 
digested within 2000 sec. As noted in the text, this magnitude of retrotranslocation is 
similar to the fraction of ∆gpαf-BOF found in the cytosol after the microsomes have 
been sedimented (Fig. 40). 
Temperature effects 
Complete RRMs were incubated in parallel with or without cytosolic proteins at 
different temperatures to evaluate the effect of temperature on retrotranslocation (Fig. 
53, left). Since the cytosol-free background quenching was temperature-dependent (Fig. 
53; broken lines, left), each cytosol-free signal was subtracted from the corresponding 
signal in the presence of cytosol (Fig. 53; solid lines, left) to yield the net αBOF-
dependent quenching at each temperature (Fig. 53; right). These data revealed that both 
the rate and extent of mammalian retrotranslocation are temperature dependent under our 
conditions. There was not any retrotranslocation detected at 4°C during the one-hour 
incubation period. Hence, no retrotranslocation occurs while our samples are on ice prior 
to raising their temperature at t0 to initiate retrotranslocation. The net αBOF-dependent 
quenching (retrotranslocation) was essentially the same at 37°C and 30°C (Fig. 53). 
Thus, our experiments were done at 30°C because the non-retrotranslocation related  
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Figure 53. Temperature dependence of ∆gpαf-BOF release. (A) Parallel samples of complete RRMS in 
either complete cytosol and 2 mM ATP or only ATP (= background, dotted line) were incubated at 4°C 
(blue), 15°C (green), 30°C (red), or 37°C (cyan). The average (n = 2) αBOF-dependent quenching of 
∆gpαf-BOF is shown. (B) The net quenching due to retrotranslocation is shown after background 
subtraction. 
 
release of ∆gpαf-BOF by apparent microsomal rupture (see above) was greater at 37°C 
than at 30°C. 
Discussion 
The real-time continuous detection of ∆gpαf-BOF retrotranslocation and its 
dependence on various components provides a unique perspective on the mechanisms 
and roles of individual proteins during retrotranslocation in mammals. This study of the 
cytosolic requirements revealed that ∆gpαf- BOF retrotranslocation occurred rapidly and 
was complete within minutes. ∆gpαf- BOF retrotranslocation required both ATP and the 
proteasome. When purified 26S proteasomes or purified PA700 replaced the cytosol, 
∆gpαf- BOF retrotranslocation occurred at the same rate as with total cytosolic proteins. 
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The degradation of ∆gpαf- BOF was ubiquitin independent. The AAA protease p97 with 
its cofactor did not play a role in ∆gpαf- BOF retrotranslocation.  
The novel fluorescence approach developed in this research project characterizes 
retrotranslocation with unprecedented time resolution. ERAD substrate movement from 
the lumen to the cytosol is detected directly and in real time, thereby allowing both the 
kinetics and extent of retrotranslocation to be reproducibly quantified and compared. 
Since this spectral approach is non-destructive, substrate environment can be monitored 
continuously. Most important, this approach examines substrate retrotranslocation under 
native conditions. Since membranes and macromolecular complexes are intact 
throughout, the functional effects of even weak or transient interactions or assemblies 
can be detected without being disrupted by the detergent required for some analyses. 
Furthermore, since different aspects of the fluorescence signal can be monitored [e.g., 
intensity, anisotropy, lifetime, fluorescence resonance energy transfer or FRET, 
accessibility to quenchers (Johnson, 2005a; Johnson, 2005b), spectral changes can 
simultaneously monitor both retrotranslocation and other changes in substrate 
environment and conformation. The ability to resolve different intermediate states and 
interactions of the substrate allows mechanistic questions to be addressed at a higher 
resolution. For example, spectroscopically differentiating between ∆gpαf-BOF exposure 
to and degradation in the cytosol (Fig. 48) shows that retrotranslocation precedes 
substrate proteolysis, as expected, and that the actual rate of retrotranslocation is best 
determined using fluorescence rather than proteolysis assays. 
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It is more than likely that the characterization of some other ERAD substrate may 
require other components or pathways for retrotranslocation than the ∆gpαf-BOF 
examined here. For example, certain lumenal factors appear to be involved in the 
retrotranslocation of glycosylated ERAD substrates (Hebert et al., 2005). But the 
experimental approach described here can, in principle, be used with any soluble ERAD 
substrate or derivative. The biochemical reconstitution of samples provides great 
flexibility in examining the influence of specific soluble proteins or small molecules on 
either side of the membrane on the rate and extent of retrotranslocation. Not only are the 
samples homogeneous and well defined in terms of components and their 
concentrations, the substrates are in a uniform environment and conformation inside the 
lumen. Deleting a wild-type protein or replacing it with a purified mutant protein during 
reconstitution, as was done here, provides the same flexibility in a mammalian system 
that is achieved genetically in yeast. 
The presence of p97, Npl4, and Ufd1 in the cytosol, either by themselves or added to 
total cytosolic proteins, did not stimulate ∆gpαf retrotranslocation (Fig. 42). Since these 
proteins facilitate the retrotranslocation of most examined ubiquitinylated substrates 
(Bays and Hampton, 2002; Tsai et al., 2002) and ∆gpαf is not ubiquitinylated, this result 
may be expected. But it shows, contrary to some suggestions, that p97 is not required for 
the retrotranslocation of every ERAD substrate (Carlson et al., 2005; Carlson et al., 
2006; Kothe et al., 2005; Lee et al., 2004). Instead, PA700 is sufficient for maximal 
∆gpαf retrotranslocation (Fig. 45). Since ATP is also required (Fig. 36) and NEM-
treated PA700 was defective in retrotranslocation (Fig. 46), it seems likely that AAA 
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ATPase components of PA700 are involved in powering substrate movement through 
the membrane via the chaperone-like properties of PA700 (Liu et al., 2006; Strickland et 
al., 2000). These findings also create a new set of questions. For example, what are the 
roles of individual PA700 subunits in retrotranslocation? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 154
CHAPTER V 
LUMENAL REQUIREMENTS FOR  
THE RETROTRANSLOCATION OF A FLUORESCENCE-LABELED ERAD 
SUBSTRATE* 
Lumenal proteins are required for maximal ∆gpαf retrotranslocation 
In order to determine whether lumenal proteins are essential for ∆gpαf-BOF 
retrotranslocation, RRMs were reconstituted with ∆gpαf-BOF, ATP and various 
combinations of lumenal proteins. When RRMs without any lumenal proteins were 
compared with complete RRMs, the net αBOF-dependent quenching was substantially 
reduced (Fig. 54, red).  
Thus, lumenal proteins are required for maximal ∆gpαf-BOF retrotranslocation. 
However, some ∆gpαf-BOF retrotranslocation occurred at a slow rate even in the 
absence of lumenal proteins.  
In order to determine the amount of lumenal proteins that would maximize the 
retrotranslocation rate, an increasing amount of purified soluble lumenal proteins were 
encapsulated into RRMs with ∆gpαf-BOF and ATP before retrotranslocation was 
commenced. The lumenal protein concentration that gave maximal retrotranslocation 
was found to be 3.5 mg/ml (Fig. 55). Increasing the concentration of lumenal proteins to  
                                                 
* Part of the data reported in this chapter is reprinted with permission from “Real-Time 
Fluorescence Detection of ERAD Substrate Retrotranslocation in a Mammalian In Vitro 
System” by Wahlman et al., 2007. Cell, 129 (5). 943-955. Reprinted in accordance with 
Copyright © Elsevier (2007)  
 
 
 
 155
 
 
 
Figure 54.  The retrotranslocation ∆gpαf-BOF depends on lumenal components. RRMs containing 
∆gpαf-BOF and 2 mM ATP were reconstituted with the following components: total lumenal proteins 
(black); no lumenal proteins (red, n = 5). Each RRM was then incubated with complete cytosol at 30°C. 
For comparison, complete RRMs incubated in the absence of all cytosolic proteins are shown (blue). The 
net αBOF-dependent spectral changes are shown after subtraction of no cytosol background (Fig. 39). 
 
 
7.0 mg/ml did not increase the rate or extent of ∆gpαf-BOF retrotranslocation.  Thus, the 
3.5 mg/ml concentration of soluble lumenal proteins was used throughout this study. 
Each successive preparation of soluble lumenal proteins was then titrated to ensure that 
it provided the same maximal rate of retrotranslocation. 
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Figure 55. Lumenal content required for maximal retrotranslocation rate. RRMs containing ∆gpαf-
BOF and 2 mM ATP were reconstituted with an increasing amount of soluble lumenal proteins: total 
lumenal proteins used in the experiments (blue; 3.5 mg/ml); more lumenal proteins (orange; 7 mg/ml; 
n=2); fewer lumenal proteins (cyan and green; 1mg/ml and 2 mg/ml respectively; n=2). Each RRM was 
then incubated with complete cytosol at 30°C. For comparison, complete RRMs incubated in the absence 
of all lumenal proteins are shown (red). The net αBOF-dependent spectral changes are shown after 
subtraction of cytosol-free background (Fig. 39). 
 
The retrotranslocation of ∆gpαf-BOF does not depend on BiP 
To assess whether individual lumenal proteins stimulate retrotranslocation, RRMs 
containing only BiP, ATP and ∆gpαf-BOF in the lumen were incubated in a complete 
set of cytosolic proteins. BOF quenching was higher with these RRMs than with RRMs 
lacking all lumenal proteins (Fig. 56; red), which showed that BiP stimulated ∆gpαf-
BOF retrotranslocation. However, the extent of BiP stimulation was much less than that 
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Figure 56. The retrotranslocation of ∆gpαf-BOF does not depend on BiP. RRMs containing ∆gpαf-
BOF and 2 mM ATP were reconstituted with the following components: total lumenal proteins (black); no 
lumenal proteins (cyan, n = 5); 10-20 µM BiP (red, n = 4). Each RRM was then incubated with complete 
cytosol at 30°C. For comparison, complete RRMs incubated in the absence of all cytosolic proteins are 
shown (blue). Net αBOF-dependent spectral changes are shown after subtraction of no cytosol 
background (Fig. 39). 
 
seen with a full complement of lumenal proteins, and was not increased by increasing 
the BiP concentration further. The amount of BiP that was necessary to maximize the 
retrotranslocation rate was also determined by titration. Increasing amounts of purified 
BiP were encapsulated into RRM with ATP and ∆gpαf-BOF, and the concentration was 
chosen that did not increase the retrotranslocation rate any further (Fig. 57). The optimal 
BiP concentration was between 10-20 µM, since more BiP (Fig. 57; cyan) did not 
change the retrotranslocation rate significantly. In addition, fewer encapsulated BiP (2 
µM and 5 µM; Fig. 57; green and red, respectively) did not significantly stimulate the 
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Figure 57. BiP concentration required for maximal retrotranslocation. RRMs containing ∆gpαf-BOF 
and 2 mM ATP were reconstituted with an increasing amount of BiP: total BiP used in the experiments 
(gray; 10-20 µM); more BiP (cyan; 20-30 µM; n=2); and less BiP (green and red; 2 µM and 5 µM 
respectively; n=2). Each RRM was then incubated with complete cytosol at 30°C. For comparison, 
complete RRMs incubated in the absence of all lumenal proteins are shown (black). The net αBOF-
dependent spectral changes are shown after subtraction of the cytosol-free background (Fig. 39). 
 
retrotranslocation of ∆gpαf-BOF, since these microsomes had nearly the same rate as 
RRMs of retrotranslocation lacking all soluble lumenal proteins (Fig. 57; black). 
The retrotranslocation of ∆gpαf is stimulated by oxidized PDI 
In contrast to BiP when only PDI, ATP, and ∆gpαf-BOF were reconstituted into 
RRMs, the maximal rate and extent of BOF quenching were essentially equivalent to 
those obtained with RRMs containing a full complement of lumenal proteins (Fig. 58; 
red). Thus, only PDI is required in the ER lumen for maximal ∆gpαf-BOF 
retrotranslocation.  
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Figure 58. The lumenal requirements for ∆gpαf retrotranslocation can be substituted by purified 
PDI. RRMs containing ∆gpαf-BOF and 2 mM ATP were reconstituted with the following components: 
total lumenal proteins (black); no lumenal proteins (cyan, n = 5); untreated PDI (red, n = 7). Each RRM 
was then incubated with complete cytosol at 30°C. For comparison, complete RRMs incubated in the 
absence of all cytosolic proteins are shown (blue). The net αBOF-dependent spectral changes are shown 
after subtraction of the cytosol-free background (Fig. 39). 
 
Interestingly, the PDI used in these experiments (Fig. 58) was not treated with any 
oxidized or reduced glutathione (GSSG or GSH, respectively) before encapsulation into 
the RRMs. However, PDI becomes oxidized in aqueous solution exposed to air (Neil 
Bulleid, personal communication). Evidence that PDI is air-oxidized is also shown by 
the fact that untreated (air-oxidized) and GSSG-oxidized PDI had similar affinities for  
∆gpαf-BOF.  The PDI concentration required to obtain maximal ∆gpαf-BOF 
retrotranslocation rate was determined by titration of an increasing amount of PDI into 
RRMs (Fig.59). The optimal concentration was between 10-20 µM (Fig. 59; pink), but 
this optimum also depended on the individual PDI preparation. The addition of 
additional PDI (20-30 µM, Fig. 59, cyan) did not significantly increase the rate.  
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Figure 59. PDI concentration required for maximal retrotranslocation rate. RRMs containing ∆gpαf-
BOF and 2 mM ATP were reconstituted with increasing amounts of air-oxidized PDI: total PDI used in 
the experiments (red, 10-20 µM); more PDI (cyan, 20-30 µM, n=2); less PDI (purple, 5 µM n=2). Each 
RRM was then incubated with complete cytosol at 30°C. For comparison, complete RRMs incubated in 
the absence of all lumenal proteins are shown (green). The net αBOF-dependent spectral changes are 
shown after subtraction of the cytosol-free background (Fig. 39).  
 
 
The optimal concentration of BiP together to determine their collective effect on 
∆gpαf-BOF retrotranslocation (Fig, 60; red). When these two chaperones were 
encapsulated together in RRMs with ATP, the rate of ∆gpαf-BOF retrotranslocation was 
essentially unchanged from that of PDI alone (Fig. 60; blue). This finding indicates that 
in the presence of BiP does not interfere with the PDI interaction with ∆gpαf-BOF. 
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Figure 60. PDI and BiP combined did not increase the retrotranslocation rate compared to PDI 
alone. RRMs containing ∆gpαf-BOF and 2 mM ATP were reconstituted with both BiP (10-20 µM) and 
PDI (10-20 µM) (red, n=3). Each RRM was then incubated with complete cytosol at 30°C. For 
comparison, complete RRMs incubated in the absence of all lumenal proteins are shown (cyan), all 
lumenal proteins in the presence (blue) and absence of cytosol (green). The net αBOF-dependent spectral 
changes are shown after subtraction of the cytosol-free background (Fig. 39).  
 
PDI binds directly to ∆gpαf-BOF that lacks cystine 
PDI must stimulate retrotranslocation by interacting with the ER membrane and/or 
the substrate. Free purified ∆gpαf-BOF was therefore titrated with either reduced, 
oxidized PDI or untreated PDI to determine if PDI associated with ERAD substrate 
directly. PDI binding to ∆gpαf-BOF was detected by an increase in BOF anisotropy 
caused by the slower rotational rate of PDI•∆gpαf-BOF than of ∆gpαf-BOF alone (Fig. 
61).  Both oxidized and reduced PDI associated with ∆gpαf (Fig. 61), but reduced PDI 
(Fig. 61; red) had a significantly higher affinity for this ERAD substrate than did 
oxidized or untreated PDI (Fig. 61; blue and black respectively) (Kd values of ~30 and 
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Figure 61. ∆gpαf-BOF binds more strongly to reduced PDI than to oxidized PDI. ∆gpαf-BOF (0.2 
µM in Buffer A) was titrated at 4°C with oxidized PDI (0-12 µM; red; n = 6), reduced PDI (0-10 µM; 
blue; n = 7), or un treated PDI (0-6 µM; black; n = 7). PDI was reduced or oxidized by a 30 min, 30°C 
incubation in 5 mM DTT or 5 mM GSSG, respectively. 
 
~900 nM, respectively). Thus, PDI binds tightly to ∆gpαf-BOF even though it lacks 
disulfides and free thiols. 
In contrast, BiP did not detectably bind to ∆gpαf-BOF in the presence of ATP (Fig. 
62; red). ATP-free wild type BiP (Fig. 62; blue) and a BiP mutant (T37G) (Fig. 62; 
orange) that has a mutation in its nucleotide binding domain and does not release its 
substrate showed a slightly higher affinity for ∆gpαf-BOF than did BiP with ATP (Fig. 
62; red). However, ATP-free BiP still had much lower affinity for ∆gpαf-BOF than did 
the untreated PDI (Fig. 62; cyan). The higher affinity of these two BiPs for ∆gpαf-BOF 
(Fig. 62; orange and blue) is perhaps due to the inability of BiP to release its substrate in 
the absence of nucleotides or with T37G BiP mutation in its nucleotide-binding domain. 
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Figure 62. ∆gpαf-BOF does not bind tightly to BiP. ∆gpαf-BOF (0.2 µM in Buffer A) was titrated at 
4°C with BiP and ATP (0-6 µM; red; n = 3), BiP without any nucleotide (0-6 µM; blue; n = 3), or purified 
BiP mutant (T37G) (0-6 µM; orange; n = 3). BiP was incubated with 2 mM ATP for 10 min, 30°C. For 
comparison the association between untreated, air-oxidized PDI and ∆gpαf-BOF (0-6 µM; cyan; n = 7) are 
shown. 
 
Does the higher affinity of ∆gpαf for reduced PDI than for oxidized PDI affect the 
rate of retrotranslocation? 
 When ∆gpαf-BOF was reconstituted into RRMs with ATP and either oxidized or 
reduced PDI, the rate of retrotranslocation was significantly lower with reduced PDI 
(Fig. 63; orange) than with either oxidized (Fig. 63; red) or untreated (Fig. 58; red) PDI 
(PDI purified using our procedures is air-oxidized). Thus, although the reduced form of 
PDI binds ∆gpαf more tightly, maximal retrotranslocation rates require oxidized PDI 
and/or oxidation conditions in the lumen. 
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Figure 63. Maximal retrotranslocation rates require oxidized PDI. RRMs containing ∆gpαf-BOF and 
2 mM ATP were reconstituted with: total lumenal proteins (black); 10 µM oxidized PDI + 5 mM GSSG 
(red, n = 3); or 10 µM reduced PDI + 5 mM DTT (orange, n = 3). For comparison, complete RRMs were 
incubated in the absence of cytosolic proteins (green). The net αBOF-dependent spectral changes are 
shown after subtraction of the cytosol-free background (Fig. 39). 
 
The association between PDI and ∆gpαf-BOF was also examined by 
photocrosslinking and immunoprecipitation. ∆gpαf-BOF was translated in vitro in the 
presence of [35S]Met and Nε-(5-azido-2-nitrobenzoyl)-Lys- tRNALys (εANB-Lys-
tRNALys) that contained a photo-reactive dye (ANB). After translocation into KRMs in 
the dark, ANB was activated by UV light to form photoadducts between radioactive any 
∆gpαf-BOF interacting lumenal proteins. The KRMs were sedimented and proteins were 
analyzed on SDS-PAGE gel. The photoadducts were identified by immunoprecipitation 
using antibodies to calnexin (αCNX), BiP (αBiP), Sec61α (αSec61), and PDI (αPDI).  
Antibodies to PDI were able to recognize a complex between PDI and ∆gpαf-BOF (Fig. 
64; red circle), which indicates that ∆gpαf-BOF associates directly with PDI as was 
suggested by the anisotropy data (Fig. 61). 
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Figure 64. Direct association between ∆gpαf-BOF and PDI detected by photocrosslinking and 
immunoprecipitation. p∆gpαf mRNA was translated in vitro in the presence of either [35S] and εANB-
Lys-tRNALys or Lys-tRNALys as in Fig. 24 and translocated into KRMs in the dark. KRMs were 
sedimented and then photolyzed either before or after a 15-min 30°C incubation. Photolyzed samples were 
split and immunoprecipitated with affinity-purified antibodies to αSec61α, αBiP, αCNX or αPDI, as 
indicated. ∆gpαf-PDI photoadducts are showed (•). 
 
RRMs do not contain any residual lumenal chaperones after pH extraction 
The next question was whether XRMs, after pH extraction, would still contain any 
residual PDI or BiP that could account for the slow release of ∆gpαf-BOF from the (Fig. 
54; red). RRMs were reconstituted with increasing amount of purified PDI, or BiP  
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Figure 65. XRMs do not contain any residual PDI after pH extraction. RRMs were reconstituted with 
decreasing concentrations of PDI (lanes 1-4) or no PDI (lane 5). Then these RRMs were sedimented, 
resuspended in SDS-PAGE buffer and run on a 10-15% SDS-PAGE gel. The amount of PDI present in 
these vesicles was detected by western blotting. Increasing amounts of PDI were also loaded directly the 
gel as control (lanes 6-8). Derlin-1, an ER membrane protein, was also detected by antibodies to Derlin-1 
to show that an equivalent amount of RRM membranes was present. 
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Figure 66. XRMs do not contain any residual BiP after pH extraction. RRMs were reconstituted with 
2 mM ATP and decreasing concentrations of BiP (lanes 1-7) or no BiP (lane 8). Then these RRMs were 
sedimented, resuspended in SDS-PAGE buffer and run on a 10-15% SDS-PAGE gel. An increasing 
amount of KRMs (lanes 9-10) and purified BiP (lanes 11-13) were also loaded on the gel as controls. The 
amount of BiP present in these vesicles was detected by western blotting. Derlin-1, an ER membrane 
protein, was also detected by antibodies to Derlin-1 to show that each sample contained an equivalent 
amount of RRM membranes. 
 
sedimented by centrifugation and run on an SDS-PAGE gel. Antibodies to either PDI 
(Fig. 65) or BiP (Fig. 66) were used to determine the amount of these chaperones present 
in the vesicles. No detectable PDI (Fig. 65; lane 5) or BiP (Fig. 66; lane 8) were in 
XRMs, so the only PDI or BiP that contributed to retrotranslocation of ∆gpαf-BOF were 
added exogenously. 
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Discussion 
The rate of ∆gpαf-BOF retrotranslocation was maximal with either the full 
complement of lumenal proteins or with oxidized PDI. This retrotranslocation rate was 
greatly decreased in the absence of all soluble lumenal proteins, and by purified BiP by 
itself stimulated retrotranslocation only slightly over the no-lumenal-protein sample. 
When reduced PDI was encapsulated with ∆gpαf-BOF, the retrotranslocation rate was 
decreased compared to that of RRMs containing oxidized PDI. 
Several aspects of these data were unexpected. BiP has been shown in previous 
studies to be required for the retrotranslocation of several substrates in yeast  (Nishikawa 
et al., 2005), including ∆gpαf (Brodsky and McCracken, 1999; Kabani et al., 2003), yet 
BiP had only a small stimulatory effect on ∆gpαf retrotranslocation from mammalian 
microsomes (Fig. 56). Also, although BiP can function as a chaperone, it appears to bind 
weakly, if at all, to ∆gpαf (Fig. 62). The role of BiP in retrotranslocation may therefore 
be more complex than currently appreciated.  
In contrast, only oxidized PDI was required in the lumen to obtain maximal 
retrotranslocation (Fig. 61). The mechanism by which PDI promotes retrotranslocation is 
not yet understood, but may involve PDI binding to the ERAD substrate (Gillece et al., 
1999; Tsai et al., 2001). Since PDI promotes the folding of proteins that lack disulfide 
bonds and unreacted cystine (Cai et al., 1994; Puig and Gilbert, 1994; Wilkinson and 
Gilbert, 2004), it was not surprising that PDI bound ∆gpαf (Fig. 61 and 64). However, 
the lower affinity of ∆gpαf for oxidized than reduced PDI was unexpected because 
retrotranslocation was faster with oxidized PDI than with reduced PDI (Fig. 63). This 
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result suggests that tight binding of PDI to ∆gpαf inhibits retrotranslocation. It is also 
possible that oxidized, but not reduced, PDI interacts with the retrotranslocation 
machinery at the membrane, and/or that the presence of 5 mM DTT in the microsomes 
reduces lumenal disulfide bonds and slows retrotranslocation. But since cholera toxin 
movement from the lumen to the cytosol was promoted by reducing agents (Tsai and 
Rapoport, 2002; Tsai et al., 2001; Tsai et al., 2002), PDI involvement in 
retrotranslocation is likely substrate-dependent. 
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CHAPTER VI 
MEMBRANE PROTEIN REQUIREMENT FOR  
THE RETROTRANSLOCATION OF A FLUORESCENCE-LABELED ERAD 
SUBSTRATE* 
Sec61 is not essential for ∆gpαf retrotranslocation 
ERAD substrates must cross the ER membrane in order to degrade in the cytosol. 
There are several membrane proteins that were proposed to be the part of the 
retrotranslocation channel (Fig.16).  One of the candidates that might facilitate the 
transport of an ERAD substrate from the lumen to the cytosol across the ER membrane 
is the Sec61α translocon. Other recent studies implicated Derlin-1, a membrane protein 
with four transmembrane segments, as a component of a retrotranslocation site (Lilley 
and Ploegh, 2004; Schekman, 2004; Ye et al., 2004). In order to assess the involvement 
of Sec61α and Derlin-1 in ∆gpαf-BOF retrotranslocation, both fluorescence and 
photocrosslinking techniques were used.  
It was previously shown that affinity-purified antibodies against Sec61α (αSec61α) 
blocked iodide ion passage through the aqueous pores of ribosome-free translocons 
(Hamman et al., 1998). It was therefore possible to use a similar approach to block the 
 
                                                 
* Part of the data reported in this chapter is reprinted with permission from “Real-Time 
Fluorescence Detection of ERAD Substrate Retrotranslocation in a Mammalian In Vitro 
System” by Wahlman et al., 2007. Cell, 129 (5). 943-955 . Reprinted in accordance with 
Copyright © Elsevier (2007)  
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Figure 67. Modes of translocon pore blockage that may inhibit ∆gpαf-BOF retrotranslocation. 
Complete RRMs containing ∆gpαf-BOF and 2 mM ATP were reconstituted with lumenal proteins and 
preincubated on ice with either αSec61α (Α) or translating ribosome-nascent chain complexes (B). Some 
RRMs were also reconstituted first with the T37G BiP mutant  (C) and then with lumenal proteins and 
∆gpαf-BOF with 2 mM ATP. 
  
exit of an ERAD substrate from the microsomes that were preincubated with antibodies 
to various membrane proteins from the cytosolic side (Fig. 67). Thus, ∆gpαf-BOF 
retrotranslocation might be inhibited by αSec61α  if retrotranslocation took place 
through the Sec61α translocon complex. After RRMs were preincubated with excess 
αSec61α at 0 °C, retrotranslocation was initiated by either the addition of EGS with a 
full set of cytosolic proteins (Fig. 68) or with purified 26S proteasomes (Fig. 69). The 
preincubation of complete RRMs with αSec61α did not alter the extent of 
retrotranslocation at times greater than 5 minutes rate significantly, but did show the 
initial rate substantially and created a transient 2-5 minute lag period (Fig. 68; right 
panel). This lag period was not apparent with the addition of purified 26S proteasomes 
(Fig. 69; right panel). 
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Figure 68. ∆gpαf-BOF retrotranslocation is only inhibited initially by αSec61α. On the left, complete 
RRMs (~10 Eq) were preincubated with 3 µg/ml αSec61α (red, n = 3) before the addition of cytosol and 
incubation at 30°C. For comparison, complete RRMs incubated in the presence (blue) or absence (cyan) of 
cytosol are shown. The longer time-scale graph is shown on the left and the shorter time-scale is on the 
right. 
 
 
 
Figure 69. ∆gpαf-BOF retrotranslocation is only slightly inhibited by αSec61α in the presence of 
26S proteasomes. On the left, complete RRMS (~10 Eq) were preincubated with 3 µg/ml αSec61α (red, n 
= 4) before the addition of purified 10 µg/ml 26S proteasomes and incubation at 30°C. For comparison, 
complete RRMs incubated in the presence (blue) or absence (cyan) of 10 µg/ml purified 26S proteasomes 
are shown. The longer time-scale graph is shown on the left and the shorter time-scale is on the right. 
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Figure 70. ∆gpαf-BOF retrotranslocation is not blocked by RNCs. On the left, complete RRMs (~10 
Eq) were preincubated with 10-20 nM RNCs, 40 nM SRP and 1 mM GTP (red, n = 2), or 10-20 nM non-
translating ribosomes without any nascent chain and 40 nM SRP and 1 mM GTP (green, n = 2), or with 
only 40 nM SRP and 1 mM GTP (purple, n=2) before the addition of cytosol and incubation at 30°C. For 
comparison, complete RRMs incubated in the presence (black) or absence (blue) of cytosol are shown. On 
the right, the same graph is shown on an expanded scale. 
 
Translating ribosome-nascent chain complexes (RNCs), which bind to the cytosolic 
side of the translocon tightly, can also block the translocon (Crowley et al., 1994; Gillece 
et al., 2000; Schmitz et al., 2000). Although this blockage is not stoichiometric (~50% of 
RRM translocons are bound under these conditions; (Hamman et al., 1998) one might 
expect a 50% reduction in potential retrotranslocation channels to reduce the maximal 
rate of retrotranslocation, if the translocons actually do constitute the sites of 
retrotranslocation. RNCs with an 86-residue preprolactin (pPL86) nascent chain were 
purified by gel-filtration. pPL86 was translated in the presence of  [35S]Met to quantify 
RNC binding to RRMs by scintillation counting. This truncated version of pPL86 has no 
stop codon, so the nascent chain remains ribosome-bound at the end of the translation. 
These RNCs can be added back to ER vesicles in the presence of SRP and GTP to be 
properly targeted to Sec61α translocons. Thus, complete RRMs with the ERAD 
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substrate encapsulated inside were incubated with SRP to target the RNCs to 
Sec61α translocons. The resulting RRMs were incubated with complete cytosol to 
initiate retrotranslocation. The rate of ∆gpαf retrotranslocation was not affected 
significantly by the tight binding of RNCs to translocons (Fig. 70; red). Ribosomes 
without nascent chains (Fig. 70; green), and SRP and GTP alone (Fig. 70; purple) were 
used as controls to exclude the possible effect of these other components. 
 
 
 
Figure 71. ∆gpαf-BOF retrotranslocation is not blocked by BiP from the lumenal side. XRMS (~10 
Eq) were preincubated with 20 µM T37G BiP mutant (red, n = 5) or 20 µM wt BiP (cyan, n = 5) with 2 
mM ATP before encapsulation of ∆gpαf-BOF and all lumenal components to form compete RRMs. These 
RRMs were incubated in complete cytosol before the addition of cytosol and incubation at 30°C.  For 
comparison, complete RRMs incubated in the presence (blue) or absence (green) of cytosol are shown. On 
the right, the same graph is shown on an expanded scale. 
 
The lumenal end of the aqueous translocon pore can be closed by BiP, either directly 
or indirectly (Alder et al., 2005; Haigh and Johnson, 2002; Hamman et al., 1998). 
Whereas BiP-mediated closure is regulated and reversible under normal conditions, the 
pores in ribosome-free translocons are closed irreversibly if RRMs are prepared with 
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ATP and a T37G BiP mutant in which communication between the nucleotide and 
peptide binding domains is defective (Alder et al., 2005). After pH treatment, the open 
microsomes were incubated with T37G BiP (Fig. 71; red) or wild type BiP (Fig. 71; 
cyan) in the presence of ATP, and then resealed with a full set of lumenal proteins, 
∆gpαf-BOF, and 2 mM ATP. When these RRMs were incubated with complete cytosol 
and EGS, the rate and extent of αBOF-dependent quenching did not differ significantly 
from samples without any extra BiP added (Fig. 71; blue). Thus, these data strongly 
suggest that ∆gpαf-BOF does not pass through the translocon pore during 
retrotranlocation, or that there is an alternative route through which retrotranslocation 
can take place in case of translocon blockage/occupation. 
Antibodies to Derlin-1 block ∆gpαf retrotranslocation 
In contrast, when complete RRMs were preincubated with αDer1 (affinity-purified 
antibodies that bind to the C-terminal region of Derlin-1), αBOF-dependent quenching, 
and hence ∆gpαf- BOF retrotranslocation, was reduced by more than 80% compared to 
positive control (Fig. 72; red). Similar results were obtained when the complete cytosol 
was substituted by purified 26S proteasomes (Fig. 73; red). 
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Figure 72. ∆gpαf-BOF retrotranslocation is inhibited by αDer-1. On the left, complete RRMS (~10 
Eq) were preincubated with 3-g/ml αDer1 (red, n = 6) before the addition of cytosol and incubation at 
30°C. For comparison, complete RRMs incubated in the presence (blue) or absence (cyan) of all cytosolic 
proteins are shown. On the right, the same graph is shown on an expanded scale. 
 
 
 
Figure 73. ∆gpαf-BOF retrotranslocation is inhibited by αDer-1 in the presence of 26S proteasomes. 
On the left, complete RRMS (~10 Eq) were preincubated with 3 µg/ml αDer1 (red, n = 4) before the 
addition of 10 µg/ml purified 26S proteasomes and incubation at 30°C. For comparison, complete RRMs 
incubated in the presence (cyan) or absence (blue) of purified 26S proteasomes are shown. On the right, 
the same graph is shown on an expanded scale. 
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These data suggest that αDer1, but not αSec61α also blocked 26S proteasome 
stimulation of retrotranslocation (Figs. 68-69 and 72-73; red). Yet the αDer1 effect was 
more complex than simple blockage, since even after RRMs were incubated with an 
excess of αDer1 at 0°C, the rate of αBOF-dependent quenching was initially unaltered 
(right panels, Figs. 72 and 73; red). But after 2 min at 30°C, ∆gpαf-BOF 
retrotranslocation was totally blocked. Thus, αDer1 can block the retrotranslocation 
machinery, but only after a short lag. 
Do other derlin proteins play a role in ∆gpαf-BOF retrotranslocation? 
Recently, two derlin homologues other than Derlin-1 were suggested to play a role in 
retrotranslocation (Derlin-2 and Derlin-3) (Oda et al., 2006). This raised the question 
whether the αDer would cross-react with Derlin-2 and 3 because, if so, perhaps the 
observed blockage of retrotranslocation cannot be attributed solely to Derlin-1 (Figs. 72 
and 73). Since Derlin-2 and Derlin-3 have lower molecular weights (28 kDa and 27 kDa 
respectively) than Derlin-1 (29 kDa), western blotting technique was used to evaluate the 
cross-reaction of αDer1 with these other two proteins (Fig. 74). Since only one band was 
observed on the SDS-PAGE gel with the molecular weight of Derlin-1, and there were 
no cross-reaction between αDer1 and Derlin-2 or Derlin-3. Antibodies obtained to the 
C-terminal region of Derlin-2 and Derlin-3 were also tested to determine whether they 
could block the retrotranslocation of ∆gpαf-BOF from RRMs. When the RRMs were 
preincubated αDer2, there was only a small reduction change in the retrotranslocation 
rate of the ERAD substrate from the ER lumen (Fig. 75; cyan) when compared to a  
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Figure 74. The antibodies to Derlin-1 do not cross-react with Derlin-2 and 3. Microsomal proteins 
were separated by SDS-PAGE, and only one band was observed after Western blotting with αDer1. Since 
Derlin-2 and Derlin-3 differ in molecular weight from Derlin-1, the gel shows that there is no detectable 
cross-reaction. According to the manufacturer of this antibody (Novus), these antibodies were raised 
against a peptide sequence that was present in Derlin-1, but was absent in Derlin-2 and Derlin-3.  
 
 
sample lacking αDer2 (Fig. 75; blue). Antibodies to Derlin-3 had a slightly more 
profound initial effect than αDer2 (Fig. 75; red) on the retrotranslocation rate, but the 
extent of retrotranslocation was only somewhat reduced. Thus, in contrast to αDer1, 
αDer2 and αDer3 have little effect on retrotranslocation. Hence retrotranslocation is 
blocked by antibodies specific for Derlin-1, but not for antibodies specific for Derlin-2 
or Derlin-3. 
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Figure 75. ∆gpαf-BOF retrotranslocation is not completely inhibited by αDer-2 or αDer-3. On the 
left, complete RRMS (~10 Eq) were preincubated with 3 µg/ml αDer2 (cyan, n = 3), 3 µg/ml αDer3 (red, 
n = 3), or 3 µg/ml αDer1 (orange) before the addition of cytosol and incubation at 30°C. For comparison, 
complete RRMs incubated in the presence (blue) or absence (green) of all cytosolic proteins are shown.  
  
 
Figure 76. ∆gpαf-BOF retrotranslocation is not completely inhibited by αHrd1. On the left, complete 
RRMs (~10 Eq) were preincubated with 3 µg/ml αΗrd1N (N-terminal; red, n = 2), 3 µg/ml αΗrd1C (C-
terminal; black, n =2), or 3 µg/ml αDer1 (cyan) before the addition of cytosol and incubation at 30°C. For 
comparison, complete RRMs incubated in the presence (blue) or absence (green) of all cytosolic proteins 
are shown. 
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Do antibodies to Hrd1 interfere with ∆gpαf-BOF retrotranslocation? 
Another important membrane complex that has been suggested to play a role in ERAD is 
the Hrd1 ubiquitin ligase (Bordallo et al., 1998; Kikkert et al., 2004). This protein has a 
short C-terminal domain in the cytosol and a large N-terminal cytosolic domain that 
contains the ubiquitin ligase activity. The N-terminal domain has been found to interact 
with several cytosolic components, including ubiquitin-conjugating enzymes and p97 
(Gauss et al., 2006). Antibodies to both the C- and N-termini were obtained (αHRD1C 
and αHRD1N) and tested for their ability to interfere with the rate and extent of ∆gpαf-
BOF retrotranslocation (Fig. 76, red and purple). Interestingly, antibodies bound to the 
C-terminus of Hrd1 were slightly more inhibitory than antibodies to N-terminus (Fig. 76; 
black vs. red). There was an almost a complete blockage of retrotranslocation for the 
first 350 seconds with αHrd1C, and both the rate and extent of retrotranslocation were 
less with αHrd1C than without any antibody (Fig. 76; blue). When antibody to the N-
terminus was used, a decrease in the initial rate was observed, but not to the same extent 
as with the C-terminus antibody. These data suggest that Hrd1 is located proximal to the 
site of ∆gpαf. The partial inhibition prevents us from identifying a clear role for Hrd1 in 
retrotranslocation, in contrast to the data obtained with αDer1 that blocked 
retrotranslocation completely after the first few minutes. 
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∆gpαf photocrosslinks Derlin-1 
 In order to uncover which molecules were adjacent to ∆gpαf during 
retrotranslocation, photoreactive probes were incorporated into p∆gpαf in an in vitro 
translation containing Nε-(5-azido-2-nitrobenzoyl)-Lys-tRNALys (εANB-Lys-tRNALys; 
(Krieg et al., 1989) (Fig. 20). After microsomes were pelleted and resuspended in 
complete cytosol, the sample was divided and photolyzed either before or after 
retrotranslocation was initiated by raising the temperature to 30°C. After the crosslinking 
reaction, the samples were sedimented by centrifugation and the pellet was resuspended, 
divided into thirds, and immunoprecipitated with antibodies to Der1, Sec61α, or TRAM, 
a core component of the translocon (Johnson and van Waes, 1999) (Fig. 77). A 
photoadduct was immunoprecipitated with αDer1 (Fig. 77; lanes 1 and 2), but not with 
αSec61α (Fig. 77; lanes 5 and 6) or αTRAM (Fig. 77; lanes 9 and 10). No photoadducts 
were seen in the absence of probe (Fig. 77; lanes 3 and 4). Since photolyzed ANB has a 
short reactive lifetime, photoadducts are formed only with molecules in close proximity 
to ∆gpαf at the time of photolysis. Therefore, ∆gpαf was adjacent to Derlin-1, but not 
detectably proximal to Sec61α or TRAM. Yet the yield of ∆gpαf-Derlin-1 photoadduct 
was approximately the same at 0°C and 30°C (Fig. 77; lanes 1, 2), which shows that 
∆gpαf was adjacent to Derlin-1 both before and after retrotranslocation was initiated 
(see below). Since the photoreactive probes were incorporated randomly into the 9 Lys 
codons of ∆gpαf, not all probes in a ∆gpαf were adjacent to retrotranslocation site 
proteins at the time of photolysis. Furthermore, only a few photoreactive ∆gpαf were in  
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Figure 77. ∆gpαf photocrosslinking to Derlin-1. p∆gpαf mRNA was translated in the presence of either 
εANB-Lys-tRNALys or Lys-tRNALys as in Fig. 24 and translocated into microsomes in vitro in the dark as 
indicated. Microsomes were purified and then photolyzed either before or after a 15-min 30°C incubation. 
Photolyzed samples were split and immunoprecipitated with affinity-purified antibodies to αDer1, 
αSec61α, or αTRAM as indicated. ∆gpαf-Derlin-1 photoadduct,•; unidentified species also seen in non-
immune IgG control, ▲. 
 
 
the retrotranslocation site at the time of photolysis. For these reasons, the yield of 
∆gpαf- Derlin-1 photoadduct was relatively low. However, the critical observation was 
that ∆gpαf photoadducts were formed with Derlin-1, but not with Sec61α or TRAM. 
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Figure 78. ∆gpαf photocrosslinking to lumenal, cytosolic, and membrane components. p∆gpαf 
mRNA was translated in the presence of εANB-Lys-tRNALys as in Fig. 77 and translocated into 
microsomes in vitro in the dark. Microsomes were purified in the dark and then incubated in complete 
cytosol at 30°C (0’ samples were on ice throughout). Sample aliquots were photolyzed at the times 
indicated and then split in two. One half of each aliquot was analyzed directly by SDS-PAGE (A, total 
sample), while the other half was sedimented to separate the microsome pellet from the supernatant prior 
to SDS-PAGE analysis of the radioactive species in the supernatant (B) and the microsome pellet (C). 
∆gpαf, ●. 
 
 
The photocrosslinking samples were also examined on an SDS-PAGE gel before 
immunoprecipitation. Aliquots were removed at three different time-points (0’, 5’ and 
15’) to examine photoadduct formation in the total sample and in the microsomes and 
supernatant fractions (Fig. 78). The number of ∆gpαf photoadducts to cytosolic proteins 
increased over time, thereby indicating that the photoreactive ∆gpαf was transported 
through the retrotranslocation site during the 30 min incubation (Fig. 78). 
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Is the N-terminus or C-terminus of ∆gpαf transported across the ER membrane 
first? 
The primary ∆gpαf-BOF construct used in this project to investigate the direct 
involvement various components in retrotranslocation contained a BOF at the C-terminal 
end. But a different ∆gpαf derivative was labeled with BOF. This allowed us to 
determine whether the rate and extent of retrotranslocation differed for N-terminal or C-
terminal probes. Since quenching of BOF only occurs upon binding to αBOF in the 
cytosol, comparing the rate of exposure to the cytosol and quenching by αBOF can in 
principle reveal which end of the ∆gpαf emerges first from the retrotranslocation site. If 
the N-terminally-labeled ∆gpαf is quenched more rapidly than the C-terminally-labeled 
∆gpαf, then the N-terminus of the polypeptide passes solely or preferentially through the 
retrotranslocation site first. If there is not difference in the rate of quenching N- and C-
terminal probes, then either ∆gpαf passes through the membrane in random orientation 
(ie. N-terminus first = C-terminus first) or in a folded conformation so that one end does 
not go significantly before the other. When BOF was placed on the front of the protein 
(T25C), and retrotranslocation was initiated by epoxomicin-treated cytosol (to avoid the 
fluorescence change due to substrate degradation), the initial quenching rate was about 
twice as fast as it was with BOF on the C-terminus (Y165C) (Fig. 79; red vs. blue). As 
expected, the final extent of quenching was the same for both derivatives. Thus these 
data strongly indicate that the N-terminal end of ∆gpαf moves preferentially through the 
retrotranslocation site before the C-terminal end. This result also provides experimental 
support for the widely-held view that retrotranslocation is an active process involving 
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Figure 79. ∆gpαf-BOF retrotranslocation is detected more quickly with an N-terminal probe. On the 
left, complete RRMS (~10 Eq) were reconstituted with either ∆gpαf-BOF labeled on the N-terminus 
cysteine (T25C) (red, n=3), or at the C-terminus (Y165C) (blue) as before. RRMs were incubated with 
ATP and epoxomicin-treated cytosol to eliminate ∆gpαf degradation. For comparison, complete RRMs 
incubated in the absence (green) of all cytosolic proteins are shown. The αBOF-dependent quenching is 
shown after subtraction of the no-cytosol background of the appropriate construct. On the right, the same 
graph is shown on an expanded scale. 
 
substrate recognition and protein-mediated transport because the direction of substrate 
passage through the retrotranslocation site is not random. This result strongly indicates 
that the lumenal and/or membrane proteins that mediate substrate selection and targeting 
direct the N-terminus of a substrate polypeptide into the retrotranslocation site. 
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Discussion 
The membrane proteins that form the channel through which ERAD substrates are 
transported from the lumen to the cytosol have not been identified. Retrotranslocation 
was initially proposed to occur via the Sec61α translocon pore (Pilon et al., 1998; 
Plemper et al., 1999a; Wiertz et al., 1996b; Zhou and Schekman, 1999), and some 
subsequent data are consistent with this model (Gillece et al., 2000; Kalies et al., 2005; 
Lee et al., 2002; Lee et al., 2004; Ng et al., 2007; Schmitz et al., 2000). Other studies 
have proposed that Derlin-1 and its homologues, Derlin-2 and Derlin-3, are located at 
the site of retrotranslocation (Lilley et al., 2006; Lilley and Ploegh, 2005; Oda et al., 
2006; Ye et al., 2005). Here, we found that the rate and extent of ∆gpαf-BOF 
retrotranslocation were not dramatically affected by closing either end of the translocon 
pore (Figs. 68-71). Instead, two independent techniques, ∆gpαf photocrosslinking to 
Derlin-1 (Fig. 77) and αDer1 blockage of ∆gpαf-BOF retrotranslocation (Fig. 72 and 
73), strongly indicated that Derlin-1 is located at the site of retrotranslocation. These 
data therefore strongly suggest, but do not prove, that Derlin-1 is a structural and/or 
functional component of the site of ∆gpαf retrotranslocation. It is also possible that more 
complex ERAD substrates are retrotranslocated through different retrotranslocation sites, 
molecular assemblies, and/or pathways.  
The continuous monitoring of retrotranslocation revealed that αDer1 did not block 
∆gpαf retrotranslocation at t0, but did block retrotranslocation after 2 min (Fig. 72; 
right). The delay presumably resulted from αDer1 being initially unable to bind to 
Derlin-1 or block its function when the antibodies were mixed with the RRMs. One 
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possible explanation is that αDer1 does not bind to a Derlin-1 that is already engaged 
with an ERAD substrate, but does bind to an unoccupied Derlin-1. Then any ∆gpαf-
BOF bound to the retrotranslocation site at 0°C would be transported normally to give 
the maximal initial rate of retrotranslocation, but further exit would be blocked when 
αDer1 bound to retrotranslocation sites following substrate release. Since ∆gpαf 
photocrosslinking to Derlin-1 was the same at t0 and at t15 minutes (Fig. 77), ∆gpαf was 
positioned adjacent to Derlin-1 at both 0°C and 30°C. These combined data suggest that 
∆gpαf can be trapped at an intermediate stage of retrotranslocation by varying the 
temperature. ∆gpαf appears to be targeted to a Derlin-1 containing retrotranslocation site 
at low temperature to form a membrane-bound intermediate, and only passes through the 
site when the temperature is raised (Figs. 72, 73, 78, 53). If so, the C-terminal end of 
∆gpαf that contains the BODIPY dye must move through the retrotranslocation site in 
less than 2 min (Fig. 72; right). The real-time spectroscopic characterizations of 
retrotranslocation using various substrates and the mammalian biochemical approach 
described here will provide additional insights into the mechanisms that regulate and 
accomplish retrotranslocation.  
Other membrane components that have been suggested to play a role in facilitating 
the transmembrane movement of an ERAD substrate have also been examined. Derlin-2 
and -3 also had some effect on the initial retrotranslocation rate, but further experiments 
are necessary (perhaps photocrosslinking) to understand the exact nature of their 
involvements. Similarly, αHrd1 had some influence on the initial rate, but it is difficult 
to assess to what extent Hrd1 involved in retrotranslocation because of the intermediate 
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magnitude of the quenching rate. These observations perhaps indicate that Derlin-2, 
Derlin-3, and/or Hdr1 may be involved in either as components of the Derlin-1-
containing retrotranslocation or as an alternative retrotranslocon in mammalian 
microsomes. The high-resolution fluorescence approach also provided some insight into 
how this particular ERAD substrate may leave the vesicles. By labeling either the C- or 
N-terminus, it was revealed that the N-terminus of ∆gpαf-BOF leaves the ER lumen 
first. This finding suggests that the protein is retrotranslocated as a linear polymer and 
that it is binding to PDI may effect this unfolding, and PDI may target the N-terminus of 
∆gpαf-BOF to the membrane. Of course, other ERAD substrates might cross the 
membrane by the C-terminus first, and may be folded during transport. In particular, it 
will be very interesting to determine how glycoproteins with their large glycan moieties 
are able to cross the ER membrane. 
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CHAPTER VII 
SMALL MOLECULES THAT ARE REQUIRED FOR  
THE RETROTRANSLOCATION OF A FLUORESCENCE-LABELED ERAD 
SUBSTRATE* 
Ca2+ ions and their role in ER 
Ca2+ ions have been suggested to play a role in the retention of resident ER proteins, 
in the export of secretory proteins, in protein folding, and in the processing and 
degradation of proteins in addition to the important role in cellular signaling (Sambrook, 
1990). Ca2+ ions also play a role in Golgi protein trafficking and cargo packaging, 
perhaps independently from the ER. In the Golgi, Ca2+ ions are taken up by both SERCA 
and SPCAs (secretory-pathway Ca2+ -ATPases). Mn2+ ions have been also shown to 
influence both O and N-glycosylation in mammalian and yeast cells (Kaufman et al., 
1994).  
An increase in the Ca2+ concentration in the cytosol can be attributed in most cell 
types to release of Ca2+ from the ER. ER serves as a dynamic calcium storage facility, 
since the Ca2+ concentration inside the ER ([Ca2+]ER) is a 1000 fold larger than in the 
cytosol ([Ca2+]c). Changes in the Ca2+ levels inside or outside the organelle can control 
the organelle function, because [Ca2+]ER regulates ER homeostasis by activating the 
                                                 
* Part of the data reported in this chapter is reprinted with permission from “Real-Time 
Fluorescence Detection of ERAD Substrate Retrotranslocation in a Mammalian In Vitro 
System” by Wahlman et al., 2007. Cell, 129 (5). 943-955 . Reprinted in accordance with 
Copyright © Elsevier (2007)  
 
 
 
 190
release or uptake channels. To date, the biophysical properties of the ER membrane are 
not well understood. The rate of Ca2+ uptake is usually controlled by [Ca2+]ER, which can 
range between 0.1 mM and 1mM.  The mechanism by which the SERCA2b pump is 
regulated has been recently hypothesized (Li and Camacho, 2004) to involve the 
oxidoreductase Erp57 and the lumenal chaperone calreticulin. If [Ca2+]ER is too high, it 
provides a driving force for Ca2+ movement out of the lumen. Since the release of Ca2+ 
ions from the ER is rapid and takes place through specific channels, it is likely the ER 
membrane has a low resting resistance or high resting conductance. This would allow 
the ER membrane to stabilize after rapid Ca2+ release. The Ca2+ binding proteins buffer 
the Ca2+ ions in the ER lumen (Meldolesi and Pozzan, 1998). These proteins have low 
affinity, but high capacity for Ca2+ ions. Calsequestrin and calreticulin are able to bind 
up to 50 Ca2+ ions at the same time via their acidic tails (Campbell et al., 1983). Other 
ER resident chaperones, including BiP, PDI, Erp72 or the membrane protein calnexin 
have been suggested to bind Ca2+ ions, although in smaller quantities than calsequestrin 
(Krause and Michalak, 1997; Lamb et al., 2006).  
In this chapter, the involvement of Ca2+ ions in ERAD has been examined by 
reconstituting Ca2+ ions into the ER lumen and/or adding them to the cytosol. This 
approach provides the first direct evidence of the involvement and importance of a 
specific ionic environment in ERAD. 
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Ca2+ ions in the ER lumen increase the rate and extent ∆gpαf retrotranslocation  
Complete RRMs were reconstituted with ∆gpαf-BOF, 2 mM ATP, and 
concentrations of Ca2+ ions between 0.1 mM and 10 mM to examine whether these ions 
have any effect on ∆gpαf retrotranslocation (Fig. 80). The calcium ion concentration in 
 
 
 
Figure 80. ∆gpαf-BOF retrotranslocation rate and extent increase with increasing Ca2+ 
concentration in the ER lumen. Complete RRMs containing ∆gpαf-BOF and 2 mM ATP were 
reconstituted with the following components: no added Ca2+ (black, n=14); 10 mM Ca2+ (cyan, n = 9); 1 
mM Ca2+ inside (green, n = 5); 0.1 mM Ca2+ inside (red, n = 3). Each RRM was then incubated with 
complete cytosol at 30°C. For comparison, complete RRMs incubated in the absence of all cytosolic 
proteins are shown (blue). The longer time-scale graph is shown on the left and the shorter time-scale is on 
the right. 
 
the ER is thought to be 0.1-1 mM [Ca2+]ER  (Fig. 80; red and green), although it has also 
been reported to be 5-10 mM (Meldolesi and Pozzan, 1998). Thus, the range of [Ca2+]ER 
that examined was therefore significantly above (Fig. 80; cyan) and also below (no extra 
Ca2+ included, Fig. 80; black) the physiological [Ca2+]ER limits. Interestingly, the 10 mM 
[Ca2+]ER (Fig. 80; cyan) caused a small, but significant alteration in both the rate and 
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extent of ∆gpαf retrotranslocation from the beginning of the time-trace when compared 
to the control that had no Ca2+ ions added (Fig. 80; black). Differences between 0.1 - 1 
mM  [Ca2+]ER and no [Ca2+]ER were not pronounced in the first 500 seconds (Fig. 80; red 
and green vs. black, right). But by 700 seconds, the RRMs with higher [Ca2+]ER  clearly 
exhibited a higher extent (and hence higher rate) of retrotranslocation. 
Lumenal Mn2+ ions, but not Mg2+ ions, have the same effect as Ca2+ ions in the ER 
To show that the rate increase seen with Ca2+ ions was ion specific and not simply 
ionic-strength dependent change, RRMs were reconstituted with two different divalent 
cations (Mg2+ and Mn2+). Mn2+ ions have a size and charge very similar to Ca2+ ions 
since their size and charge are very similar, but Mg2+ ions are much smaller (Fig. 81).  
 
 
 
Figure 81. The rate and extent ∆gpαf-BOF retrotranslocation are increased by the addition of Mn2+ 
ions to the ER lumen, but not Mg2+ ions. Complete RRMs containing  ∆gpαf-BOF and 2 mM ATP were 
reconstituted with the following components: 1 mM Mg2+ (orange, n = 3); 1 mM Mn2+ (red, n = 3); 1 mM 
Ca2+ (green, n = 3) and no extra ions (blue, n=14). Each RRM was then incubated with complete cytosol at 
30°C. For comparison, complete RRMs incubated in the absence of all cytosolic proteins are shown 
(cyan).  
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When RRMs contained 1 mM Mg2+ ions (Fig. 81; orange), the rate of ∆gpαf 
retrotranslocation did not differ from the observed rate with RRMs that had no divalent 
ions included (Fig. 81; blue). In contrast, 1 mM Mn2+ (Fig. 81; red) inside the ER 
increased the retrotranslocation rate and extent to the same levels observed with 1 mM 
Ca2+ inside (Fig. 81; green). This finding suggests that Ca2+ or divalent metal ions of the 
same size within the ER lumen stimulate retrotranslocation. 
The absence of Ca2+ ions in the ER lumen decrease the rate of retrotranslocation  
Since neither of the RRMs nor the lumen proteins were treated by chelating agents 
before reconstitution, it seemed likely that some endogenous Ca2+ was still present inside 
the RRMs. However, this residual Ca2+ concentration was undoubtedly less than the 
physiological [Ca2+]ER concentration. Yet because the ER lumen is a dynamic Ca2+ 
storage compartment, the ER chaperones and folding enzymes located in the lumen are 
presumably able to adapt to the fluctuation of Ca2+ concentration. Thus it was necessary 
to determine the retrotranslocation rate in the RRMs in the absence of [Ca2+]ER (Fig. 80). 
RRMs were therefore reconstituted with EGTA (Ethylene glycol-bis-(2-aminoethyl)-
N,N,N', N'-tetraacetic acid), a chelating agent that would preferentially bind to the Ca2+ 
ions on both sides of the ER membrane during the encapsulation procedure. EGTA at 5 
mM would therefore bind most of any Ca2+ ions present, and would also chelate Mg2+ 
ions in the sample buffer. However, since the sample buffer contained 10 mM Mg2+ and 
40 mM K+, there would be sufficient Mg2+ unchelated to associate with ATP and allow it 
to function properly. As it is evident in Fig. 82, the initial rate of retrotranslocation with 
RRMs that contained EGTA in the lumen (red) was significantly reduced compared to 
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Figure 82. The lack of Ca2+ ions in the ER lumen decreases retrotranslocation rate. Complete RRMs 
containing  ∆gpαf-BOF and 2 mM ATP were reconstituted with 5 mM EGTA (pH. 7.5) (red, n = 3). Each 
RRM was then incubated with complete cytosol at 30°C. For comparison, complete RRMs incubated in 
the presence (blue) or absence (cyan) of all cytosolic proteins are shown. The longer time-scale graph is 
shown on the left and the shorter time-scale is on the right. 
 
that were not treated with EGTA (blue). The presence of 10 mM Mg2+ (Fig. 80; blue) 
instead of the 5 mM Mg2+ used previously (Fig. 39; red) did not significantly alter 
∆gpαf retrotranslocation. So the observed influence of EGTA on the rate of 
retrotranslocation was probably due to the removal of Ca2+ ions that are somehow 
required to obtain maximal retrotranslocation rates. 
Ca2+ ions in the cytosol decrease the rate and extent of ∆gpαf retrotranslocation  
When [Ca2+]c, the Ca2+ ion concentration in the cytosol, increases dramatically due 
to a disturbed ER homeostasis, cell death is eventually triggered. [Ca2+]c is normally 
1000-fold smaller than [Ca2+]ER and is maintained at this level. For example, following 
metabolic stimulus, the released Ca2+ ions into the cytosol from the ER are returned into 
the lumen via the SERCA2b pump. To determine if [Ca2+]c affects ∆gpαf 
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Figure 83. Ca2+ ions in the cytosol reduce the rate and extent of ∆gpαf retrotranslocation. Complete 
RRMs were reconstituted with ∆gpαf-BOF and 2 mM ATP. Each RRM was then incubated with complete 
cytosol at 30°C in the presence of 1 µM Ca2+ (green, n = 3), 0.1 mM Ca2+ (red, n = 3), or 0.3 mM Ca2+ 
(purple, n = 3). For comparison, complete RRMs incubated in the presence (blue) and absence (cyan) of 
all cytosolic proteins were incubated in the usual buffer containing 5 mM Mg2+. The longer time-scale 
graph is shown on the left and the shorter time-scale is on the right. 
 
 
retrotranslocation, the cytosolic proteins were supplemented with various Ca2+ ion 
concentrations before being added to the RRMs (Fig. 83). When [Ca2+]c was present 1 
µM, there was no significant change in the rate and extent of ∆gpαf retrotranslocation as 
observed with no added Ca2+ (Fig. 83; green vs. blue). Thus, cytosolic Ca2+ at normal 
cytosolic conditions do not affect ERAD. However, elevating the Ca2+ concentration had 
a significant effect. When [Ca2+]c was 100-fold larger than the normal 1 µM 
physiological concentration, the retrotranslocation rate was slowed dramatically (Fig. 83; 
red). When [Ca2+]c was increased further to 300 µM (Fig. 83; purple), the amount of 
∆gpαf transported out of the ER lumen was further reduced when compared to cytosol 
containing physiological [Ca2+]c (Fig. 83; green). The increased [Ca2+]c may place the 
cell under stress conditions such that no further ERAD occurs in the anticipation of 
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imminent apoptosis. Alternatively, perhaps an ER membrane complex involved in 
transporting ERAD substrates through the membrane is inhibited or otherwise altered 
when [Ca2+]c increased. 
∆gpαf retrotranslocation is maximized by removing all Ca2+ from cytosol 
The hemoglobin-free cytosol prepared from rabbit reticulocyte lysate is not likely to 
contain any Ca2+ ions, because the cytosolic proteins are treated briefly with 1 mM 
EDTA to remove any Ni2+ ions after their column separation from hemoglobin (see: 
Chapter II). This EDTA is then dialyzed out of the cytosol, so neither EDTA nor Ca2+ 
ions remain in the cytosolic protein sample. However, to determine unequivocally 
whether a presence of a chelating agent would alter the retrotranslocation rate, EGTA or 
EDTA was added to the cytosol before the initiation of ERAD (Fig. 84). Interestingly, 
the presence of a chelating agent in the cytosol increased the retrotranslocation rate of 
∆gpαf from the lumen (Fig. 84; red and green). Since placing Ca2+ ions on the lumenal 
side increased the retrotranslocation rate, in a manner very similar to placing EGTA on 
the cytosolic side, it is reasonable to ask whether having both lumenal Ca2+ ions and 
cytosolic EGTA in the same sample would act synergistically or independently. When 
0.1 mM Ca2+ was enclosed in the ER lumen, and 3 mM EGTA was added to the cytosol 
(these experiments were done with 10 mM Mg2+ in both compartments), the rate of 
ERAD increased even further (Fig. 84; purple). Although the uncertainty of the data 
points shown in Fig. 84 is too large to permit an accurate quantification of the extents of 
retrotranslocation, the extent of Ca2+in/EGTAout retrotranslocation is approximately the 
sum of the extents observed individually with Ca2+in and with EGTAout. 
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Figure 84. An absence of cytosolic Ca2+ ions the increases the rate and extent of ∆gpαf 
retrotranslocation. Complete RRMs encapsulated  ∆gpαf-BOF and 2 mM ATP. Each RRM was then 
incubated with complete cytosol at 30°C with either 3 mM EDTA (green, n = 4), or with 3 mM EGTA 
(red, n = 4). Some complete RRMs also contained 0.1 mM Ca2+ inside and were incubated with complete 
cytosol at 30°C with 3 mM EGTA (purple, n = 3). For comparison, complete RRMs incubated in the 
presence (blue) or absence (cyan) of all cytosolic proteins are shown without any additional ions on either 
side. The longer time-scale graph is shown on the left and the shorter time-scale is on the right.  
 
Inhibition of SERCA2b alters the rate and extent of ∆gpαf retrotranslocation  
Ca2+ ions are transported into the ER lumen by an ATP-driven pump, SERCA2b. 
This pump and its functional states have been extensively investigated (Inesi et al., 2006; 
Ma et al., 2005). There are several inhibitors that can block the Ca2+ entry into the ER, 
thereby depleting the ER Ca2+ store over time. This Ca2+ depletion can induce a stress 
response, and eventually cell death. The best-known inhibitors are a sesquiterpene 
lactone (thapsigargin) and quinones (DBHQ).  
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Figure 85. Inhibition of SERCA2b alters the rate and extent of ∆gpαf retrotranslocation. Complete 
RRMs encapsulated  ∆gpαf-BOF and 2 mM ATP. Each RRM was preincubated with either 1 µM 
thapsigargin  (red, n = 5), or with 1 µM butyl-hydroquinone (green, n = 3). These RRMs were then 
incubated with complete cytosol at 30°C. For comparison, complete RRMs incubated in the presence 
(black) and absence (blue) of all cytosolic proteins are shown. The longer time-scale graph is shown on the 
left and the shorter time-scale is on the right. 
 
 
When thapsigargin or DBHQ was preincubated with complete RRMs to inhibit the 
SERCA2b channels, the ∆gpαf retrotranslocation rate and extent both decreased (Fig. 
85; red and green). This observation suggests that the SERCA2b pump has an important  
regulatory role in ∆gpαf retrotranslocation by maintaining a high lumenal Ca2+ ion 
concentration. 
Maximal ∆gpαf retrotranslocation requires ATP on both sides of the ER 
membrane   
The ERAD substrates must cross the ER membrane in order to degrade in the 
cytosol.  It is not known how this dislocation process is powered, although a requirement 
for ATP has been observed by many groups (Albring et al., 2004; Kothe et al., 2005; Lee 
et al., 2004; McCracken and Brodsky, 1996; Wahlman et al., 2007). To investigate 
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Figure 86. ATP is necessary on both sides of the ER membrane for ∆gpαf retrotranslocation. 
Complete RRMs were reconstituted with ∆gpαf-BOF and either 2 mM ATP or 30 units/ml apyrase. Each 
RRM with 30 units/ml apyrase inside was then incubated with complete cytosol and either 30 units/ml 
apyrase (purple, n=7) or EGS   (green, n = 5). Each RRM with 2 mM ATP inside was then incubated with 
complete cytosol and either 30 units/ml apyrase (red, n = 5) or EGS (black). For comparison, complete 
RRMs incubated in the absence of all cytosolic proteins, but presence of ATP on both sides are shown 
(cyan). The longer time-scale graph is shown on the left and the shorter time-scale is on the right. 
 
whether ATP is required is solely on the cytosolic or lumenal side of the membrane, 
apyrase was added to either or both of these compartments. When apyrase was located 
only in the ER lumen, the retrotranslocation rate was significantly reduced (Fig. 86; 
green). The rate was reduced a comparable amount when apyrase was in the cytosol 
(Fig. 86; red). This equivalence in reduction of retrotranslocation may indicate that ATP 
is required on both sides of the membrane. However, it is very possible that ATP is 
transported from one side of the membrane to the other during the retrotranslocation 
incubation. 
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The data revealed that ATP requirements more likely originate from the cytosolic 
side (less ERAD is detected) than from the lumenal side, although it is equally probable 
that ATP is required on both sides.  
When apyrase was included on both sides to eliminate any extra ATP, which is 
possibly bound to many of the cytosolic, lumenal and membrane proteins, 
retrotranslocation was completely inhibited (Fig. 86; purple). These findings confirm the 
requirements for ATP during the retrotranslocation of ∆gpαf. 
Discussion 
There is relatively little information about the requirement for specific ions in the ER 
lumen for quality control. The paucity of data can be attributed largely to the lack of 
available techniques that can discriminate between different ions, in the complex 
macromolecular system or can determine the exact ionic concentrations within the 
organelles. But reconstituting RRMs with different ions may reveal the importance of 
various ions or small molecules in the retrotranslocation of ∆gpαf.  
When the Ca2+ ion concentration inside the RRMs was increased, an increase in 
ERAD rate was observed (Fig. 80). This finding revealed that Ca2+ ions are involved 
directly or indirectly on the lumenal side to facilitate retrotranslocation. Indirect 
involvement might be attributable to Ca2+ ion requirement by membrane and soluble ER 
lumenal proteins. The increased Ca2+ concentration may also promote the involvement of 
PDI in ∆gpαf unfolding and targeting (Lucero and Kaminer, 1999). It is also 
conceivable that the negatively charged ∆gpαf binds Ca2+ ions directly, and thereby 
reduce the aggregation prone nature of this ERAD substrate. The presence of Ca2+ ions 
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within the lumen may also regulate the structure or functions of one or more membrane 
proteins, including the retrotranslocation complex.  
When Ca2+ ions in the ER lumen were bound by EGTA, a Ca2+ chelator, a decrease 
in the export rate was observed (Fig. 82). This result could be caused by an effect of 
Ca2+ on the ∆gpαf substrate, on a soluble lumenal protein such as PDI, or on a 
membrane component whose interaction Ca2+ with affects ERAD. 
The Ca2+ effects on retrotranslocation can be duplicated by adding Mn2+instead of 
Ca2+, but are not reproduced by adding extra by Mg2+ (Fig. 81). The observed Ca2+-
dependent effects are therefore divalent metal ion-specific. Since Mn2+ is nearly the 
same size as Ca2+, while Mg2+ is much smaller, Mn2+ and Ca2+ are often exchangeable in 
binding to proteins to elicit structural and/or functional changes (Johnson et al., 1983). 
However, given the large number of Ca2+ ion-binding proteins in the ER, it is impossible 
at this point to identify which proteins are increasing retrotranslocation by binding Ca2+. 
To further explore the role of Ca2+ in retrotranslocation, Ca2+ ions were added to the 
cytosol (Fig. 83). When a physiological number of Ca2+ ions were included in the cytosol 
(50-100 nM), there was not any significant effect on the rate and extent of ∆gpαf 
retrotranslocation (Fig. 82; green). However, when the cytosolic Ca2+ ion concentration 
was increased significantly upon adding much more than physiological concentration, 
∆gpαf ERAD rate was significantly reduced (Fig. 81; red and purple). Clearly high 
[Ca2+]cyto inhibits retrotranslocation. 
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 Interestingly, when excess EGTA was added to the cytosol to remove any Ca2+ ions 
still present, an increase in ERAD rate was observed. It was very curious to see this rate 
increase, because the cytosol was already void of any Ca2+ ions due to a 1 mM EDTA 
treatment after Hb-removal and extensive dialysis. Yet, when both EGTA and EDTA 
were included in the cytosol in the presence of enough Mg2+ concentration to have 
functional ATP present, the decrease in retrotranslocation rate was very obvious (Fig. 
83; red and green). Apparently the gradient of Ca2+ across the membrane is critical in 
determining the rate and extent of retrotranslocation. Further evidence supporting this 
view showed that a combined effect of 1 mM Ca2+ in the ER lumen and excess EGTA 
gave the largest Ca2+ -dependent change in the rate (Fig. 83; purple).  
To investigate the possible involvement of the SERCA2b Ca2+ pump, which is an 
isoform of the SERCA pump family that is present in the ER membrane, several 
inhibitors were used. SERCA2b pump is a P-type ATPase that couples Ca2+ movement 
from the cytosol to the lumen to ATP hydrolysis. SERCA2b contains eleven (ten for 
SERCA2a) transmembrane helices and two large cytosolic loops (Toyoshima and Inesi, 
2004; Toyoshima and Mizutani, 2004; Toyoshima et al., 2003; Toyoshima et al., 2004). 
SERCA2b has been shown to be upregulated by the UPR and hence may have a 
significant role in quality control and ERAD. The extra transmembrane segment (M11) 
is only present in the ER resident SERCA2b, raising the possibility that this segment 
may associate with resident protein of the ER membrane. One of the cytoplasmic loops 
binds ATP and utilizes the energy of one γ-phosphate hydrolysis to move two Ca2+ ions 
through the membrane. In order to accomplish this process, SERCA2a moves through 
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Figure 87.  Putative structural changes of the Ca2+-ATPase (SERCA2a) during its reaction cycle, 
based on the crystal structures in five different states.  (1) Ca2+ binding to E2, which is the ground 
state, straightens the M5 helix and breaks the closed configuration of the three cytoplasmic domains, 
exposing the catalytic site. Two Ca2+ are bound in the high affinity sites formed by transmembrane helices 
M4, M5, M6 and M8. The cytoplasmic gate is open and bound Ca2+ exchange with those in the cytoplasm. 
The M1 helix is deeply embedded in the lipid bilayer, stabilized indirectly by the bound Ca2+. (2) ATP 
binds and crosslinks the P- and N-domains, so that the γ-phosphate of ATP and a Mg2+  binds to the P-
domain to bend it. The N-domain is fixed in a highly inclined position and makes contact with the A-
domain in a strained position. The M1 helix is pulled up and bent so that the top of the transmembrane part 
closes the cytoplasmic gate of the Ca2+ binding sites. (3) Phosphoryl transfer to Asp 351 allows the 
dissociation of ADP, which triggers the opening of the N- and P-domain interface; the A-domain rotates 
so that the TGES loop wedges into the gap and interacts with the phosphorylation site. This causes a 
marked rearrangement of the transmembrane helices M1–M6; large downward movements of M4, sharp 
bending of M5 and rotation of M6 destroy the Ca2+-binding sites. The lower sections of M1 and M2 push 
against M4L, opening the lumenal gate and releasing the bound Ca2+  into the lumen. (4) The TGES loop 
of the A-domain fixes a particular water molecule and catalyses its attack on the aspartylphosphate. The 
release of the phosphate and Mg2+ unbends the P-domain. This in turn releases M1 and M2 so that M4L 
closes the lumenal gate. The top amphipathic part of M1 (M1’) forms a part of a cytoplasmic access funnel 
leading to Glu 309, the gating residue of the Ca2+  binding sites.”  Figure is reprinted and text is cited from 
(Toyoshima et al., 2004) by the permission of Nature publishing group. 
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several conformational states (Fig. 87). The crystal structures of five different 
operational modes of SERCA2a have been determined, and it can be applied to 
SERCA2b. These changes mostly involve the three cytosolic domains (N, P and A), and 
a complicated twist in the membrane spanning helices. These various conformational 
intermediates are largely different from one another. The P-domain, the phosphorylation 
domain has very dissimilar conformations in the Ca2+ bound and unbound states. The N-
domain is the nucleotide-binding domain, while the A-domain is called the actuator 
domain. The N- and A-domains are connected to the rest of the proteins by flexible 
loops, suggesting that these domains are free to move. Among the membrane helices, six 
of them (M1-M6) are re-arranged upon binding to either two Ca2+ ions or two protons 
(H+). 
Thapsigargin, a potent inhibitor of SERCA2b pump, stabilizes this protein in the 
Ca2+-free conformation (Fig. 85; E2). This inhibitor dramatically reduced the rate and 
extent of ∆gpαf retrotranslocation when complete RRMs were pretreated with 
thapsigargin (Fig. 83; red). This finding is consistent with the requirements of a high 
lumenal and a low cytosolic Ca2+ result is faster retrotranslocation rate (Fig. 84; purple). 
Perhaps the Ca2+-free state of the SERCA2b pump is in contact directly or indirectly 
with the putative retrotranslocon and inhibits it. Also, SERCA in the E2 state might be in 
contact with the ERAD machinery, and thereby reduce the rate. SERCA2b was found to 
interact with several ER resident proteins, including Erp57, CRT and CNX. These 
specific proteins might regulate SERCA2b function from the lumenal side (Li and 
Camacho, 2004), since Erp57 and CRT were found to interact with SERCA2b directly 
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and slow down Ca2+ influx when [Ca2+]ER was insufficient. These chaperones dissociate 
from the pump, thereby making it possible for Ca2+ ions to enter the lumen and replenish 
the Ca2+ store. Several other interaction partners have been also reported for SERCA2, 
for example Bcl2, insulin receptor substrate proteins (IRS 1 and 2) (Vangheluwe et al., 
2005).  
The thapsigargin results show that the relative Ca2+ ion concentration in the cytosol 
and ER lumen are somehow coupled to retrotranslocation, which cannot enter back again 
since the pump is inhibited. Does this mean that Ca2+ ions move passively from the 
lumen to the cytosol due to retrotranslocation and SERCA2b must actively pump Ca2+ 
ions into the lumen to maintain the [Ca2+] gradient? If so, thapsigargin would be 
expected to block retrotranslocation. Another Ca2+ pump inhibitor, DBHQ, had an effect 
similar to that of thapsigargin (Fig. 83; green), thereby confirming the importance of 
active Ca2+ pumping into the lumen for retrotranslocation. The details of Ca2+ 
involvement in retrotranslocation are still very obscure. For example, are Ca2+ ions 
important because they bind to the substrate during retrotranslocation? This seems 
unlikely give the spectrum of different polypeptide substrates. More likely, Ca2+ acts to 
stimulate one or more proteins or assemblies involved in retrotranslocation. 
Furthermore, since gradient of [Ca2+] across the ER membrane is required for 
retrotranslocation, the Ca2+-sensitive protein or assembly is almost surely 
transmembranous. It will be very interesting to determine which component(s) requires a 
[Ca2+] gradient and why. 
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The dependence of retrotranslocation on cytosolic or lumenal ATP was also 
investigated (Fig. 84). When apyrase was encapsulated inside the lumenal without any 
ATP, but EGS on the cytosolic side, there was a significant reduction in 
retrotranslocation rate and extent even though ATP was present in the cytosol (Fig. 84; 
green). This decrease was much less than was seen when apyrase was present on the 
cytosolic side, and the RRMs contained 2 mM ATP. This was not surprising, since it 
was shown earlier that the retrotranslocation of ∆gpαf required the 19S RP ATPase on 
the cytosolic side (Lee et al., 2004; Wahlman et al., 2007) (Fig. 84; red).  
The reduction of ∆gpαf retrotranslocation rate was not as large when ATP was 
removed from either the lumen or the cytosol as it was when ATP was removed from 
both sides of the ER membrane  (Fig. 84, purple), perhaps a small amount of ATP is 
transported across the membrane. This observation maybe explained if ATP is 
transported at a low, but significant rate across the membrane in both directions during 
the retrotranslocation assay. In this situation, the [ATP] maybe present in either the 
lumen or cytosol at a concentration that is suboptimal for extraction of this ERAD 
substrate (McCracken and Brodsky, 2005).  
ATP in the cytosol is most likely required by the six 19S AAA proteins (Lee et al., 
2004; Wahlman et al., 2007). Some ERAD substrates also employ the p97 AAA 
protease (Chapter I) that requires ATP for proper function (Bar-Nun, 2005; Lord et al., 
2002; Rabinovich et al., 2002; Ye et al., 2001). The molecule in the lumen that requires 
ATP has not yet been identified for ∆gpαf retrotranslocation since PDI does not bind 
and hydrolyze ATP. Presumably a membrane protein requires ATP during 
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retrotranslocation, but this has not yet been shown. BiP has been shown to be required 
for the retrotranslocation of many ERAD substrates (Hegde et al., 2006; Kabani et al., 
2003; Plemper et al., 1997; Popescu et al., 2005) other than ∆gpαf (Wahlman et al., 
2007), and BiP requires ATP to function. But the steps in the retrotranslocation involve 
ATP have not yet been identified.  
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CHAPTER VIII 
SUMMARY 
 
The results of the experiments described in this dissertation have uncovered several 
important facts about retrotranslocation of an ERAD substrate from the ER lumen into 
the cytosol that would be very interesting to study further. First, the role of glycans 
needs more study. A mutant yeast ERAD substrate, ∆gpαf, is retrotranslocated equally 
well from mammalian and yeast ER. Yet, the wild type protein, 3gpαf, is recognized by 
the mammalian quality control system as a misfolded protein and targeted back to the 
cytosol for degradation, but is not recognized by the yeast ERAD machinery. As a future 
endeavor, it would be interesting to determine whether the wild type and mutant versions 
take alternative routes to exit the ER.  
Another ERAD substrate (A1PiZ), which is a protein with medical significance, has 
been shown to retrotranslocate from the ER (Kruse et al., 2006; Palmer et al., 2003). 
However, the reconstitution of purified A1PiZ into RRMs will not be trivial. This 
protein has no disulfide bonds, but does have three glycosylation sites that complicate 
the purification procedure. One has to choose an overexpression system that promotes 
glycosylation, but does not simultaneously degrade the substrate. It is also important to 
control the configuration of glycans after purification, since these various forms are 
recognized differentially in the ER lumen, and appear to determine the ultimate fate of 
the protein along the secretory pathway (Cabral et al., 2001; Dejgaard et al., 2004). 
CPY* has been shown to be retrotranslocated to different extents when one of its four 
 
 
 209
glycans has been eliminated (Wolf and Schafer, 2005). The position of the specific 
glycan on CPY* also played a major role in recognition of the polypeptide by the quality 
control apparatus (Kostova and Wolf, 2005).  
Second, the importance of cytosolic factors has been established, and they need more 
study. For instance, ∆gpαf was not retrotranslocated in the absence of cytosol and ATP. 
It was later found that the sole cytosolic protein component responsible for maximal 
extraction of ∆gpαf from the ER lumen was the 19 RP. 19S RP is an ATPase, which 
explained the necessity for ATP. Yet, it is possible that ATP is required on the lumenal 
side of the ER during retrotranslocation. It has also been shown that the 
retrotranslocation of many ERAD substrates requires AAA protease, p97 with or without 
its two cofactors (Npl4 and Ufd1) (Ye et al., 2001). Such studies are usually based on 
immunoprecipitation assays, and they revealed the association of 19S RP with ER 
membrane (Carvalho et al., 2006), but did not explain the nature of this binding. As one 
of the future goals, the role of 19S RP at the ER membrane can be examined to 
determine whether 19RP binds to one specific membrane protein in the ER membrane, 
as it has been proposed (Kalies et al., 2005; Ng et al., 2007), to multiple components, 
and/or to the membrane lipids. It is also highly likely that the 19S RP is post-
translationally modified and regulated at the ER membrane (data not shown). 
 Third, the role of the oxidizing atmosphere in the ER lumen deserves more study 
since the maximal ∆gpαf retrotranslocation required oxidized PDI in the ER lumen. PDI 
has been shown to act as a chaperone without facilitating the formation of disulfide bond 
formation in the ER (Cai et al., 1994; Koivunen et al., 1999; Lumb and Bulleid, 2002; 
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Luz and Lennarz, 1996; Noiva, 1999; Puig and Gilbert, 1994; Sun et al., 2000; Tian et 
al., 2004; Tsai et al., 2001; Wang and Chang, 2003; Wilson et al., 1998). Perhaps PDI is 
a normal part of the lumenal retrotranslocation machinery and works universally on all 
ERAD substrates. Examining the role of PDI in the retrotranslocation of other substrates 
is another area of the future research. 
Fourth, the roles of Derlin-1 and other potential retrotranslocon components need to 
be identified. Derlin-1 was identified in yeast (Hitt and Wolf, 2004; Knop et al., 1996), 
and later was suggested to be the part of the retrotranslocation channel in the mammalian 
ER (Lilley and Ploegh, 2004; Ye et al., 2004). In this dissertation, the involvement of 
Derlin-1 in ∆gpαf retrotranslocation was established, although one cannot conclude 
from our data that this protein actually forms the channel. Identification of the protein 
that forms the pore in the retrotranslocon will require a combination of fluorescence and 
crosslinking experiments to determine both the environment (aqueous or nonaqueous) 
and interactions (crosslinks to the substrate or not) of various residues in Derlin-1. One 
can also purify and reconstitute Derlin-1 into liposomes that encapsulate fluorophores of 
different sizes (e.g., (Heuck et al., 2003) to determine if Derlin-1 can , by itself, form  
pores. But it is more the likely that the retrotranslocon has multiple membrane 
components (e.g. Derlin-2, Derlin-3 and/or Hrd1), and that there is more than one exit 
route from the ER (Mancini et al., 2003).  
An alternative approach for identifying the pore-forming protein(s) is to trap an 
ERAD substrate during retrotranslocation by fusing it to DHFR. The binding of 
methotrexate (MTX) to DHFR stabilizes the formation of its globular domain and hence 
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blocks its passage through the membrane (Eilers et al., 1988; Schatz, 1996). Thus, an 
ERAD substrate and the MTX-bound DHFR domain will be halted during 
retrotranslocation unless the pore is huge. This chimeric ERAD substrate can therefore 
be reconstituted into RRMs with photocrosslinking probes positioned at known sites in 
the ∆gpαf sequence. When such a sample is illuminated with light at the end of the 
retrotranslocation incubation, the substrate will preferentially photocrosslink to the 
protein that is forming the retrotranslocon pore. 
Another important and interesting finding of this study that warrants further 
investigation is the dependence of retrotranslocation on Ca2+. The data discussed in 
Chapter VII raised the possibility that the SERCA2b pump might contribute to 
retrotranslocation in a very interesting way. Perhaps this protein also interacts with other 
lumenal, membrane and cytosolic components (Arnaudeau et al., 2002; Hojmann Larsen 
et al., 2001; Li and Camacho, 2004; Roderick et al., 2000; Stefanovic et al., 2004) that 
play a role in ERAD. Ca2+ ions and proper homeostasis are very important for the proper 
functioning of ER chaperones, which might get disrupted by Ca2+ depletion. But at 
present, the role(s) of Ca2+ ions in retrotranslocation is (are) almost completely unknown. 
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